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Abstract 
 
This thesis investigates the application of physiological measures made using 
magnetic resonance imaging (MRI) to study cerebral haemodynamics and 
pharmacological modulation of brain activity.  In particular, this thesis has an 
emphasis on the technical developments of Arterial Spin Labelling (ASL), and 
their applications in neuroimaging. 
 
Blood Oxygen Level Dependent (BOLD) fMRI methods, together with ASL, 
were applied to a pharmacological study of the effect of beta-blockers on the 
brain’s response to emotional visual stimuli, ASL being performed for 
improved quantitative understanding.  The study aimed to test the James-
Lange theory, which states that emotions result from the perception of bodily 
arousal.  Autonomic nervous system responses to emotional stimuli can be 
predicted by the level of activity in the limbic system (including amygdala, 
brainstem and salience network), and previous studies have demonstrated 
reduced amygdala response to emotional memory encoding and retrieval 
under the influence of centrally acting beta-blockade.  However, this 
modulation may be a direct central effect.  To disentangle these possible 
confounds, this thesis assesses the action of the peripherally acting beta-
blocker, nadolol, on the fMRI response to neutral, pleasant and unpleasant 
visual stimuli, and during rest; the hypothesis being that nadolol suppresses 
the neuronal response to emotional stimuli in comparison to neutral stimuli.  
BOLD and ASL contrasts were exploited for the application of 
pharmacological functional MRI at 3 T.  80 mg nadolol and placebo tablets 
were administered to twenty healthy subjects in a double blinded, randomised, 
placebo controlled crossover design.  In addition, resting state perfusion was 
assessed for drug induced changes, and resting state BOLD for beta-blocker 
modulation of resting state functional connectivity.  Drug induced reduction in 
insula response to emotional stimuli supports results from previously 
published studies, and the James-Lange theory.  The preliminary finding of 
drug induced increase in amygdala response is contradictory. 
 
i
ASL methods were applied to the techniques of Territorial ASL (TASL) and 
multi-phase ASL for advanced investigation of the vascular territories, and 
quantitative perfusion and blood transit times.  Territorial ASL and multi-
phase ASL were first implemented and optimised for use at 3 T during the 
course of a pilot study.  Further, TASL and multi-phase ASL were used in 
combination for the assessment of the location and haemodynamic properties 
of the cerebral watershed regions.  Watershed region masks formed from the 
combined assessment of TASL and multi-phase ASL exhibited reduced 
perfusion and lengthened transit times compared to other cortical regions.  
Each technique in isolation provided approximate location of watershed 
regions, while the accuracy of the two techniques was shown to be enhanced 
by their combined use.  Furthermore, territorial ASL is developed and 
implemented at 7 T.  Alternative labelling schemes were compared and 
parameters optimised for control condition efficiency, and TASL assessment 
was performed in three healthy volunteers.  The benefits of this preliminary 
study at ultra-high magnetic field strength were discussed, along with the 
challenges still to be overcome. 
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1 Introduction 
 
People have always yearned to understand the processes that happen inside the 
body and, until the last century, the only way to do that was by dissection.  
The discovery of x-rays led to advances in medical imaging but it was later 
found that substantial exposure to x-rays was harmful.  Early medical imaging 
used techniques derived from the introduction of an ionising radiation emitting 
contrast agent [1].  Contemporary medical imaging methods include positron 
emission tomography (PET), computed tomography of x-rays (CT) and single-
photon emission computed tomography (SPECT), which still depend on 
ionising radiation, thus care must be taken with long term exposure.  The 
technique of nuclear magnetic resonance (NMR) was first developed for 
observing nuclei in a thin gaseous state in 1938 [2] and further modified for 
the study of nuclei in other materials in 1946 [3].  Magnetic Resonance 
Imaging (MRI) is non-invasive and has not been shown to cause any long term 
side effects, and thus is deemed safe. 
 
Early advances in magnetic resonance imaging (MRI), demonstrated that it 
was possible to acquire an image of a slice through the body non-invasively, 
marking the advent of high speed imaging [4].  Today, MRI provides a non-
invasive way of obtaining information about the internal structure of the body, 
allowing the identification of pathological tissue boundaries.  Functional 
neuroimaging is an advancing field that allows us to study processes such as 
blood flow and neuronal activation using inferences about measurable 
parameters to quantify changes over time.  It is now possible to observe 
patterns of regional changes in deoxygenated haemoglobin and cerebral 
perfusion that are associated with neuronal activity.  This is used to determine 
which areas of the brain are activated by the external application of a stimulus 
or by performing a task.  Blood flow in the brain can be measured 
quantitatively using endogenous contrast arterial spin labelling (ASL), which 
applies an inversion pulse to label inflowing blood to the brain, and images the 
blood as it is perfused into the tissue.  Further, it is possible to observe 
modulations in patterns measured using blood oxygen level dependent contrast 
(BOLD) or ASL that are caused by pharmacological intervention or disease.  
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Many studies reported in the literature use MRI to study drug modulation of 
resting state BOLD or perfusion measurements or the neuronal response to a 
stimulus [5].  Magnetic resonance imaging now has broad applications in, for 
example, psychology, psychiatry, pharmacology and medicine. 
 
MRI is commonly used for the investigation of complex brain function; one 
relevant example is to observe the processing of emotional stimuli.  Further, 
MRI can be used to study the pharmacological modulation of such a neuronal 
process, thus allowing the testing of theories such as the James-Lange [6] and 
two factor [7] theories of emotion, as reported later in this thesis. 
 
1.1 The scope of this thesis 
 
The work presented in this thesis took place at the University of Nottingham 
between September 2008 and November 2011.  During my time at the 
University of Nottingham, I have been affiliated with both the division of 
Radiological and Imaging Sciences (formerly the division of Academic 
Radiology), School of Clinical Sciences and the Sir Peter Mansfield Magnetic 
Resonance Centre (SPMMRC), School of Physics and Astronomy.  The initial 
remit of the PhD funding was to study the pharmacological modulation of 
brain function and functional connectivity using advanced neuroimaging 
techniques, including functional magnetic resonance imaging (fMRI).  During 
the course of my study, I have performed experiments on healthy adult 
volunteers using the non-invasive MRI methods of BOLD and ASL to gain 
information on resting perfusion and both resting and task-induced neuronal 
activity within the healthy human brain. 
 
Chapter 2 of this thesis introduces the concepts in physics required to 
understand nuclear magnetic resonance and magnetic resonance imaging.  
Further, current state of the art technology is explained, including the source 
of image contrasts. 
 
Chapter 3 introduces the relevant principles of neurophysiology and how these 
properties of the human brain can give additional sources of contrast, such as 
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blood oxygen level dependent (BOLD) contrast and arterial spin labelling 
(ASL).  The techniques outlined in this chapter provide insight into processes 
occurring in the brain, such as cerebral perfusion, neuronal activity or 
functional connectivity between spatially disparate brain regions.  Further, this 
chapter will explain the interpretation of images acquired using such 
techniques and outline the applications of these techniques. 
 
Chapter 4 presents the methods and results from a study investigating the 
effect of the peripherally acting beta blocker, nadolol, on both the activity 
associated with an emotional visual stimulus task, and the functional 
connectivity during resting state.  Study design, recruitment, data acquisition, 
processing, analysis, results and their interpretation are described in this 
chapter.  The aims of this chapter are: 
 To determine whether nadolol modulates activity in brain regions 
within the salience network during the presentation of emotional visual 
stimuli; 
 To determine whether any drug induced differences in activity are 
specific to the valence of the stimulus (pleasant or unpleasant); 
 To determine whether BOLD changes are associated with perfusion 
changes as measured using ASL; 
 To determine whether nadolol modulates activity in regions not 
implicated in the salience network or the processing of emotional 
stimuli, indicative of a confound by direct central action of a beta-
blocker; 
 To determine whether there are changes in resting perfusion or resting 
functional connectivity in response to nadolol, which could explain the 
differences in response to stimuli, if found. 
 
In Chapter 5, a study using Territorial Arterial Spin Labelling and multi-phase 
Arterial Spin Labelling at 3 T in healthy volunteers is described.  The vascular 
territories associated with the major cerebral blood vessels are mapped and 
blood transit times and perfusion rates are considered.  The methods of data 
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acquisition, processing, analysis and interpretation are described.  Here, the 
experimental aims are: 
 To acquire selective maps of the vascular territories of the internal 
carotid arteries and basilar artery and to define the vascular territory 
boundary of the anterior cerebral arteries; 
 To compare the locations and boundaries of the watershed regions at a 
group level using the three different methods of territorial ASL, and 
arterial and tissue transit time maps; 
 To assess transit time variance across a range of cortical areas, 
providing useful information for planning future ASL studies and for 
functional MRI studies using perfusion weighted contrast. 
 
The development of territorial arterial spin labelling for use at ultra-high field 
(7 T) is described in Chapter 6.  This involved optimising the techniques for 
use at 7 T.  The advantages and challenges of applying such a technique at 
ultra-high field are discussed.  The processes used in optimisation are 
described, along with results in healthy volunteers.  The aim of this chapter is: 
 To develop a technique for performing TASL at 7 T, and further to 
optimise this technique for assessment of vascular territories in healthy 
adults. 
 
Chapter 7 provides a general discussion of the results obtained in this thesis, 
strengths and weaknesses of experimental design and implementation and 
concludes with a discussion of the impact of this work, and possibilities for 
future research in these areas. 
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2 NMR theory and Magnetic Resonance Imaging (MRI) 
 
This chapter provides an overview of the nuclear magnetic resonance (NMR) 
theory and magnetic resonance imaging (MRI) techniques necessary to 
understand and reproduce the work presented in this thesis.  The chapter 
begins with an explanation of the physics of nuclear magnetic resonance, 
which is followed by the specific physics of magnetic resonance imaging.  
Finally, this chapter will outline the different applications of magnetic 
resonance imaging used in this thesis, describing how images of different 
contrast are formed and interpreted. 
 
2.1 The NMR signal 
 
Nuclear magnetic resonance (NMR) refers to the behaviour of a nucleus or 
nuclei in the presence of a magnetic field.  Principally, nuclei will absorb and 
re-emit energy in the form of electromagnetic (EM) radiation with specific 
properties.  This phenomenon was first described by Isidor Rabi in 1938 in the 
paper titled “A New Method of Measuring Nuclear Magnetic Moment” [1].  
Rabi was awarded the Nobel Prize in Physics in 1944 for results obtained in an 
experiment using an adaptation of Stern’s molecular beam method to observe 
the magnetic properties of atomic nuclei in a thin gaseous state.  A similar 
technique was developed by Bloch and Purcell in 1946 [2], which allowed the 
study of matter in other states without causing any disturbance to the 
composition of the sample, thus opening the technique up to much broader 
applications.  Bloch and Purcell were jointly awarded the Nobel Prize in 1952 
for their work. 
 
2.1.1 The concept of spin 
 
It is not just protons that are MR sensitive, but many nuclei with odd-
numbered atomic mass, such as 
13
C [3].  Currently, the vast majority of 
magnetic resonance imaging of the human body is acquired using hydrogen 
nucleus (proton) excitations.  This is because the hydrogen nucleus is highly 
abundant in the human body (being present in every water molecule).  It is 
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now possible to achieve nuclear magnetic resonance using a wide range of 
nuclei, including much heavier nuclei such as xenon, krypton and fluorine; 
however discussion of these experiments is not within the capacity of this 
thesis. 
 
In quantum mechanics, an elementary particle is conventionally described in 
terms of the fundamental properties of charge, mass, spin (also known as 
intrinsic angular momentum) and spin quantum number.  The simplest nucleus 
is that of a hydrogen atom; a single proton with charge (Q) 1.6×10
−19
 
Coulombs, mass (m) 1.7×10
−27
 kg and spin (I) ½.  The intrinsic spin quantum 
number is represented by I, where the magnitude of I is described by Eqn. 
[2.1].  A nucleus can also have orbital angular momentum, J.  J and I are 
related thus; where ħ is h (Planck’s constant) divided by 2π, as described in 
Eqn. [2.2].  I can take integral and half integral values as follows; for example 
hydrogen (
1
H), I = ½, carbon-13 (
13
C), I = ½, oxygen-17 (
17
O), I = 
5
/2. 
 
          Eqn. [2.1] 
  
             Eqn. [2.2] 
 
When a magnetic field is applied, a particular spin quantum number, I, can 
take different spin states, mI. I can take the discrete values –I, (-I+1), ... , (I-1), 
I.  There are (2I + 1) spin eigenstates (energy levels), each corresponding to a 
particular direction of spin [4]. 
 
The z component of the orbital angular momentum, Jz is a measurable quantity 
that represents the projection of the orbital angular momentum onto the axis of 
the intrinsic angular momentum.  Jz is related to the spin quantum number, mI 
as shown in Eqn. [2.3].  Therefore, for the proton of mI = ±½, Jz = ± ½ħ, as 
demonstrated in Figure 2.1. 
 
       Eqn. [2.3] 
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 Figure 2.1: Orientation of the intrinsic angular momentum vector. 
 
2.1.2 The magnetic dipole moment 
 
A moving charge will generate a magnetic field.  As the hydrogen nucleus, or 
proton, has a charge, and is rotating, it will generate a nuclear magnetic dipole 
moment, μ. μ is proportional to the proton’s orbital angular momentum, J, 
where μ and J are vectors: 
 
     Eqn. [2.4] 
 
where γ refers to the gyromagnetic ratio, or magnetogyric ratio, of units rad s-1 
T
-1
 or MHzT
-1
.  For a charge, q, of mass, m, in classical mechanics the 
gyromagnetic ratio is calculated as follows: 
 
  
 
  
 Eqn. [2.5] 
 
In quantum mechanics, this is multiplied by the g factor, a dimensionless 
quantity that characterises the properties of that particular nucleus.  For a 
proton, the g factor takes a value of approximately 5.585.  Table 2.1 gives 
some example values of the gyromagnetic ratio for different nuclei [5]. 
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Nucleus Intrinsic Spin, I γ (MHzT-1) 
1
H ½ 42.58 
13
C ½ 10.71 
17
O 
5
/2 5.77 
19
F ½ 40.08 
31
P ½ 17.25 
Table 2.1: Intrinsic spin quantum numbers and gyromagnetic ratio for nuclei [5]. 
 
In the presence of a static magnetic field (B0), the magnetic moments will all 
align parallel or antiparallel to B0.  Therefore, the z-component of the orbital 
angular momentum of a proton in a B0 field can take one of two values: 
 
    
 
 
 Eqn. [2.6] 
 
In classical theory, this nucleus placed in a magnetic field, B0, will have an 
energy represented by: 
 
        Eqn. [2.7] 
 
Combining with Eqn. [2.2] and Eqn. [2.3] gives: 
 
                 Eqn. [2.8] 
 
There are two possible energy values corresponding to the two possible values 
of mI (±½ for a proton); the nucleus can align parallel (taking the lower energy 
state) or antiparallel (higher energy state) with B0.  This splitting into multiple 
discrete energy states in the presence of a magnetic field is known as Zeeman 
splitting, with the two different energy levels for a proton taking the values 
E1,2 = ±½γħB0, and the difference between energy states being described by 
Eqn. [2.9] (see Figure 2.2 illustrating Zeeman splitting).  NMR is concerned 
with inducing changes in the quantum state of a system by applying 
electromagnetic radiation.  For transitions between the two states, we can use 
Planck’s law that is equated to the energy, ΔE, to determine the frequency of 
the applied electromagnetic radiation: 
9
           Eqn. [2.9] 
 
where ν is the frequency of the electromagnetic radiation needed to move the 
proton from one spin state to another. 
 
 
Figure 2.2: Illustration of Zeeman splitting caused by the presence of a static magnetic 
field along the Bz axis. 
 
2.1.3 Precession of spins 
 
Quantum theory dictates that the magnetic moments of the protons do not 
exactly align to the direction of the combined magnetic field, B, but that they 
precess about B at a frequency, ω (see Figure 2.3 illustrating precession).   
 
 
Figure 2.3: Precession of the magnetic moment vector about the axis of the static 
magnetic field, Bz. 
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A proton experiences a torque, τ, when placed in a magnetic field, equal to the 
rate of change of its orbital angular momentum (J) with respect to time.  In 
addition, the torque can also be expressed in terms of a vector product of the 
magnetic moment, μ, and the magnetic field, B.  These relationships are 
represented in Eqn. [2.10]. 
 
  
  
  
     Eqn. [2.10] 
 
Substituting Eqn. [2.4] for μ into Eqn. [2.10] and rearranging gives a form of 
the Bloch equation, which describes how a magnetic moment behaves under 
the influence of a magnetic field.  It holds true under the assumption that any 
changes in the orientation of the magnetic moment vector are caused by its 
interaction with an external magnetic field [5]: 
 
  
  
      Eqn. [2.11] 
 
2.1.4 Boltzmann Statistics 
 
So far, this thesis has only described the behaviour of a single proton.  
However, it is more common to deal with the protons found in matter, for 
which the number of protons is of the order of Avogadro’s number; 6.02×1023.  
In quantum mechanics it is possible to explain the behaviour associated with 
NMR.  This is acceptable for a single nucleus but becomes complicated when 
dealing with matter that contains several nuclei, each undergoing interactions 
with the magnetic field and with each other.  Therefore it is usually 
appropriate to refer to a classical description of bulk magnetisation. 
 
Boltzmann statistics can be used to predict the behaviour of many protons.  By 
applying Boltzmann’s methods to a system with a temperature above absolute 
zero, one can consider the net magnetisation as the sum of the magnetic 
moments in the sample.  This is shown in Eqn. [2.12], where N↑ is the number 
of protons in the lower energy state with magnetic moment parallel to B0 and 
N↓ is the number of protons in the higher energy state with magnetic moments 
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antiparallel to B0.  This ratio is dependent on the temperature of the sample, T, 
and Boltzmann’s constant kB: 
 
  
  
  
  
     
 
    
    Eqn. [2.12] 
 
The expression can be expanded using a power series which, if γħB0 << kBT 
approximates to give Eqn. [2.13]. 
 
  
  
   
    
   
 Eqn. [2.13] 
 
Further, the number of spins in the sample that result in NMR signal is 
determined by the fractional difference between the populations of the two 
states, as given in Eqn. [2.14], which is linearly dependent on the strength of 
the magnetic field, B0.  At a typical imaging field strength of 3 T, this fraction 
is approximately 3×10
-6
 (3 parts per million). 
 
     
  
 
    
   
 Eqn. [2.14] 
 
At room temperature, the population difference between the two states is 
small, so the ratio given in Eqn. [2.14] will be small.  However, the ratio is 
also dependent on ΔE, the energy difference between the two states.  From 
Eqn. [2.9] it is clear that ΔE is proportional to B0, the magnetic field strength – 
thus greater sensitivity is achieved at higher field strengths. 
 
2.1.5 Bulk Magnetisation 
 
To describe the effect of large numbers of protons in magnetic fields, we deal 
with a quantity known as the bulk magnetisation, M, which is the vector sum 
of all the magnetic moments of the constituent protons: 
 
      Eqn. [2.15] 
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Hence the Bloch equation can be modified to give the form of bulk 
magnetisation.  The rate of change of bulk magnetisation can be described 
thus: 
 
   
  
        Eqn. [2.16] 
 
This states that the rate of precession increases linearly with the magnetic field 
strength, and also that the bulk magnetisation increases with magnetic field 
strength.  Using Eqn. [2.4], and the concept of bulk magnetisation, the 
following equation can be deduced: 
 
     Eqn. [2.17] 
 
Substituting the above equation into the Bloch equation for bulk magnetisation 
gives: 
           
   
  
      Eqn. [2.18] 
 
2.1.6 Excitation 
 
The energy level of protons in the sample can be manipulated by introducing a 
specific amount of energy in the form of electromagnetic radiation that 
matches the Zeeman splitting energy, ΔE.  This is achieved by applying a 
pulse of an additional magnetic field of lower amplitude than B0; this 
additional field is a non-static magnetic field that oscillates at the same 
precession frequency, in phase with the rotation of the nuclei within the 
sample.  This oscillating magnetic field is referred to as a B1-field and can be 
described as a pulse of amplitude B1 = |B1| with its time dependence given in 
Eqn. [2.19]. 
 
    
       
       
 
  Eqn. [2.19] 
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As the frequency of this B1-field (designed to be similar to the frequency of 
precession) is in the radiofrequency range, it is often described as a 
radiofrequency (RF) field and RF pulse.  The amount of energy required to 
move protons from one energy state to another is proportional to the magnetic 
field strength, B0, as demonstrated in Eqn. [2.9], therefore while higher field 
strength provides greater sensitivity, it also causes an increase in the amount 
of energy required to excite protons from the lower to the higher state. 
 
We can describe the frequency of the RF pulses needed to be absorbed from or 
emitted by a proton to make a transition from one energy state to another (see 
Eqn. [2.9]). 
 
  
  
 
    Eqn. [2.20] 
 
The specific frequency that allows transitions is described as the resonant 
frequency of the system, hence the use of the term magnetic resonance, and is 
also referred to as the Larmor frequency, ωL. 
 
The application of the B1 field causes the magnetic moments to precess at 
angular frequency, ω, at an angle, θ, about the B vector.  The total angular 
displacement effect of the magnetisation is dependent on the amplitude and 
duration of the applied B1 pulse.   
 
It is conventional to describe the effect of an applied B1-field using a rotating 
frame of reference as opposed to the laboratory frame (x, y, z).  In the 
laboratory frame, the spin precesses, whereas in the rotating frame (x’, y’, z), 
the spin and the B1 vector become stationary, with B1 pointing along the x’ 
axis.  The bulk magnetisation vector, M0, now appears to rotate about the B1 
vector, as shown in Figure 2.4 (A).  The rotating frame of reference thus vastly 
simplifies the mathematics required to understand the process of excitation.  
This is pictured in Figure 2.4 (B).   
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 Figure 2.4: The motion of the bulk magnetisation vector, M0, when influenced by a 
radiofrequency (B1) pulse.  The two diagrams represent the same motion in (A) the 
laboratory frame and (B) the rotating frame. 
 
The angle by which the magnetic moment vector is displaced in the rotating 
frame of reference is now given by Eqn. [2.21]. 
 
           
 
 
 Eqn. [2.21] 
 
where the additional pulse of B1 is applied for a given duration, T. 
 
RF pulses are conventionally referred to by the angle through which they tip 
the bulk magnetisation, the “flip angle”.  For example, a pulse with a 90° flip 
angle refers to a B1 pulse that displaces the bulk magnetisation by 90°.  As 
shown in the Eqn. [2.21], this angle can be manipulated simply by controlling 
either the amplitude or the duration of the B1 pulse. Sinc pulses are often used 
for this purpose as the Fourier transform of a sinc pulse gives a sharp profile. 
 
2.1.7 Relaxation 
 
Following the application of a B1 RF pulse, the magnetisation vector, M0, is 
displaced; the magnetisation precesses about the magnetic field vector and is 
in a non-equilibrium state.  The perturbation will then decay as the spins relax 
back into their lower energy, or equilibrium state.  The magnetisation at 
equilibrium (M0) has a given z value (as described previously by Boltzmann 
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statistics) with random phase.  The behaviour of relaxation is described 
mathematically by the Bloch equations and is called free induction decay 
(FID).  This behaviour can be easier to visualise when separated into the two 
components in the rotating frame of reference; a longitudinal component, 
describing relaxation along the z axis, and a transverse component, describing 
relaxation in the xy-plane [6].  Relaxation curves are time (t) dependent and 
conventionally start from time, t = 0 s referring to the moment that the RF 
pulse ceases to be applied.  The decay of the longitudinal magnetisation is due 
to interactions between the magnetic dipole moment and the thermal motion of 
nuclei within the lattice structure of the sample material (spin-lattice 
interactions), and is described by the longitudinal relaxation time constant, T1.  
The transverse magnetisation decay is largely due to the magnetic dipole 
moments interacting with other magnetic dipole moments (spin-spin 
interactions), and the mathematics of this is dependent on the transverse 
relaxation time constant, T2 or T2* (see Section 2.1.7.2).  T1 and T2 / T2* 
relaxation processes are mutually independent.  The Bloch equation given 
above for the time dependent change of bulk magnetisation can now be 
augmented with these time constants to give an equation representative of the 
FID (below).  Figure 2.5 gives a graphical representation of these two types of 
exponential decay phenomena using values T1 = 600 ms, T2 = 100 ms and off-
resonance frequency, Δω = 10 Hz. 
 
  
  
       
      
      
          
  Eqn. [2.22] 
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 Figure 2.5: Simulation of free precession (relaxation) of magnetisation following 
excitation [7]. 
 
As suggested earlier in this chapter, relaxation causes the emission of 
electromagnetic radiation, Eqn. [2.9].  This induces a voltage in a 
radiofrequency coil through the principle of Faraday induction.  In the case of 
the 90° pulse described earlier, the magnetisation is tipped into the transverse 
plane and a signal that oscillates at the Larmor frequency is emitted [8]. 
 
Relaxation is represented by an exponential function using the relaxation times 
T1 and T2 [5].  By looking at the rate of change of magnetisation with respect 
to time, we can derive a set of differential equations that describe the rate of 
change of the magnetisation vector over time.  These are known as the Bloch 
equations [5], and are given below as three inter-dependent equations 
modelling the magnetisation in each Cartesian direction: 
 
      
  
                          
  
  
 
      
  
                          
  
  
 
      
  
                          
          
  
 
Eqn. [2.23] 
 
Terms can be added to the equations above, for example to account for the 
resonance offset and for the effects of flow, as outlined in Chapter 3. 
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 The three dimensional vector for the magnetisation can then be rewritten in 
terms of components of transverse magnetisation, Mxy, and longitudinal 
magnetisation, Mz, as demonstrated in Eqn. [2.24]. 
 
   
      
  
   
  
             
  
   
Eqn. [2.24] 
 
2.1.7.1 Longitudinal relaxation (T1) 
 
Longitudinal relaxation (i.e. the decay of the z component of the bulk 
magnetisation to return it to the equilibrium state after the application of a 
radiofrequency pulse in the rotating frame of reference), can be described by 
the following Bloch equation: 
 
   
  
 
    
  
 Eqn. [2.25] 
 
Two common imaging sequences that utilise T1 contrast are saturation 
recovery and inversion recovery.  A saturation recovery sequence uses a 90° 
pulse to tip the bulk magnetisation entirely into the transverse plane so that the 
z component of the magnetisation in the rotating frame of reference is 
saturated (nulled) and allowed to recover. 
 
Inversion recovery inverts the bulk magnetisation so that the magnetic 
moments are antiparallel to their equilibrium position.  Solving Eqn. [2.25] 
gives the following expression for the relaxation of the longitudinal relaxation 
following an inversion pulse, as shown in Figure 2.6. 
 
             
       Eqn. [2.26] 
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 Figure 2.6: Relaxation curve of the longitudinal magnetisation following an inversion 
pulse, described by Eqn. [2.26]. 
 
T1, the time constant of longitudinal relaxation varies as an intrinsic property 
of the material being imaged, depending on the interaction of the proton 
magnetic moments with the lattice of the material.  For example it takes a 
value of approximately 1.6s in grey matter at 3T [9].  T1 weighted contrast 
uses a short TE and short to intermediate TR.  In these images, voxels with 
short T1 relaxation times (e.g. white matter) are bright, and voxels with long 
T1 relaxation times are dark (e.g. cerebrospinal fluid, CSF).  This can be 
enhanced by using an inversion recovery sequence.  To enhance image 
contrast even further, an exogenous paramagnetic ion, such as gadolinium, can 
be introduced into the imaging region.  This significantly shortens the 
longitudinal relaxation time of any tissue that absorbs it and so is often used 
for clinical diagnostic imaging. 
 
2.1.7.2 Transverse relaxation (T2, T2*) 
 
T2 is the time constant of the decay of transverse magnetisation, and represents 
the decay of the proton magnetic dipoles that is caused by their interactions 
with each other (also known as dipole-dipole interactions).  Like T1, its 
relaxation curve is also derived by solving the Bloch equations for transverse 
magnetisation (Eqn. [2.27]), with the relaxation curve following a 90° pulse 
shown in Figure 2.7. 
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      Eqn. [2.27] 
 
 
Figure 2.7: Relaxation curve of the transverse magnetisation, given in Eqn. [2.27]. 
 
However, spins are greatly affected by inhomogeneities in the external 
magnetic field which serve to further dephase the motion of the magnetic 
moments in the transverse plane, increasing the rate of decay.  T2*, or 
effective T2, is a time constant that accounts for the effects of these 
inhomogeneities, and is always less than T2 itself.  The relationship between 
T2* and T2 is described in Eqn. [2.28], where T2´ is the correction that needs to 
be made to T2 due to the dephasing effect caused by the external magnetic 
field inhomogeneities [6]. 
 
 
   
 
 
  
 
 
   
 Eqn. [2.28] 
 
Both T2 and T2* image contrast require sequences with a long repetition time 
(TR > T1) and intermediate to long echo time.  T2-weighted images are 
typically acquired using a spin echo sequence, whereas T2*-weighted images 
are collected using a gradient echo sequence.  In a T2* weighted image, voxels 
with short T2* relaxation times (e.g. those that contain iron) are dark and 
voxels with long T2* relaxation times (e.g. cerebrospinal fluid) are bright.  T2* 
decreases with field strength, and this reduces the amount of time available in 
which to acquire a signal.  T2 weighted imaging is frequently used as a 
diagnostic method in brain MRI studies due to its high sensitivity to cerebral 
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pathology, such as tumours or arteriovenous malformations.  Conversely, T2* 
weighted contrast is commonly used in functional MRI due to its sensitivity to 
blood oxygen level dependent (BOLD) contrast, which is associated with 
observing the haemodynamic response of brain tissue to neuronal activity, as 
described in Chapter 3. 
 
2.1.8 Spin Echo 
 
Magnetic dipole moments will naturally decay with random phase.  In order to 
ensure that the magnetic dipole moments decay coherently, they must first be 
refocused, using an additional gradient or radiofrequency pulse after the 
excitation.  The process of bringing the magnetic dipole moments back into 
phase is known as an echo.  One form of an echo is the spin echo, whereby the 
excitation pulse is followed by a 180° refocusing pulse.  This was first 
performed in 1950 using two consecutive 90° pulses [10].  Hahn’s spin echo 
method was then improved by replacing the second of the two 90° pulses with 
a single 180° pulse [11].  Following the 90° excitation pulse, the bulk 
magnetisation vector decays freely for a time, t, after which the second pulse 
is applied.  This causes the decaying bulk magnetisation vector to be rotated 
by 180°.  Now further “decay” will result in accumulation of phase coherence 
rather than phase loss.  After a further time, t, the bulk magnetisation will have 
returned to a coherent state, forming a spin echo [12].  Signal is acquired at 
this point in the free induction decay, as shown in Figure 2.8. 
 
 
Figure 2.8: Diagram showing a basic spin echo sequence. 
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2.2 Physics of Magnetic Resonance Imaging 
 
A magnetic resonance imaging scanner is a versatile instrument and can be 
used to create a wide variety of different image types that are adaptable to 
various purposes depending on the sequence, for example if speed of 
acquisition, sensitivity or insensitivity to specific materials or high resolution 
is required.  The work presented in this thesis uses gradient echo – echo 
planar imaging, which is a fast two dimensional imaging technique where 
contrast is formed from the differences in T2* of the material being imaged.  
This section outlines how pulse sequences are used to produce images with a 
wide variety of different types of contrast. 
 
2.2.1 Gradient echo and encoding 
 
In order to gain information from an array of adjacent, spatially distinct 
regions simultaneously, there needs to be a way to distinguish between the 
signals obtained from each voxel.  For this purpose a combination of linear 
magnetic field gradients can be used to make the signal received from each 
voxel unique.  The three schemes that are commonly used are slice selection, 
frequency encoding, and phase encoding [13], which are overviewed in the 
next sections.  Linear gradients are applied using additional electromagnetic 
induction coils known as gradient coils.  The direction and amplitude of the 
gradient is dependent on the direction and amplitude of the electric current 
flowing through the gradient coil, and the number of loops of wire in the coil.  
A gradient vector, G(t), can be expressed in terms as the gradient derivative of 
the scalar field, Bz, and represented in three spatial dimensions, in units of 
millitesla per metre (mT/m): 
 
     
      
  
  
      
  
  
      
  
  Eqn. [2.29] 
 
Gradients used on contemporary commercial systems have strength of the 
order 40 mT/m. 
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2.2.2 Slice selection 
 
The application of an additional gradient simultaneous to the excitation pulse 
can be used to limit the effect of the radiofrequency pulse to exciting only 
those nuclei that rotate at a frequency within a given bandwidth, i.e. spatially 
confining the response of the system to a thin slab of the desired orientation.  
The thickness of the slice selected is inversely proportional to the gradient 
strength, stronger gradients allowing for thinner slabs of selective excitation 
[14].  The location of the slice can be manipulated by altering the central 
frequency and bandwidth (Δω) of the RF pulse, Figure 2.9.  The relationship 
between the slice thickness and gradient strength are shown in Eqn. [2.30]. 
 
   
  
   
 Eqn. [2.30] 
 
 
Figure 2.9: Application of a slice-selection gradient to selectively excite spins in the 
region Δz using a radiofrequency pulse of bandwidth Δω. 
 
2.2.3 Phase encoding 
 
Spatial location of a source of NMR signal may be gained from spatially 
varying the phase of the magnetisation.  This requires the application of an 
additional gradient that introduces a spatially specific phase to the magnetic 
moments in that region dependent on their position along the axis of the phase 
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encoding gradient.  Typically the phase encoding gradient, Gy is applied after 
the excitation pulse and before the readout gradient. If Gy is applied for 
duration, t, it will introduce a phase shift, Ф, given by Eqn. [2.31]: 
 
        Eqn. [2.31] 
 
This describes the phase in terms of gradient strength, G(t), duration, t, and 
displacement along the y axis.  G(t) is changed incrementally to allow 
sampling of additional lines in k-space (see Section 0).  Figure 2.10 depicts an 
example of a 2 dimensional Fourier sequence, such as spin warp imaging. 
 
 
Figure 2.10: Pulse sequence showing phase encoding for a 2D Fourier sequence such as 
spin warp imaging.  Frequency encoding is also shown (see Section 0). 
 
2.2.4 Frequency encoding and k-space 
 
Frequency encoding is a form of spatial encoding that uses the concept of 
frequency space (also known as k-space, using the symbol, k, to represent 
wavenumber).  A frequency encoding gradient is applied following the phase 
encoding gradient, also shown in Figure 2.10.  This manipulates the precession 
of the excited spins so that they will precess at a range of frequencies, 
dependent on the strength of the gradient.  Spins in different regions of the 
gradient will absorb and therefore radiate at different frequencies.  If several 
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voxels are excited at different frequencies then the received radiofrequency 
signal will be a function of the sum of several different frequencies.  It was 
observed that taking the inverse Fourier transform of this signal will give the 
different frequencies at which signal is being received [15], which is 
equivalent to the locations of the signal sources.  Therefore, there is an 
intrinsic relationship between frequency and gradient, which can be exploited 
to give a frequency dependent expression for the location of the signal source 
along a given axis.  Moving the centre of the voxel by a distance Δx causes the 
magnetic field experienced at the centre of the voxel to change as shown in 
Eqn. [2.32], where in this case the vector x can take an arbitrary direction.  
This results in the change in angular frequency as expressed in Eqn. [2.33]. 
 
         Eqn. [2.32] 
  
          Eqn. [2.33] 
 
It is possible to transform these expressions into those that use the concept of 
wave number, k.  The relationship between k and the wavelength λ is given in 
Eqn. [2.34]. 
 
  
  
 
 Eqn. [2.34] 
 
If the signal, S(t) received at a time, t, after the refocusing pulse, during the 
application of a gradient, is in the form of a free induction decay, then it can 
be treated as if it is a Fourier transform of the proton density function ρ(r) at a 
vector r, i.e. S(t) = ρ(k(t)).  Eqn. [2.35] shows the expression for the signal as 
it is recorded in real time, t. 
 
                   
     
 
    Eqn. [2.35] 
 
If the signal, S(t), is to be a function of time, then k(t´) must also be a function 
of time, as it is a vector in Fourier transformed space (now known as k-space) 
and is dependent on the applied Bz and the gradient G(t) as follows, where t´ 
denotes time in the Fourier transformed domain: 
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 Eqn. [2.36] 
 
As Eqn. [2.35] is described as an inverse Fourier transform, then applying a 
Fourier transform gives the transform of the proton density function in terms 
of k: 
 
                                  Eqn. [2.37] 
 
Taking the inverse Fourier transform of this then gives the proton density 
function, thus: 
 
                   Eqn. [2.38] 
 
Therefore, by acquiring sufficient signals S(t) at different frequencies, k-space 
can be sufficiently populated.  Figure 2.11 shows the k-space trajectory for 
spin warp imaging.  The arrow signifies the trajectory through k-space that 
sampling will take; i.e. the direction in which k-space is being sampled and the 
range of frequencies sampled. 
 
 
Figure 2.11: The k-space trajectory commonly used for spin warp imaging. 
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2.2.5 Echo planar imaging 
 
Filling k-space as described in Section 0 will only encode one k-space line.  
Researchers at the University of Nottingham showed that all of k-space could 
be sampled after a single excitation pulse [16].  This was a great improvement 
on previous methods that only allowed for the equivalent of one line of k-
space to be sampled following each individual radiofrequency excitation.  Due 
to the sequence’s high signal-to-noise ratio and sensitivity to transverse 
relaxation time and temporal resolution, this pulse scheme provides a good 
way of forming images weighted to blood oxygen level dependent contrast 
(BOLD), used for functional MRI (fMRI), which is discussed at length later in 
this thesis. 
 
 
Figure 2.12: Pulse sequence diagram for the gradient echo – echo planar imaging 
acquisition.  Note that the phase encoding and frequency encoding gradients correspond 
to the trajectory of k-space sampling shown in Figure 2.13. 
 
The radiofrequency pulses and gradients used in a standard gradient echo – 
echo planar image acquisition are shown in Figure 2.12.  The radiofrequency 
pulse and slice selection gradient facilitate the excitation of a slice.  
Immediately following this, two further short gradients, Gx and Gy align the 
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frequency and phase to the extreme edge of k-space prior to the start of 
measurement.  Then, the first gradient echo in the echo train represents the 
sampling of k-space from –kx to 0 during the frequency encoding gradient, Gx.  
This is followed by a short phase encode gradient, Gy, and sampling 
progresses from 0 to +kx under another frequency encoding gradient, Gx of the 
opposite polarity.  The next phase encode gradient, Gy, moves sampling 
incrementally up to the next line of k-space, (i.e. from ky to ky+Δy).  The 
application of frequency and phase encoding gradients is repeated until the 
whole of k-space is sampled, as shown in Figure 2.13.  As alternate lines of k-
space are sampled in reverse (i.e. from +kx to –kx as opposed to from –kx to 
+kx), the sampled data must be time-reversed on those lines before the data 
undergoes Fourier transform to form an image, as described earlier in this 
chapter. 
 
 
Figure 2.13: Schematic showing the trajectory under which k-space is sampled during 
echo planar imaging (Figure 2.12).  Initial phase and frequency encoding gradients move 
the start of k-space to (-kx,max,-ky,max).  Transition along horizontal lines is caused by the 
switching of frequency encoding gradients.  Incremental vertical transitions are caused 
by phase encoding gradients. 
 
Fourier transform mathematics can be time consuming for even a powerful 
computer to perform, and there are several Fast Fourier Transform algorithms 
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used in image reconstruction.  For maximum efficiency of these methods, 
acquisition matrix sizes are confined to 2
n
 in each dimension. 
 
2.2.6 Proton density image contrast 
 
Chemicals present in the source tissue, e.g. proteins, will alter the proton 
density of the volume surrounding the resonating nuclei, changing the 
dynamics of the FID and thus change its magnitude.  This provides the most 
basic contrast, proton density contrast.  Here the bulk magnetisation of the 
sample is known and the applied gradient is optimised to elicit nuclear 
precession only in hydrogen nuclei.  The signal produced by a voxel varies 
linearly with the concentration of hydrogen nuclei present; i.e. if the 
concentration of hydrogen nuclei in a sample is doubled, then the proton 
density signal also increases by a factor of two. 
 
Proton density contrast is suitable for use in tissue that contains a high 
proportion of water and protein molecules as it provides a high signal-to-noise 
ratio, however the contrast-to-noise ratio is often limited as proton density is 
relatively uniform across different tissue types.  Therefore, proton density 
contrast is often augmented by weighting it with a relaxation time contrast that 
provides greater differences between tissue types, as described in Sections 0 
and 2.1.7.2. 
 
2.2.7 Image artefacts 
 
Magnetic resonance imaging is very sensitive to regional accuracy in the 
values of B0 and B1.  While the types of artefact are wide ranging and 
numerous, outlined here are a few that are relevant to the techniques used in 
this thesis. 
 
One artefact that is commonly seen in echo planar imaging is the Nyquist 
ghost, also known as N/2.  As the direction of trajectory taken when sampling 
k-space is antiparallel for each consecutive line through k-space, alternate 
lines in k-space can have systematic sampling errors due to inhomogeneities.  
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This is manifest in a ghost of the image appearing overlaid on top of the real 
image, but shifted in the phase encoding direction by N/2.  Solutions to this 
problem include the acquisition of an extra image where k-space is oppositely 
sampled in order to calculate phase correction. 
 
Aliasing is where a copy of the image is wrapped back onto itself, and is 
caused by under-sampling of k-space.  The Nyquist digital sampling theorem 
states that the highest frequency that can accurately be sampled to avoid 
aliasing, or the Nyquist frequency, fN, is calculated using Eqn. [2.39], where fs 
is the sampling frequency.  To avoid aliasing, k-space should be sampled at a 
frequency equal to or greater than half the maximum frequency of the system. 
 
   
  
 
 Eqn. [2.39] 
 
Susceptibility occurs at tissue boundaries where adjacent tissue types have 
different magnetic properties.  This causes inhomogeneities in the magnetic 
field in that area, resulting in phase changes.  These effects are greater at high 
field strength, where field inhomogeneities are greater, for example at a tissue-
air boundary, phase changes cause the data to be incorrectly sampled in k-
space and ultimately results in signal drop-out and degradation of the signal-
to-noise ratio.  However, where the inhomogeneities, and thus the phase 
changes are more controlled, for example around blood vessel walls, the effect 
can be exploited to give susceptibility weighted contrast.  In the extreme case, 
metal causes susceptibility artefacts across a wide portion of the images due to 
the magnetic field inhomogeneities caused by its presence. 
 
At tissue boundaries between two different types of tissue, particularly fatty 
tissue interfaces, the difference in precession rates of the proton magnetic 
moments causes the frequency encoding of the signal to incur an error.  This is 
known as chemical shift and is manifest as the two regions of tissue appearing 
spatially shifted relative to each other.  A fat-water shift artefact is commonly 
removed by saturating either the water signal or the fat signal using a selective 
saturation pulse. 
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2.2.8 Beyond two dimensional EPI acquisition 
 
Three dimensional echo planar imaging (3D-EPI) provides higher signal-to-
noise ratio and allows higher resolution to be achieved in comparison to multi-
slice imaging by virtue of the fact that data are acquired using an additional 
phase encoding gradient along the slice direction.  This allows for signal to be 
collected from the entire volume, which is reconstructed using a 3D Fourier 
transform, instead of a 2D one.  Despite the advantageous SNR increase, this 
lengthens the time required for a single acquisition, which can be problematic 
where temporal resolution is important. 
 
2.3 Practical Magnetic Resonance Imaging 
 
This section will outline the nuclear magnetic resonance (NMR) hardware.  
While the intricate details of scanner design vary from manufacturer to 
manufacturer, and can depend on the specialised purpose of the MR system, 
most scanners will have the same set of basic components; a large 
superconducting magnet, shim coils, gradient coils and coils for transmitting 
and receiving radiofrequency radiation, together with a high level of 
computing power.  A simplified schematic of the entire system is given in 
Figure 2.14.  This section will describe these main components. 
 
 
Figure 2.14: Simplified schematic of the components of a modern MR scanner. 
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Clinical systems used in hospitals typically operate at a static field of either 
1.5 T or 3 T.  Recent technological developments have seen the production of 
7 T scanners, but their use is currently limited to research institutions.  The 
work presented in this thesis has mainly been acquired using a 3 T system, 
with the work in Chapter 6 using a 7 T system.  Both of these systems were 
produced by Philips Healthcare [17]. 
 
2.3.1 Magnet 
 
In order to form an MR image of an object, it must be placed in a 
homogeneous magnetic field.  When imaging the human body, this requires 
that the field covers a large three dimensional volume.  The field needs to be 
stable in time and homogeneous in space, with a tolerance for inhomogeneity 
of around 1 in 1,000,000.  Early magnetic resonance scanners used low 
magnetic fields, of the order 0.1 T, and for these it was sufficient to use a 
permanent iron magnet.  For higher fields (greater than around 0.5 T), it is 
necessary to use a superconducting electromagnet.  This works on the 
principle of a solenoid coil, whereby a magnetic field is generated inside a 
toroid coil, which forms the bore of the magnet into which the subject is 
placed.  The field produced is dependent on the size of the electrical current in 
the coiled wire.  Wire made from superconducting metal allows a very large 
current to pass through with very low resistance when they are cooled below a 
certain temperature.  In modern systems, the superconducting metal alloy 
Niobium-Titanium is used; cooled to a temperature of around 10K by liquid 
helium.  In the past, liquid nitrogen has been used to maintain the low 
temperature of the helium, but in recent systems this is done using air or water 
chillers.  Initially supplying enough power to generate such a high magnetic 
field is extremely costly and time consuming.  The act of maintaining a very 
low temperature in the superconductor means that once the static field is 
achieved, the current in the superconducting coils can be maintained merely 
by maintaining a low temperature in the coil using water and air coolers. 
 
The imaging area of the magnet is inside the bore of the toroid coil.  However, 
this generates a fringe field extending outside the scanner.  In order to 
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minimise the spatial extent of this field, shielding is used.  Current technology 
typically uses passive shielding, where a metal with a high magnetic 
permeability such as iron limits the extent of the field outside the bore of the 
scanner.  To minimise the space and additional mass of the iron shielding, it is 
now possible to use active shielding, where additional electromagnetic coils 
generate fields that neutralise the fringe field [18]. 
 
2.3.2 Shim Coils 
 
The static field produced by the superconducting magnet alone is typically not 
homogeneous enough for the purpose of imaging over a large volume, and so 
it is necessary to make adjustments to this field to ensure homogeneity.  This 
process is known as the shimming of the MRI scanner.  Passive shimming is 
performed at the installation of the magnet, where the magnetic field 
throughout the volume of the bore is calculated, and any inhomogeneities are 
identified by comparing the measured field with that of the final target field.  
This is done when the magnet is in-situ, as inhomogeneities may be due to the 
environment around the magnet or due to flaws in the magnet itself.  Any 
differences between the two fields are known as the residual of the field.  
Residual fields are reversed by inserting pieces of a metal with high magnetic 
permeability, such as iron into the appropriate regions of the magnet [19]. 
 
In addition, the subject can introduce inhomogeneities into the magnetic field 
due to naturally occurring exogenous paramagnetic and diamagnetic materials 
in the body.  These are accounted for by the process of active shimming, 
which is performed at the start of each scan session.  Incorporated within the 
bore of the MRI scanner is an additional set of copper shimming coils that 
produce temporary magnetic fields to modify the B0 field based on 
calculations made for each subject.  This is typically done by mapping the 
static field throughout the scanner with the subject inside, and instructing the 
shimming coils to make the necessary adjustments [20]. 
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2.3.3 Gradient Coils 
 
As described in Section 2.2.1, in order to generate an image, the spatial 
location of each signal source must be uniquely known.  In order to do this, a 
gradient is used in each orthogonal axis of the scanner.  This is done using 
three additional arrangements of conducting wire coils constructed in 
concentric cylindrical layers in the scanner bore [21].  Conventionally, the 
slice select gradient in the z direction is provided by a Maxwell pair coil; two 
coils of the same radius, at a known separation carry currents in opposing 
directions to induce a uniform magnetic field gradient along the length of the 
bore, with the gradient being defined as zero at the isocentre of the magnet.  
There are now many possible ways of achieving transverse gradients in the 
bore of the scanner; ranging from simple to highly complex [18].  Commonly 
used is an arrangement of two pairs of saddle shaped wire coils, each pair of 
coils effectively produces a linear field gradient in each of the x and y 
directions.  This arrangement is known as a Golay set [22]. 
 
Gradient coils necessarily have their own cooling system to minimise heating 
within the coil [21].  Additionally, the gradient coils are shielded to protect 
any adjacent conductive scanner components from experiencing eddy currents.  
As with the shielding applied to the main magnet, this can take the form of 
passive or active shielding components [23]. 
 
2.3.4 Radiofrequency transmit and receive coils 
 
B1 pulses are typically transmitted from a volume coil making up the 
innermost layer of the MRI scanner bore.  The spectrometer generates a 
radiofrequency signal that is then convolved with a chosen pulse shape and 
passed through the amplifier.  The RF coil transmits this as a highly uniform 
electromagnetic pulse, tuned to the appropriate resonant (Larmor) frequency, 
which excites the material in the volume coil.  A simple single coil element 
(for example in a single element surface receive coil) consists of a loop of wire 
connected in parallel to a capacitor in a highly tuned resonant circuit specific 
to the resonant frequency of the material being imaged.  The received 
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radiofrequency signal induces a current in the coil by virtue of Faraday’s Law 
of induction, which is measured by the spectrometer and collated by the 
computer for preprocessing.  It is advantageous for the receive coil to be as 
near as possible to the material under investigation.  For this reason, specific 
removable volume coil arrangements are used that are customised to the shape 
of the body part being imaged.  For example, neuroimaging coils, 
neurovascular (head and neck) coils, body (torso) coils, limb (knee) coils and 
neonatal (incubator) coils.  Alternatively, surface coils can be placed on the 
area of interest.  All data presented in this thesis is acquired using a 
neuroimaging (head only) receive coil. 
 
2.3.5 Parallel imaging 
 
The neuroimaging coils used to acquire the data presented in this thesis have 8 
and 32 coil elements, arranged in a cylindrical geometry, working 
synchronously to acquire signal from the volume.  Where there are multiple 
elements to a coil, scan time can be dramatically reduced by exploiting the 
way the receiver coil receives the RF signal.  The design currently used on 
Philips scanners was pioneered in 1997 [24], later improved on in 1999 [25], 
and is now known as sensitivity encoding, or SENSE.  In a coil in which the 
field of view of each element is overlapping, knowledge of the sensitivity map 
of each coil element is used to partially fill k-space so that some trajectories do 
not need to be sampled.  The signal from regions detectable by two or more 
elements is under-sampled, without compromise to the spatial resolution.  
Alternatively, the field of view can be expanded without increase in scan 
duration.  When the data is reconstructed to form an image, the sensitivity 
maps are used to calculate weighting values that are used to fill k-space 
without aliasing.  Scan time is reduced by an acceleration factor, R.  Scans 
acquired with higher values of R at the same spatial resolution inevitably lead 
to higher noise in the image. 
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2.3.6 Computer Interface 
 
The scanning hardware is controlled by computer using an interface that 
enables the user to input parameters of the subject being scanned, such as 
identification information, and select the scans to be performed.  The 
computer calculates the bandwidth of frequencies across which the 
radiofrequency pulse will emit, and also the power at which the gradients will 
be applied – this information is then sent to the waveform generator as a 
digital signal.  The signal is converted to analogue and each of the RF and 
gradient waveforms is amplified before being sent to the coils for 
transmission.  Once the signal of interest has been received, it is amplified and 
converted to a digital signal before being reconstructed into an image. 
 
2.3.7 Pulse programming 
 
The interface provides options for the user to enhance and optimise protocols 
before scanning, and to customise the sequence for a particular investigation.  
However, advancements in knowledge and understanding can be made by 
coding scanner sequences that are atypical or previously untried.  It is possible 
to develop these sequences off-line using a scanner simulation package known 
as a pulse programming environment (PPE).  This enables the user to make 
alterations to the code controlling, for example the wave form, and to observe 
the consequences of these changes without directly altering the way the 
scanner performs.  Successful alterations can then be transferred to the scanner 
interface by means of a software patch.  This method has been used in 
Chapters 5 and 6 of this thesis. 
 
2.3.8 Data handling 
 
Data can be stored in its raw format, before Fourier transform is performed, so 
that post-processing corrections can be performed.  Alternatively, or 
additionally, transformed images can be exported from the scanner for pre-
processing and analysis.  Typically, data may require correction for subject 
motion and / or removal of artefacts before it can be analysed.  This is done 
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off-line, after the data has been exported from the scanner and stored 
elsewhere. 
 
2.3.9 Safety 
 
As long as safety is taken into consideration, there are no known medical side 
effects of MRI, a marked difference when MRI is compared to other 
diagnostic imaging methods such as those requiring the use of x-rays or 
ionising radiation (gamma, positron emission).  Patients must be carefully 
assessed for exclusion criteria such as the presence of a metal implant that 
would be detrimentally affected by the magnetic field, for example a 
pacemaker, aneurism clip or cochlear implant.  For research scanning, criteria 
are more stringent, excluding subjects with any metal implant, as the risks of 
scanning have no clinical diagnostic benefit to the subject, and image quality 
may be poor due to the susceptibility imaging artefacts caused by such items.  
Any person moving in or around the magnetic field must first remove all loose 
metal objects, as these create a projectile risk if they are sharply attracted 
towards the bore of the magnet. 
 
Conductive materials must not be allowed to form a current loop within the 
scanner during the application of gradients, as the gradient can induce a 
current in the loop, which may cause heating.  It is advisable to remove any 
metal jewellery during scanning, even if it is not loose.  Some tattoo ink can 
also contain metal particles, and heating can occur within the tattoo.  In these 
cases, it is sufficient to warn the subject of the risks prior to the scan and, if 
necessary, immediately apply cooling to prevent or treat skin burn on removal 
from the scanner.  The human body can also form a current loop within the 
scanner, so care must be taken to ensure that surfaces of bare skin are not 
allowed to touch, and if necessary, an insulating layer is placed between the 
subject’s skin and the bore of the scanner to prevent any surface burns. 
 
Specific absorption rate, or SAR, is a measure of the rate of absorption of 
radiofrequency electromagnetic radiation by the human body.  It is defined as 
power absorbed per unit mass of tissue, and has units Watts per kilogram 
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(W/kg).  Sequences with high SAR can cause heating of the subject.  Gradient 
switching is the change in the total magnetic field per unit time (dB / dt), and 
is the property of a gradient that induces a coil in a current loop.  By the same 
mechanism, it can cause peripheral nerve stimulation, which in most cases is 
merely unpleasant, but at a high enough gradient switching rate, could become 
dangerous to the subject by interfering with the cardiac electrical signal.  
Gradient switching causes small amounts of motion within the scanner 
hardware that happen very rapidly.  The vibration produces high amplitude 
acoustic noise, and for this reason, subjects must wear ear protection in the 
form of ear plugs and ear defenders. Commercial scanners have in-built 
software intended to limit both SAR and gradient switching and prevent any 
harm coming to subjects undergoing an MRI scan.  For gradient switching, 
regulatory agencies have imposed an absolute value of dB / dt to which human 
scanners must be limited.  To limit SAR, the scanner uses its own 
measurements of the subject to calculate the maximum power it can use for 
the excitation pulse. 
 
Contrast agents used in MRI scanning are based on paramagnetic materials, 
such as gadolinium, and act to create or enhance the contrast of an image by 
significantly shortening the longitudinal relaxation time of tissue.  Gadolinium 
is toxic, and must be delivered into the body in a chelated form so that it is 
chemically inert in the body and is removed from the blood with other waste 
products.  For subjects with renal impairment, however, the disposal of the 
chemical is compromised, and it is best to avoid using gadolinium based 
contrasts in order to reduce the risk of nephritic problems.  As with the 
administration of any exogenous chemical to the body, any patient carries a 
small but still very real risk of anaphylactic reaction to the contrast agent. 
 
Transient effects such as dizziness, nausea and magnetophosphenes (bright 
lights in the visual field) are less of a direct safety concern, but some people 
find them disturbing nonetheless.  These effects can be reduced, if not avoided 
by taking care to move slowly through the static field. 
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Cryogens are the low temperature materials essential to maintaining the 
current in the superconducting magnet.  When cooling gases are in their cold 
(cryogenic) state, the main risk from them is cold burns if they were to come 
into contact with skin.  However, if cryogens are allowed to heat up, for 
example in the case of a leak, they rapidly expand, displacing any air from the 
area.  This carries the risk of asphyxiation to anyone in the vicinity.  Very 
occasionally, a large amount of cryogen can be released instantaneously, for 
example, in the event of a scanner quench, the entire helium supply is allowed 
to boil off in order to dissipate the heat from rapidly increasing the resistance 
in the superconducting wires that form the magnet.  For this reason, every 
MRI scanner must be fitted with a quench pipe, which provides a safe escape 
route for the rapidly expanding gas.  This prevents asphyxiation risk and also 
prevents the explosion risk of having a large amount of rapidly expanding 
material in an enclosed space. 
 
2.3.10 Ethics 
 
All experiments on humans, animals, or human tissue must have prior 
approval from a body of ethics governance.  Most medical institutions and 
research institutions that are actively undertaking such experiments will have 
their own ethics committee overseeing all such experimentation and ensuring 
that ethical standards are maintained.  All experiments reported in this thesis 
were carried out with prior approval from the University of Nottingham 
Medical School Ethics Committee. 
 
2.3.11 Advantages and disadvantages of high field 
 
Work in this thesis has been performed at 3 T and 7 T.  At higher magnetic 
field, a higher proportion of the magnetic dipole moments will align parallel 
with the field.  This results in higher signal to noise ratio.  In addition, 
magnetic field strength influences the way the excited magnetic dipole 
moments interact with each other and with the surrounding lattice of the 
material.  This results in longer T1 relaxation times and shorter T2 decay times 
of tissue at high field, theoretically increasing the contrast to noise ratio of the 
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weighted image.  However, as the magnetic field strength increases, higher 
frequency RF pulses are required to excite the precession of the magnetic 
dipole moment into the transverse plane.  This results in a higher specific 
absorption rate and acoustic noise.  While high field offers the possibility of 
improved image quality, caution must be used to ensure the safety and comfort 
of human subjects.  In addition, it is more difficult to create and maintain a 
homogeneous static field when the field strength is higher as it is more 
susceptible to inhomogeneities produced by introducing a subject into the 
field.  Perturbations in the magnetic field (ΔB) are linearly dependent on the 
B0 magnetic field, related proportionally by magnetic susceptibility (χ) as 
shown in Eqn. [2.40].  Magnetic susceptibility (χ) is constant for a given 
material. 
 
       Eqn. [2.40] 
 
This makes the active shimming of the magnet for each scan at high field 
critically important. 
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3 Neuroimaging 
 
3.1 Introduction to Neuroanatomy 
 
Early insight into neuroanatomy came from sciences such as phrenology.  This 
took the extreme view that every task has an anatomical region associated with 
it.  At the opposite end of the spectrum were subscribers to the concept of 
equipotentiality, who believed that no brain function can be localised 
discretely, and that any given process in the brain depends on patterns of 
activity spread throughout the whole brain.  Towards the middle of that 
spectrum lie the studies of cognitive neuropsychology and neurology, which 
have developed over a period of several decades.  From these studies, 
scientists have deduced that while many mental functions are associated with a 
specific region or regions of the brain, others can be attributed to patterns of 
activity that span large-scale neurocognitive networks [1].  One of the most 
widely used atlases of the human brain was devised by the German anatomist 
Korbinian Brodmann, who divided the brain into 52 discrete areas, known as 
Brodmann Areas, BA [2], based on their histological features. 
 
Magnetic resonance imaging can be used to gain information about the 
structure of the brain.  As described in the previous chapter, pulse sequences 
can be designed to elicit different contrast between tissue types, for example, 
grey matter and white matter, or cerebrospinal fluid.  Structural imaging of 
this kind is highly useful for the diagnosis of clinical conditions where the 
anatomy of the brain is altered, for example the detection of a brain tumour.  
In addition to structural imaging, magnetic resonance techniques can be used 
to interrogate functional processes that occur in the brain.  Later chapters in 
this thesis report on experiments that investigate the cerebral blood flow and 
the vascular territories that make up the cerebral blood supply.  Another 
chapter will report measurement of brain activity, exploiting the change in 
blood oxygenation level dependent (BOLD) contrast at the site of brain 
activity, and also the increase in perfusion observed in an active area of the 
brain.  This chapter will discuss the mechanisms behind the processes that are 
investigated in this thesis. 
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3.1.1 The Brain 
 
Within the human skull is the brain, consisting mainly of white matter and 
grey matter.  The subarachnoid space and ventricles are filled with a protective 
liquid called cerebrospinal fluid (CSF).  Grey matter contains the majority of 
the neurons in the brain, while white matter consists mainly of axons that are 
covered in a sheath of electrically insulating material, myelin.  Both white 
matter and grey matter are supplied oxygenated blood by the cerebral 
vasculature, with grey matter being more highly perfused than white matter.  
The majority of grey matter is distributed across the surface of the cerebral 
cortex, and additionally deep grey matter structures exist in the cerebellum, 
deep cerebellar nuclei and brainstem.  The neuronal cells in the grey matter are 
responsible for most of the brain function.  Tracts of white matter connect 
areas of grey matter together, transmitting electrical signals in the form of an 
electrical current across an action potential. 
 
The brain is supplied with oxygenated blood by the internal carotid arteries 
and the vertebrobasilar system, consisting of the two vertebral arteries and the 
basilar artery.  The basilar artery and internal carotid arteries join the anterior 
and posterior cerebral arteries and anterior and posterior communicating 
arteries at the Circle of Willis, from which the cerebral arterial system is 
distributed.  This is shown in a Time of Flight (TOF) contrast angiogram in 
Figure 3.1. 
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 Figure 3.1: The cerebral vasculature with major arteries labelled, shown using a time of 
flight contrast angiogram. 
 
3.1.2 Brain function 
 
Neurons and axons exhibit an action potential caused by the flow of a current 
of electrically charged ions across membranes of the cell.  Neurons receive 
signals through dendritic and somatic connections from other neurons, and 
then transmit these integrated signals to other neurons.  The signal itself is a 
tiny ionic current passed through an ion channel in the cell membrane [2].  
When several such cells are oriented similarly to each other and share 
synchronous activity, these action potentials become large enough to detect 
from outside the brain.  This can be done using techniques such as 
electroencephalography (EEG), which detects the voltage fields of the action 
potential on the scalp, of the order 10 – 100 microvolts, or using 
magnetoencephalography (MEG), where the magnetic dipole fields, of the 
order 10 – 1000 femtotesla, associated with the action potentials are detected 
from outside the head. 
 
We know that when a brain region is active, the neurons in that area generate 
an electromagnetic signal.  Functional magnetic resonance imaging (fMRI) 
methods do not directly measure this neuronal signalling, but instead use 
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inferences from physiological changes that are correlated with neuronal 
activity, such as increased oxygen demand and blood flow. 
 
Observing brain function requires fast image acquisition, so that images are 
acquired at a similar frequency to the haemodynamic changes that occur.  
There are different MR methods of imaging these short term changes that 
occur in the brain, with those used in this thesis being:  
1. Blood-oxygen level dependent (BOLD) contrast or T2* weighted fMRI.  
This is the most widely used fMRI method, which indirectly measures 
neuronal activity by using the relative change in blood oxygenation in 
an active area of the brain. 
2. Arterial spin labelling (ASL).  This is a non-invasive method of 
directly assessing blood flow by using an endogenous contrast in the 
form of magnetically labelled arterial water as it enters the brain. 
 
This section will discuss the MR methods that are most useful for the study of 
pharmacological fMRI, i.e. assessing the modulation of these signals by an 
exogenous chemical, such as a drug. 
 
3.2 Measuring brain function using BOLD 
 
When Ogawa et al placed test tubes of deoxygenated blood in a container of 
saline, they found that the presence of the deoxygenated blood decreased the 
MR signal in the surrounding saline in a T2* weighted image [3].  In-vivo, 
deoxygenated blood induces a field inhomogeneity in surrounding tissue in the 
form of microscopic magnetic field gradients surrounding the capillaries.  
These field gradients accelerate the dephasing of the transverse magnetisation 
of the magnetic dipole moments, decreasing T2*.  The magnetic properties of 
oxygenated and deoxygenated haemoglobin molecules are different.  
Oxygenated haemoglobin is diamagnetic; meaning that it has no magnetic 
moment and is weakly repelled by a magnetic field.  Deoxygenated 
haemoglobin is paramagnetic; therefore, its non-zero magnetic moment causes 
it to have a weak attraction to a magnetic field.  A T2* weighted image shows 
high signal in areas where there is high blood oxygenation due to the higher 
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T2* of oxygenated blood.  Neuronal activity modulates the relative amount of 
deoxyhaemoglobin present in immediately surrounding tissue.  It is thought 
that there is an increase in the amount of oxygenated haemoglobin in active 
brain areas, as a result of increases in cerebral blood flow and blood volume 
that exceed the cerebral metabolic rate of oxygen (CMRO2) consumption, 
leading to an excess of oxygenated blood.  This is known as the functional 
Blood Oxygen Level Dependent (BOLD) signal [2], and is illustrated 
diagrammatically in Figure 3.2. 
 
 
Figure 3.2: The mechanism behind the generation of BOLD contrast. 
 
3.2.1 The Haemodynamic Response Function 
 
The shape of the BOLD signal response to a short neuronal activation, termed 
an ―event‖, is called the haemodynamic response function (HRF).  Much 
research has involved modelling the shape of this haemodynamic response 
function [4, 5].  The shape of the HRF is shown in Figure 3.3 and has three 
key features; the initial dip (1), the positive overshoot (2) and the post-
stimulus undershoot (3). 
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 Figure 3.3: Haemodynamic response function (HRF) of a short stimulus, showing the 
initial dip (1), the positive overshoot (2) and the post-stimulus undershoot (3). 
 
Some studies have suggested the existence of an ―initial dip‖; namely a 
decrease of up to 1% in the BOLD signal preceding the characteristic increase 
in MR signal, which is up to 3 – 5 % at 3 T.  It has been postulated that the 
initial dip is caused by an increase in the oxygen extraction to meet the 
increased metabolic demands before the compensatory increase in cerebral 
blood flow takes place [6].  The effect seems to be highly dependent on field 
strength (making it almost undetectable at low field strength) and continues to 
be controversially discussed as it is not consistently detectable, even at high 
field strength.  As the ―initial dip‖ may be due to oxygen extraction, it may 
provide a more accurate measure of the spatial location of neuronal activity 
than the subsequent higher amplitude peak in the haemodynamic response 
curve [7]. 
 
The peak of the BOLD signal occurs at the point of maximum oxygenated 
haemoglobin, approximately 5 – 6 seconds after a short stimulus or event.  
After the BOLD signal has peaked, the signal then decreases to below the 
original baseline level, termed the ―post-stimulus undershoot‖.  The cause of 
this effect is still a hotly debated topic [8, 9, 10].  One potential mechanism is 
that the cerebral blood flow returns to its baseline level faster than the cerebral 
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blood volume, leading to a larger amount of deoxygenated haemoglobin being 
present, and the BOLD signal falls to a value below baseline.  Then, as the 
blood volume slowly falls to its original level, the BOLD signal rises to return 
to its baseline level [10].  An alternative explanation is that cerebral blood 
flow (CBF) and cerebral blood volume (CBV) are coupled, whilst the cerebral 
metabolic rate of oxygen consumption (CMRO2) is uncoupled from these 
quantities [8, 9]. 
 
The BOLD response to a stimulus event is assumed to follow a linear 
relationship with neuronal activity [11, 12].  This assumption is used in the 
application of General Linear Model (GLM) analysis methods.  However, 
more realistically, repeated activation of the same region of the brain causes 
less change in the BOLD signal with each repetition.  This is called the 
nonlinear or refractory effect, and describes the adaptation of brain tissue.  The 
refractory effect appears to last as long as the neuronal activity, as shown in 
studies involving visual attention [13], and this has been shown to be 
approximately 6 seconds [11,14]. 
 
Images with BOLD contrast are optimally acquired using an echo time that is 
approximately equal to the T2* of the tissue being imaged, which is field 
strength dependent, with values of T2* decreasing for a given material as field 
strength increases.  In grey matter, T2* takes a value of approximately 40 to 60 
ms at 3 T and 25 to 33 ms at 7 T, dependent on the cortical area under 
investigation [15,16].  T2* weighted acquisitions typically use an echo time 
(TE) of approximately 35 to 50 ms at 3 T [16] and approximately 25 ms at 7 T 
[15, 16]. 
 
3.2.2 Acquisition of BOLD fMRI Data 
 
The strength of the BOLD response increases significantly with the magnetic 
field strength [17], in terms of both the percentage signal change compared to 
baseline and the sensitivity to microvasculature. Thus, increases in the 
magnetic field strength can have a profound effect on the quality of the 
functional BOLD images.  However, T2*-weighted images are highly prone to 
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susceptibility artefacts that are due to inhomogeneities in the magnetic field 
where there is an air-tissue boundary.  These effects increase with magnetic 
field strength and with proximity to the air-tissue interface.  This effect can be 
overcome, at least in part, by simultaneously acquiring data using multiple 
echo times, as use of a shorter echo time is less susceptible to signal dropout.  
In this case, a weighted summation image of the two images acquired at 
different echo times can be used.  One disadvantage of using BOLD contrast is 
the indirect relationship between changes in BOLD signal and neuronal 
activity.  Using BOLD fMRI, it is possible that a change in neurovascular state 
can result in the change in the brain activity observed.  This makes 
interpretation of BOLD fMRI data highly complex and great care must be 
taken to avoid such inaccuracies. 
 
The BOLD signal change in response to a task is defined as the difference in 
the signal in BOLD weighted images during that task compared to the BOLD 
weighted signal during some control, or baseline condition. Any areas in 
which the BOLD signal has increased during the task in comparison to 
baseline is deemed to be ―more active‖ during the task.  Conversely, ―negative 
BOLD‖ signal refers to any regions that are less active during the task in 
comparison to baseline, i.e. the BOLD signal has decreased during the task in 
those areas.  However, as activations are inferred based on signals that are 
being measured relative to other signals, great care must be taken when 
interpreting the ―negative BOLD‖ signal. 
 
Functional MRI is often enhanced by being used in conjunction with another 
technique, for example electroencephalography (EEG), in which electrical 
potentials in the brain are measured, magnetoencephalography (MEG), which 
measures the magnetic flux caused by neuronal activity, lesion (any abnormal 
tissue) study, or transcranial magnetic stimulation (TMS) using an 
electromagnetic coil. 
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3.2.3 BOLD Task-Driven Experimental Design 
 
It is important to optimise the experimental design of any study to extract the 
maximum statistical power from the data.  BOLD signal changes are very 
small; sometimes less than 1% of the static signal, and thus a drug induced 
modulation of this change is even smaller.  Experimental designs that involve 
observing pharmacological modulation of known task induced activity usually 
fall into the categories of presenting subjects with either a block design task, 
or an event related task.  These tasks can take a variety of forms, such as a 
visually or auditory cued motor task or cognitive task, or a passive visual, 
somatosensory or auditory stimulus.  There are also mixed or semi-random 
designs, which combine aspects of both blocked and event related designs.  
The block based experiments (Figure 3.4A) are a good way of measuring 
state-related processes, i.e. processes that represent modes of brain function, 
like mood induction.  They have good detection power but have limited use 
for estimation of the haemodynamic response function [2].  Event related 
designs are good at measuring stimulus-related processes (Figure 3.4B), i.e. 
the response function of a process caused by an individual event or stimulus.  
The advantage of this design is that it is good for estimating the shape of the 
haemodynamic response, but it provides weaker power when detecting 
changes in brain state during a task [2].  Mixed designs can occasionally prove 
to be a good compromise on detection and estimation power.  Additional to 
this, the power for optimised detection and estimation can be increased by 
varying the inter-stimulus interval randomly, which is called jittering. 
 
 
Figure 3.4: Two standard approaches to designing a functional MRI stimulus; (A) block 
design and (B) event related design. 
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Sample sizes are also critical in ensuring that the results of a study reach 
statistical significance.  For fMRI research studies, such as the one reported in 
Chapter 4 of this thesis, it is advised that the sample size should be a minimum 
of 15 to 20, depending on the size of the effect being observed [18]. 
 
3.2.4 fMRI Data Preprocessing and Analysis 
 
Once raw data has been reconstructed into images, preprocessing steps are 
typically applied before analysis can take place.  These are often run using one 
of the widely available software packages, such as FMRIB Software Library 
[19] or Statistical Parametric Mapping [20].  Preprocessing steps typically 
include removal of physiological noise, motion correction, co-registration and 
smoothing.  Physiological noise correction removes noise from subject heart 
beat and respiration, and additionally scanner drift.  Work presented later in 
this thesis uses the RETROICOR method [21].  Motion correction uses a 
mathematical algorithm to calculate any gross head motion (either translation 
or rotation) and realign all the images by minimising the sum of the square of 
the residual signal.  Typically, a 6 parameter rigid-body registration is used.  It 
is necessary to exclude subjects from the analysis for whom their motion is so 
excessive that motion correction may introduce motion correlated artefacts 
into the data (defined to be motion greater than one voxel in this thesis).  
Following this, images can be normalised to a common template to allow 
group comparisons.  This is often done using a standard brain template such as 
the MNI brain [22] or the Talairach atlas.  Finally, in order to increase the 
signal-to-noise of an image, spatial smoothing is applied.  The level of 
smoothing is defined by the full-width half-maximum (FWHM) of the curve 
used to convolve with the data.  While increasing the signal-to-noise ratio, 
either temporally or spatially, this will in turn decrease the resolution, either 
temporally or spatially, therefore care must be taken in choosing the level of 
smoothing to apply.  For the preprocessing of fMRI data collected in this 
thesis data have been smoothed across 1.5 to 2 voxels, which corresponds to a 
FWHM of between 5 and 8 mm. 
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Subsequent statistical analysis often takes the form of a univariate or 
multivariate approach to a General Linear Model (GLM), followed by the 
formation of parameter maps that are then interrogated using hypothesis 
testing.  Typically, single subject analysis will take the form of a fixed effects 
analysis, which treats the variance of each scan as being identical, i.e. from a 
single subject or from an identical population, and that the variances are fixed.  
Analyses for larger groups will typically take the form of random effects 
analysis.  Random effects analysis assumes that the sample of subjects was 
taken randomly from a population, and so the effect size in each subject will 
need to be greater than the variance between subjects [23].  Depending on the 
nature of the interrogation, i.e. the hypothesis being tested, higher level group 
statistical testing can be in the form of single group, two group or paired t tests 
or multi-way analysis of variance (ANOVA) tests.  The latter are more 
flexible, particularly for analysis of data from pharmacological studies, as 
several levels of comparison are needed. 
 
3.2.5 Applications / Uses of BOLD fMRI 
 
There are numerous applications of fMRI that have been published over the 
years.  These range from the study of basic neuroscience to understand simple 
sensory tasks such as the brain’s response to motor, visual and somatosensory 
stimuli; to the study of attention – focussing the consciousness on a particular 
object or location; and the study of memory – the distribution of different parts 
of the brain associated with memory processes and studying the functional 
differences between memory encoding and memory retrieval.  The main 
application of fMRI reported in this thesis is to study the physiological and 
functional effects of a pharmacological agent on the brain’s response to an 
emotional visual stimulus.  Notably, the changes in cerebral haemodynamics, 
neuronal response and functional connectivity are of particular interest. 
 
3.2.6 Pharmacological Modulation of BOLD 
 
Many studies have used BOLD as a measure of brain activity to assess how 
certain exogenous pharmacological agents modify the brain’s response to a 
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given task [24, 25].  Commonly, addictive substances are studied, such as 
caffeine, amphetamine and nicotine, to investigate the behaviour of arousal or 
reinforcement associated with the drug.  Also of interest are the effects of 
modulating the production and uptake of neurotransmitters, such as dopamine, 
on cognitive task performance and task related BOLD signals.  This has been 
used to successfully demonstrate the mechanism behind the perceived and 
observed changes caused by that drug.  In addition, the known effect of a drug 
can be exploited to enhance functional MRI studies.  To give one example; 
caffeine is an adenosine receptor antagonist and thus a cerebral 
vasoconstrictor, which decreases the resting cerebral blood flow [26, 27, 28].  
Some research has suggested that this property can be exploited as a BOLD 
contrast enhancer; as deoxyhaemoglobin levels are lower at baseline, but 
increase normally on activation, thus increasing the BOLD contrast.  This 
increase in BOLD contrast was found to be between 22% and 37% for a 
visually cued motor task [26], suggesting that caffeine could be used as a 
contrast enhancement agent in BOLD fMRI studies.  Caffeine has been shown 
to modulate the shape of the haemodynamic response to a stimulus through the 
comparison of parameters such as the time to peak, the full width half 
maximum, the maximum peak, and the amplitude of the initial dip.  It is 
theorised that this is due to modulation of the cerebral blood flow and the rate 
of oxygen metabolism [27].  Caffeine has also been shown to significantly 
reduce the time to peak of the haemodynamic response [28], and the 
magnitude of the initial dip [29]. 
 
3.3 Pharmacological fMRI Study Design 
 
A literature review on pharmacological fMRI (termed phMRI) in 2000 [24], 
suggests phMRI to be a relatively non-invasive way of mapping a 
pharmacological modulation of task related brain activity.  The review 
predicts the increase and development of phMRI as an analytical tool in the 
area of drug research, and its use by monitoring the effect of pharmacological 
intervention on a neurological disorder or condition.  There have been several 
studies published that use fMRI to quantitatively study the action of a 
pharmacological agent.  For example recreational drugs such as ketamine [30], 
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or more widely used substances such as caffeine [26, 31] and prescribed 
medication [32] on the human brain [25]. 
 
There are two main questions that can be answered by pharmacological fMRI 
(phMRI) studies.  One approach is to seek regional and / or global changes in 
BOLD or perfusion signal that are associated with the action of a 
pharmacological agent, but are not associated with any task-induced activity.  
An alternative approach is to test for a change in task-induced activity that is 
caused by the administration of the pharmacological agent.  This can be done 
using any task that can usefully be observed using fMRI (Section 3.2).  For 
best results, the modulation of the state of interest should be observed in their 
comparison to a control state.  Depending on the experimental design and the 
exact research question being investigated, the control condition can take the 
form of a measurement made before the administration of the drug, a control 
group of healthy volunteers or a condition where a placebo is given, to 
eliminate any activity that is due to the subject anticipating the administration 
of the drug.  To maximise the power of studies where repeated measurements 
are being taken, the crossover repetition of drug or stimulus should always be 
randomised to account for the effect of order on the two conditions.  An 
example placebo controlled crossover study design is given in Figure 3.5.  
This design is used for the study of the effect of beta-blockers on task related 
brain activity, which is the focus of Chapter 4. 
 
 
Figure 3.5: An example study design using a randomised placebo controlled crossover. 
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3.4 Functional connectivity 
 
The previous section described task-driven BOLD responses.  During the 
performance of a task or the processing of a stimulus, spatially disparate areas 
of the brain can also be observed to function synchronously (correlate) with 
each other as part of a network; this is termed functional connectivity (fc) [40].  
Studying functional connectivity gives insight into which areas of the brain 
form networks and how these networks are modulated.  Connectivity between 
brain areas is usually assessed by numerical correlation of the signal 
fluctuations in such brain areas over time, typically over the course of a few 
minutes.  One standard method to assess such correlation is in terms of the 
Pearson correlation coefficient of signal timecourses from two spatially 
distinct areas [33], which can range from -1 to +1.  Large positive values 
signify high correlation (i.e. signal is in synchrony between regions), while 
large negative values show an inverse correlation between two regions (i.e. as 
the signal goes down in one region, it goes up in the other).  Values near zero 
signify absence of, or very little correlation.  Correlation is also often referred 
to in terms of functional distance, which is given by the inverse of the 
magnitude of correlation (independent of the sign of the correlation).  
Therefore, pairs of voxels with a strong positive or negative correlation have a 
low functional distance between them, whilst pairs of voxels with little or no 
correlation are described as being separated by a very large functional 
distance. 
 
Early task driven functional connectivity studies were performed by looking 
for brain regions exhibiting signal intensities with a high degree of temporal 
correlation.  This was first done for simple tasks where the networks of inter-
communicating brain regions are known (e.g. motor, visual, auditory 
networks).  It was shown using BOLD fMRI that a significant amount of the 
noise in the measurement was not random in nature, but had a significant 
spatio-temporal correlation [34].  Functional connectivity can be assessed by 
applying temporal correlation analysis using an internal reference of a known 
activation pattern in the brain e.g. the signal timecourse of a known ―seed‖ 
region of interest [35, 36, 1].  There is no absolute threshold above which 
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correlation coefficient values are considered significant, as this depends on the 
strength of correlation in the system being observed, and the duration over 
which the correlation is assessed.  However, for data typically acquired over a 
period of 5 minutes, voxels with correlation coefficients of magnitude greater 
than 0.3 are generally considered to reflect a significant correlation [37]. 
 
3.4.1 Resting state functional connectivity 
 
Functional connectivity can be used to characterise the temporal coherence of 
disparate brain regions while the subject is at rest [38] to provide information 
on the networks of interconnected brain regions.  Many resting state networks 
have been identified; of the order of a dozen [37].  An example of a network 
of interconnected brain regions active during rest is the default mode network 
(DMN), shown in Figure 3.6.  The default mode network consists of 
interconnected regions where activation correlates during rest.  Typically, the 
default mode network comprises the posterior cingulate cortex and the inferior 
parietal lobules [39, 37].  Regions within the default mode network are usually 
active in the resting brain, therefore when comparing activity during a task to 
baseline; one might expect these regions to be less active during the task.  This 
must not be interpreted as a negative BOLD signal associated with the task 
being performed, only with the deactivation of the default mode network. 
 
 
Figure 3.6: Correlation between disparate brain regions comprising the default mode 
network. 
 
The salience network is of particular interest later in this thesis as it is 
concerned with the processing of emotional responses.  The salience network 
mainly exhibits connectivity between the bilateral insulae and the anterior 
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cingulate cortex (shown in Figure 3.7).  The primary sensory regions make up 
the sensory networks, such as the sensorimotor network (primary 
somatosensory and motor cortices) and the visuospatial network (primary 
visual cortex). 
 
 
Figure 3.7: Correlation in the salience network showing coherence between the bilateral 
anterior insula and anterior cingulate cortex. 
 
3.4.2 Functional connectivity: Acquisition and Analysis Methods 
 
Acquisition methods used are largely very similar to those used in task-driven 
BOLD functional MRI; EPI acquisition with an echo time of approx 40 ms, 
however it is most important to maximise temporal resolution, thus limiting 
the TR, and typically a TR of 2 seconds is used. 
 
Functional connectivity analysis can be approached in a number of ways.  
Seed based connectivity analysis, as described above, is often used to 
determine the pattern of a network and the strength of the correlation.  The 
technique was pioneered in a study assessing correlations in the motor cortex 
during resting state [40].  This involves the selection of a seed of interest from 
an a priori hypothesis.  For example, either from a known anatomical region, 
or alternatively, on the basis of areas identified from functional activation 
provided by general linear model analysis.  The timecourse of the voxel, or the 
mean timecourse of the group of voxels from the seed, is then extracted from 
the data.  Then, in a voxel to voxel method, the Pearson correlation coefficient 
is calculated for the timecourse of that voxel with the seed.  This produces a 
map of Pearson correlation coefficients.  These maps can be threshold and 
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quantitatively compared between subject groups, or drug conditions, by 
comparing the magnitude and extent of supra-threshold clusters.  A recent 
study by Hale et al [37] used this method to demonstrate the presence of the 
default mode and sensorimotor networks during resting state and compared the 
strength of the functional connectivity between field strengths (3 T and 7 T).  
They used an anatomically defined seed in the posterior cingulate for 
definition of the default mode network.  A motor task localiser was used to 
determine appropriate seed locations for the sensorimotor network.  Their 
results showed that the use of a conservative threshold of Pearson correlation 
coefficient allowed robust definition of the both networks during resting state. 
 
A further seed-based method of assessing functional connectivity is that of 
psychophysiological interaction (PPI), a concept introduced by Friston et al 
[41].  A region of interest for the seed must first be selected; the selection of 
the seed location should be based on an a priori hypothesis about the 
functional connectivity present in the data.  The time course of the signal in 
that region is then extracted and the areas with correlating timecourses are 
identified using a general linear model, as typically used in task-driven fMRI.  
This provides statistical maps that can be compared between two conditions 
using mixed effects analysis, paired t-testing or factorial analysis, for example 
between two drug conditions [42, 43] between two subject groups [44].  This 
method is similar to the seed-based correlation coefficient method, but has the 
advantage that covariates of no interest can easily be appended to the model, 
for example to regress out the effect of motion.  Also, rather than just 
identifying all brain regions whose activity is correlated with that of the seed, 
psychophysical interaction methods particularly look for areas where activity 
is correlated to both the task and to activity in the seed.  While this latter point 
is highly relevant for assessing connectivity within task or stimulus induced 
brain activity, it is less relevant to resting state functional connectivity.  
McCabe et al used this method to assess changes in resting state functional 
connectivity in healthy volunteers between two different anti-depressant 
medications (citalopram and reboxetine) compared to placebo.  They used 
timecourses from seeds in the default mode network in their 
psychophysiological interactions analysis.  Their analysis found reduced 
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connectivity in the groups that had taken anti-depressants compared to the 
placebo group, with citalopram reducing connectivity between the amygdala 
and the ventral medial prefrontal cortex, whilst reboxetine reduced 
connectivity between the orbitofrontal cortex and both the amygdala and 
striatum.  The study published by McCabe et al [45] is of a similar 
experimental design (placebo controlled pharmacological modulation of 
resting state functional connectivity) to the data presented later in Chapter 4 of 
this thesis. 
 
Hypothesis-free methods such as independent component analysis (ICA) can 
be used to identify the components of interconnected networks within the 
brain.  Once networks of interest have been identified, it is possible to further 
interrogate these networks by choosing a seed region and assessing temporal 
correlations with the seed region.  Such analysis techniques currently in use 
are mostly derived from the singular value decomposition method applied to a 
time series from a voxel or a region of interest within the brain.  This reduces 
complex timecourse data sets to lower dimensions in order to reveal 
underlying structures in the form of orthogonal components of voxel 
timecourses.  From this, principal component analysis is derived, where one is 
able to specify an anatomical region with which to search for coherence.  This 
is the method used in early functional connectivity studies [1, 34].  In a study 
published by Bullmore et al, subjects were given a complex visually 
stimulating cognitive task.  The periodicity of the experimental design was 
used to identify individual voxels that were active during each stimulus in the 
task.  From here, singular value decomposition was used to identify pairs and 
groups of regions within the brain that exhibited ―positive‖ or ―negative‖ 
connectivity.  For example, the regions used for visual input analysis had a 
negative connectivity with all other regions [1].  The method of principal 
component analysis through singular value decomposition works well for 
hypothesis driven investigation of network connectivity; however where there 
is no clear hypothesis, independent component analysis is commonly used. 
 
Biswal et al [34] demonstrated that it is possible to simultaneously measure 
activation using BOLD and ASL signal during resting state, and that the 
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temporal correlation found with the two methods was synchronous.  Further 
discussion of arterial spin labelling (ASL) techniques, including FAIR, is 
given in Section 3.5.4.  From their data, the group concluded that task driven 
activation correlated more with BOLD functional connectivity than it did with 
functional connectivity derived from perfusion weighted data.  However, this 
technique, although advanced at the time, was not optimal for acquiring ASL 
signal as their echo time is too long and thus the resultant image is primarily 
BOLD weighted and much of the ASL signal will be lost.  Later in this 
chapter, the methods section describes a similar technique to this, where 
instead two acquisitions are performed interleaved to provide almost 
simultaneous blood flow and BOLD data with a pseudo-continuous arterial 
spin labelling method.  Notwithstanding, they hypothesised that the observed 
low frequency fluctuations that show high temporal correlation across multiple 
brain regions are, in fact, neuronal in origin. 
 
More recent research published by De Luca et al [45] used ASL and BOLD 
data separately, analysed by a probabilistic ICA method to assess functional 
connectivity during resting state and during a bilateral finger tapping task.  
Their probabilistic ICA method was used in favour of a seed based approach 
that was deemed to introduce bias into the analysis associated with specifically 
searching for coherence with a given anatomical region.  Employing a 
probabilistic independent component analysis over a model-free ICA gives the 
advantage that the results are possible to interpret with quantifiable statistical 
significance.  Comparisons between independent components derived from 
BOLD and ASL data separately showed similar patterns in several 
components.  Perfusion weighted signals generated from ASL data give the 
added, physiologically more meaningful dimension and thus inferences are not 
just based on the BOLD response.  In their discussion, De Luca et al also 
postulate that the techniques outlined may be a helpful way of addressing the 
question of whether or not functional and resting state networks are altered by 
a pharmacological intervention. 
 
 
 
61
3.4.3 Pharmacological Modulation of Functional Connectivity 
 
A number of studies on pharmacological modulation of functional 
connectivity have been reported in animal models [48, 49].  However, such 
studies in human subjects are less prevalent.  Recent studies have investigated 
the effect of a drug, such as the beta blocker propranolol or a direct 
modulation of neurotransmitter on functional connectivity in autism patients 
[50] and healthy subjects [51, 52, 53, 54, 55, 56], including smokers [47, 57]. 
 
3.5 Blood Flow and Perfusion MRI 
 
Blood flow is the transit of blood through blood vessels and is conventionally 
measured in centimetres per second (cm/s), and can be measured non-
invasively using Phase Contrast Angiography (PCA) and Time of Flight 
(TOF) contrast angiography.  Perfusion MRI directly measures the delivery of 
blood to the tissue, termed cerebral blood flow (CBF).  This is defined as the 
rate of delivery of arterial blood to a capillary bed and exchange with the 
tissue.  CBF has the units millimetres per 100 grams per minute 
(ml/100g/min), whilst CBV takes the units of millimetres per 100 grams 
(ml/100g), or is sometimes expressed as a percentage.  Perfusion can be 
measured using exogenous contrast media such as gadolinium, or endogenous 
contrast as in the technique of Arterial Spin Labelling (ASL), to enhance and 
maximize the difference in signal detected between the inflowing blood and 
the surrounding tissue. 
 
3.5.1 Flow 
 
Blood flow can be measured non-invasively using the MR methods of Phase 
Contrast Angiography (PCA) and Time of Flight (TOF) contrast angiography.  
Both of these techniques are used in Chapters 5 and 6 of this thesis to locate 
major inflowing arteries in the neck. 
 
Phase contrast angiography (PCA) uses a bipolar gradient following the 
excitation pulse, preceding the readout.  Spins that stay stationary during the 
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application of the gradient have zero phase, and spins that travel during this 
time accrue a phase difference, Δ, proportional to their velocity in the 
direction parallel to the bipolar gradient [58], as shown in Figure 3.8.  This 
produces an image contrast that is sensitive to the velocity of blood in the axis 
of the bipolar gradient, with fast moving spins producing higher signal 
intensity.  This is shown as a projection image of the blood vessels in the 
volume of 60 mm slice in the sagittal plane, Figure 3.9 (A). 
 
 
Figure 3.8: Diagram of phase accumulation in phase contrast angiography (PCA).  Spins 
located in blood flowing through a bipolar gradient will accumulate a phase (B), whereas 
stationary spins will not (A).  The vector difference (C) gives the contrast of the image. 
 
Time of Flight (TOF) contrast uses multiple saturation pulses with short TR to 
saturate the longitudinal magnetisation of stationary tissue.  Moving spins will 
not have received these pulses, so that their longitudinal magnetisation is still 
relaxed, producing higher signal intensity.  This produces an image contrast 
that is sensitive to the flow velocity.  This is acquired over many narrow slices 
that are perpendicular to the flow of blood to retain sensitivity to blood that is 
flowing slowly through the slice.  These slices are then used to form a 
maximum intensity projection (MIP) across the entire volume, as in Figure 3.9 
(B), where 100 slices of thickness 0.7 mm were acquired. 
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 Figure 3.9: Non-invasive MR angiography in the form of (A) sagittal phase contrast 
angiogram (PCA) and Time of Flight (TOF) contrast angiogram (B). 
 
3.5.2 Perfusion 
 
Dynamic susceptibility contrast (DSC) and dynamic contrast enhanced (DCE) 
MRI measures perfusion using an exogenous contrast agent in the form of an 
injected bolus of paramagnetic material, such as gadolinium.  By monitoring 
the contrast agent bolus over time, the cerebral blood flow (CBF) and cerebral 
blood volume (CBV) can be measured.  This requires knowledge of the 
concentration of the contrast agent in the blood supply, also known as the 
arterial input function (AIF).  Although DSC does give very spatially specific 
results within a specified region of interest (ROI), this technique is invasive, as 
gadolinium must be injected into the subject.  Also, one is not able to control 
the transit delay of the bolus, which is not ideal, given that only one 
measurement of signal change can be obtained per bolus of contrast.  
Therefore in recent years, non-invasive perfusion methods are being 
investigated, one of which is Arterial Spin Labelling (ASL), which is a topic 
of research in Chapters 5 and 6 of this thesis. 
 
3.5.3 Origin of Arterial Spin Labelling (ASL) signal 
 
Arterial Spin Labelling (ASL) uses a magnetic label as an endogenous contrast 
used to measure perfusion MRI.  Perfusion is the measurable quantity of the 
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flow of blood through the capillaries in tissue to deliver the oxygen and 
nutrients to the tissue, as demonstrated in Figure 3.10. 
 
 
Figure 3.10: (A) Schematic of vasculature showing perfusion and (B) diagram outlining 
perfusion measurements in terms of arterial and tissue contributions to the ASL signal.  
The arterial transit time is given by Δ, and the capillary (tissue) transit time, δ.   is the 
time taken for exchange between arterial and tissue compartments. 
 
By manipulating the magnetisation of blood flowing into a region, ASL 
provides contrast in perfused tissue non-invasively.  RF pulses are used to 
magnetically label hydrogen nuclei in blood water molecules, typically using 
hyperbolic secant or FOCI pulses to invert their longitudinal magnetisation.  
After a delay time for the labelled blood to enter the capillaries and perfuse the 
tissue (known as the inversion time or post-label delay, TI), the brain is 
imaged, resulting in a ―label‖ image.  A second, ―control‖ image is then 
collected without this magnetic labelling.  Subtracting the ―label‖ image from 
the ―control‖ image gives an ASL perfusion weighted difference signal, M 
[59]. 
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Using ASL to measure perfusion has several advantages.  Primarily, ASL 
measures a physiologically meaningful quantifiable parameter, which leads to 
an unambiguous interpretation.  In contrast to DSC, it is non-invasive and 
completely safe.  This allows for repeated measurements to be taken and 
averaged, providing a robust, reproducible measure of cerebral perfusion.  
ASL does not interfere with or alter in any way the mechanism of brain 
activity and natural perfusion as labelling occurs completely undetected by the 
blood and surrounding tissue.  For functional studies, ASL measures an 
absolute level of brain activity, rather than a change relative to baseline 
activity, an advantage over BOLD contrast.  In this way it can be used not 
only to measure resting perfusion, but also to monitor changes associated with 
task activation [60] or with the administration of a pharmacological agent [61] 
or over a period of time [62], since ASL is not reliant on a T2* weighted 
signal.  This is important when measuring the effect of a drug on the CBF.  
ASL perfusion can also eliminate the problematic nature of low frequency 
scanner drift noise due to the fact that the ASL data are acquired by collecting 
and subtracting alternating label and control images [63]. 
 
Arterial Spin Labelling can be divided into two main types of labelling 
schemes: continuous (CASL) and pulsed (PASL), as depicted in Figure 3.11.  
In continuous ASL, the blood entering a narrow slice in the neck is 
continuously labelled for approximately 2 seconds using a low power 
radiofrequency pulse, to result in a steady state of flow driven inversion.  This 
provides ASL images with a very high signal-to-noise ratio, but also requires a 
large amount of radio frequency energy resulting in a high specific absorption 
rate, SAR.  CASL also typically requires the use of separate labelling and 
imaging coils, which are not usually available on commercially supplied 
machines.  Conversely, pulsed ASL typically uses a short radiofrequency 
pulse, typically a hyperbolic secant pulse, lasting only a few milliseconds to 
label the blood entering a thick slab, with a much narrower label gap between 
the labelling region and the imaging region.  In PASL, the same RF coil is 
used for both labelling and imaging.  For both continuous and pulsed ASL 
schemes, an image is acquired after the post-label delay, TI. 
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 Figure 3.11: Diagram showing pulsed and continuous ASL; pulse sequence and relative 
placement of imaging and labelling regions. 
 
The image encoding following the application of the label must be acquired 
rapidly before the label decays.  Many different gradient echo and spin echo 
schemes are used, but most routine is Echo Planar Imaging (EPI), Gradient 
and Spin Echo (GRASE, [64]), true Fast Imaging with Steady-state Precession 
(FISP, [65]).  All the work in this thesis uses a gradient echo – echo planar 
acquisition (GE-EPI) for the ASL acquisition.  This is usually acquired using 
the shortest possible echo time (TE) for the sequence, often around 10 to 13 
ms at 3 T, in order to minimise distortion due to magnetisation transfer effects.  
It is often desired to make different acquisitions at different echo times 
following the application of a single labelling pulse, in order to increase or 
decrease the sensitivity of the acquisition to the ASL inversion label. 
 
The use of just one acquisition following an inversion pulse is known as 
single-phase (or single TI) ASL, and a post-label delay of approximately 1500 
ms is often used at 3 T for the brain, as this time allows for the passage of the 
labelled arterial blood water into the tissue without the label decaying.  
However, the post-label delay required is dependent on the field strength as 
this alters the T1 of the tissue being imaged.  Above, single-TI ASL methods 
have been described; alternatively, one may vary the number of acquisitions 
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that follow a single inversion pulse.  If measurement of arterial or tissue transit 
time is required, then a multi-phase method is used where images are acquired 
at intervals following labelling in order to follow the transit of blood through 
the brain for the duration of the T1 of blood (approximately 1500 ms at 3T) 
[66], such as Look-Locker ASL [67] or QUASAR [68].  Timings can be 
varied to alter the sensitivity of the sequence to arterial or tissue signal, thus 
giving accurate measurement of either arterial blood volume (CBVa) and 
arterial transit time (Δ) or cerebral blood flow (CBF) and capillary transit time 
(δ).  Signal readouts for each voxel can then be used to fit a curve of a 
hypothesised arterial input function for quantification of CBVa or CBF and 
the corresponding transit time [69, 70]. 
 
3.5.4 ASL Sequences 
 
There are several different sequences available for pulsed ASL.  Two of the 
most frequently used sequences are STAR (Signal Targeting Alternating 
Radiofrequency) [71] and FAIR (Flow-sensitive Alternating Inversion 
Recovery) [72].  Similar to FAIR is PICORE (Proximal Inversion with a 
Control for Off-Resonance Effects [73]).  STAR, FAIR and PICORE use the 
application of a frequency selective adiabatic inversion pulse such as a 
hyperbolic secant or a FOCI (Frequency Offset Corrected Inversion) pulse.  
STAR has a user-specified labelling region in the neck, to which is applied a 
180° inversion pulse in the labelling condition and two 180° pulses which sum 
to give a nominal 360° pulse in the control condition.  FAIR and PICORE, on 
the other hand, work by using a selective inversion pulse with a slice select 
gradient for the labelling condition and a non-selective inversion in the 
absence of a slice select gradient for the control condition.  FAIR and PICORE 
use a 180° flip angle for both label and control conditions, acquiring the 
control in the absence of a slice-selection gradient. Pulse sequences and 
positioning of selective inversion slabs with respect to labelling regions are 
shown for STAR, FAIR and PICORE in Figure 3.12. 
 
A less frequently used technique is TILT (Transfer Insensitive Labelling 
Technique), also shown in Figure 3.12.  TILT is based on the application of 
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two successive 90° pulses with a slice select gradient for both the label and 
control conditions.  In the labelling condition, the pulses are in phase, causing 
accumulation of inversion, whereas in the labelling condition, the two pulses 
are equal and opposite, thus cancelling each other out.   
 
 
Figure 3.12: Pulse sequence diagrams for commonly used ASL sequences; STAR, FAIR, 
TILT and PICORE, showing RF pulses, gradients and position of inversion pulses with 
respect to the imaging region. 
 
Another frequently used modification to pulsed ASL is QUantitative Imaging 
of Perfusion using a Single Subtraction (QUIPSS), and more recently, 
QUIPSS II.  These involve the application of a saturation pulse either to the 
imaging slice (QUIPSS) or to the labelling region (QUIPSS II).  This limits 
the duration for which labelled blood can continue to contribute to the MR 
signal (i.e. restricts the increase in cumulated signal to between two known 
time points), thus allowing quantitative CBF to be calculated using a single 
subtraction as opposed to multiple subtractions (LLEPI).  QUIPSS and 
QUIPSS II are often used in functional perfusion experiments [74, 73]. 
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A study in Chapter 4 of this thesis uses the recently developed pseudo-
continuous ASL (PCASL) scheme.  This labels a region in the neck below the 
imaging region, akin to continuous ASL, as shown in Figure 3.13.  Typical 
label thicknesses used are of the order 100 mm, with a label gap of 
approximately 85 mm.  Typically, a labelling duration of 1500 ms to 2000 ms 
is used, while post-label delay can vary from 900 ms to 1400 ms. 
 
 
Figure 3.13: Schematic of PCASL, showing locations of labelling and imaging regions. 
 
In PCASL, the repeated application of RF pulses produces a steady state in the 
absence of T1 and T2 decay [75].  If the rate of change of the direction of the 
steady state magnetisation is kept low, then the magnetisation can be 
considered to follow the steady state solution.  The z component of the 
magnetisation in the steady state conditions is dependent on the flip angle of 
the RF pulse (α), and the phase shift experienced during the time between 
pulses (φ).  It is therefore necessary to optimise the values α and φ to maintain 
the slowest rate of change of magnetisation vector.  Eqn. [3.1] shows the 
steady state z component of the magnetisation, Mz, in terms of the RF flip 
angle, α, and the phase shift, φ [75]. 
 
   
          
 
 
                    
 
 
 
 
Eqn. [3.1] 
 
The phase shift, φ, is described by a function of z position and flow velocity: 
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 Eqn. [3.2] 
 
where, γ is the gyromagnetic ratio, G is the slice-select gradient, z0 is the z 
distance from the labelling plane to the system isocentre, and v is the blood 
velocity through the labelling plane. For standard distances between the 
labelling plane and the imaging plane of approximately 100 cm,  
00
z  (the 
zeroth order gradient moment) dominates over  v
1
  (the first order gradient 
moment).  Figure 3.14 shows the steady state solution of Mz for various values 
of the flip angle, α.  The following plots show the effect of varying flip angle, 
α, on the z magnetisation as a function of phase shift, φ. 
 
 
Figure 3.14:  Alsop model for the z component of the steady state magnetisation for four 
different values of α, the RF flip angle [75, 76, 77].  For slow changes in steady state 
angle, the magnetisation can be considered to follow the steady state solution. 
 
Wu et al [78] proposed two variants of the pseudo-continuous labelling 
schemes; balanced and unbalanced, as shown in Figure 3.15.  Each scheme 
consists of a label and a control.  For both schemes the polarity of the 
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radiofrequency pulse is constant during the labelling session, and alternates 
during the control session.  The two schemes vary in their gradient properties; 
the balanced scheme uses a balanced non-zero zeroth gradient moment for 
both label and control, whereas the unbalanced scheme uses different 
gradients for the label and control conditions.  The label condition has a non-
zero balanced zeroth gradient moment whilst the control condition has nil 
zeroth gradient moment, and so no phase shift.  Figure 3.15 shows a schematic 
of the pulse sequence for the balanced and unbalanced PCASL pulse 
sequences. 
 
 
Figure 3.15: Balanced and unbalanced PCASL schemes; RF pulses and gradients shown 
for two consecutive pulses in the pulse train to demonstrate constant / alternating 
polarity of RF and gradients for each scheme. 
 
The version of PCASL commercially available on the Philips MRI system 
uses an unbalanced PCASL scheme comprising repeated Hanning window RF 
pulses.  These pulses have durations of approximately 0.5 ms and are repeated 
every 1 ms for a user-specified labelling duration. 
 
Since development, PCASL has been widely used to demonstrate the 
measurement of steady state resting perfusion in grey matter and thus 
functional MRI [79] measurement of perfusion in white matter [80], and been 
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combined with multi-phase methods to quantitatively measure cerebral blood 
flow [81].  PCASL has been compared quantitatively with 
15
O-water positron 
emission tomography (PET) for the reliability and accuracy of whole brain 
cerebral blood flow measurement and PCASL was found to reliably and 
accurately provide converging measurements in both white matter and grey 
matter regions of interest in healthy subjects and patients ranging in age from 
young to elderly [82]. 
 
3.5.5 CBF as a tool for measuring brain function 
 
Regional perfusion changes provide a more direct method to assess neural 
activity than BOLD, as it only relies on the assumption that neuronal 
activation increases oxygen consumption in the cells, and therefore increased 
perfusion directly indicates the occurrence of brain activity.  In contrast, the 
BOLD signal is dependent on a highly complex function of CBF, CBV and 
metabolic rate of oxygen consumption (CMRO2), it cannot always be 
considered to directly reflect neuronal activity, and as described above can be 
confounded by differences in baseline vasculature (due to age, metabolic state, 
and the presence of disease or medication). 
 
Arterial spin labelling presents the opportunity to detect regional perfusion 
changes with relatively high temporal resolution compared to positron 
emission tomography, which may correlate with the presentation of a task, the 
administration of a drug, or some other covariate of interest [72].  Studies have 
previously used ASL perfusion to isolate task related regional changes in 
perfusion.  For example, ASL perfusion was used to localise activity 
associated with cue-induced nicotine craving in smokers [83].  21 smokers 
underwent ASL fMRI while being shown smoking and non-smoking related 
cues.  Smoking related cues were correlated with an increased level of 
perfusion as measured by ASL in the dorsolateral prefrontal cortex and the 
posterior cingulate cortex, both areas implicated in reward substrates, and drug 
conditioned reward substrates by a priori knowledge gained from humans and 
animals. 
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3.5.6 Pharmacological Modulation of ASL Perfusion 
 
ASL can assess the effect of a drug on the brain in one of two ways; either to 
detect a global change in cerebral blood flow that correlates with drug 
administration [84, 26], or alternatively, to look for regional changes in the 
ASL signal, correlated with pharmacological interaction, which may signify 
the modulation of task related brain activity [31, 85].  In Chapter 4 of this 
thesis, both these methods are used to investigate the effects of the beta-
blocker, propranolol. 
 
In a study by Bendlin et al, the effect of caffeine was observed using BOLD 
contrast fMRI for its effect on the BOLD response to a word stem completion 
task, and on resting ASL perfusion [84].  21 healthy volunteers were randomly 
divided into three groups: one group ingested a cup of coffee containing 
approximately 222 mg caffeine (n = 10), one group received decaffeinated 
coffee (n = 5), and one group water (n = 6).  Subjects each had two scans, one 
at baseline, and one after receiving the coffee, decaffeinated coffee or water.  
In each scan, the subjects performed the word stem completion task while 
undergoing BOLD fMRI scanning.  In addition, subjects were also scanned 
using ASL perfusion at rest.  The ASL scan demonstrated, as expected, that 
caffeine significantly decreased the cerebral perfusion, whilst the two groups 
that were given decaffeinated coffee and water did not show any significant 
differences in perfusion, and so they were combined to form a single control 
group.  Comparison between the first and second sessions showed that while 
the subjects that received caffeinated coffee exhibited a significant decrease in 
the extent of BOLD activation in the second scan, no significant change in 
extent of activation was found in the subjects in the control group.  However, 
the signal intensity increased significantly in both the caffeinated coffee group 
and in the control group, with the control group having the greater rise in 
signal intensity, conflicting with previous findings [26].  Here, the use of ASL 
allowed the identification of a drug induced modulation of global perfusion 
that could explain the phenomenon detected using BOLD contrast fMRI. 
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The effect of caffeine on a visual and motor stimulus was assessed using 
simultaneous BOLD and ASL perfusion fMRI [31] using a PICORE Q2TIPS 
sequence [85].  This was performed before and after an intravenous infusion 
of either saline (placebo) or one of a number of caffeine doses.  Both BOLD 
and ASL signal were compared before and after infusion.  The maximum 
increased BOLD response was detected in the group that received an 
intermediate dose of intravenous caffeine, whereas the maximum CBF 
response as measured by ASL was detected in the group that received the 
highest caffeine dose.  This decoupling of the two differently acquired 
observations of the haemodynamic response gives great insight into the 
mechanisms behind drug action and the dependence of BOLD signal on both 
neuronal activity and changes in baseline flow. 
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4 Effect of beta-blocker on resting and task-driven brain activity 
 
This chapter reports on a healthy volunteer study into the effect of the 
peripherally acting beta-blocker, nadolol on brain activity at rest and 
associated with the processing of an emotional visual stimulus.  First, this 
chapter introduces the relevant literature on the processing of emotion and 
arousal stimuli.  The measures that were taken to design the experiment, 
acquire and analyse the data are then described, followed by the results found. 
 
4.1 Background 
 
Several published experiments have led to the general understanding that there 
is a correlation between peripheral reactivity (such as changes in heart rate and 
blood pressure) during the processing of emotions and the underlying neuronal 
activity. The James-Lange theory of emotion, developed in the late 19
th
 
century but still commonly referred to [1], states that the experience of an 
emotion results from the perception (feeling) of an aroused bodily state 
(arousal).  Subsequently, the two-factor theory of emotion [2] agrees that the 
perception of arousal is highly relevant, but states that the emotion 
experienced is due to a combination of the two factors of cognitive state and 
physiological arousal.  Further, it suggests that awareness of physiological 
arousal causes enhanced emotional state, but the nature of arousal is the same 
for all emotions and that a subject will use emotionally relevant cues to 
interpret their feeling of arousal.  Peripheral reactivity can be modulated by a 
pharmacological agent, such as a beta-adrenoceptor antagonist (beta-blocker), 
which causes a decrease in heart rate and blood pressure by blocking the 
uptake of adrenaline at the beta-adrenergic receptors. 
 
4.1.1 Neural processing of emotion and arousal 
 
The James-Lang theory of emotions is supported by many neuroimaging 
studies [3, 4, 5, 6], which demonstrate that peripheral autonomic nervous 
system responses to emotional stimuli, such as changes in heart rate and blood 
pressure, can be predicted by observing changes in the level of activity in 
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relevant brain regions, including the limbic system, comprising the amygdala, 
brainstem and the salience network (anterior insula and anterior cingulate).  
These regions have also been shown to be key areas implicated in mediating 
interoceptive awareness [7]. 
 
It is possible to describe states of mood and changes to those states in terms of 
two concepts when discussing the psychology and physiology of emotion and 
mood; valence and arousal.  Valence is an emotional value that refers to the 
intrinsic attractiveness or aversiveness of a stimulus.  Valence is scaled from 
highly aversive / highly unpleasant (corresponding to a low valence) to highly 
attractive / highly pleasant (high valence).  Arousal is the state of being 
reactive to stimuli; being awake or alert.  Stimuli can be described as ranging 
from soporific (low arousal) to highly stimulating (high arousal).  These 
concepts are relevant when discussing peripheral autonomic reactivity as the 
degree of reaction induced in the autonomic nervous system by the 
presentation of a stimulus will be approximately correlated to the subjective 
arousal rating attributed to it [7].  While the valence and arousal of a given 
stimulus are generally independent, stimuli with extreme valences (very high 
or very low) are associated with higher arousal states than stimuli of neutral 
valence. 
 
4.1.2 Functional neuroimaging studies of emotional processing 
 
In the literature, there are many studies that report investigations into the 
brain‟s response to emotional visual stimuli.  Here, some of these shall be 
outlined, and their findings reported. 
 
Visual stimuli used in studies into emotional processing and mood induction 
often take the form of photographs of emotional faces, including happy, angry, 
sad, or disgusted facial expressions taken from the Standardized Face 
Database (The Karolinska Directed Emotional Faces – KDEF [8]) [3], or 
images combining emotionally arousing faces and scenes [9], as provided by 
the International Affective Picture System (IAPS [10]) [11, 12, 13].  The order 
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of presentation of stimuli of different valences is either randomised or fixed to 
ensure that any intensity carryover effects are minimised [14].   
 
Neuroimaging in such studies is typically performed using fMRI [14] or 
Positron Emission Tomography (PET [11]).  Electroencephalography (EEG) 
[12] and magnetoencephalography (MEG) [13] recording can also be used 
either alone, or EEG in combination with fMRI. 
 
Subjective ratings of perceived mood are used to better understand neural 
processing of emotional stimuli.  Participants in such studies are often asked to 
rate pleasantness and arousal of images during the imaging study, or outside 
the scanner using a system such as a self-assessment manikin (SAM, Bradley 
and Lang, 1994, Pollatos et al 2005).  Conversely, in some studies, subjects 
are intentionally not asked to rate images, as this is viewed as a possible cause 
of alteration to brain activation patterns [16]. 
 
Critchley and co-authors assessed the link between peripheral processes and 
brain activity by identifying which regions of the brain exhibited activity that 
correlated with evoked changes in heart rate [3].  Subjects were presented with 
visual stimuli in the form of photographs of emotional faces during fMRI 
acquisition and the recording of heart rate.  Critchley et al demonstrated that 
changes in heart rate in response to an emotional stimulus can be predicted by 
the level of activity within an emotion matrix of interconnected brain regions, 
including the amygdala, insula, anterior cingulate, and brainstem. 
 
An article recently published in 2011 in the Journal of Addiction Biology by 
Kobiella et al [14] reports results from a pharmacological study similar in 
design to the one described in this chapter.  Kobiella et al studied the effect of 
the stimulant Nicotine on the brain activity elicited by a mood induction task.  
This was a double-blinded, randomised crossover design, recruiting 35 healthy 
non-smoking participants.  Subjects viewed emotional stimuli from the IAPS 
while undergoing fMRI.  They used an event related design in which 40 
images were used for each stimulus type (neutral, pleasant or unpleasant); 
each image was presented for two seconds, followed by a randomly varying 
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inter-stimulus interval of between 2.0 and 9.9 seconds (mean 6 seconds).  Data 
were assessed for brain areas that showed greater activation in each of the 
emotional stimuli when compared to neutral stimuli. 
 
Reviewing the literature, it has been shown that picture stimuli of both valence 
types (i.e. both pleasant and unpleasant images) are processed using a 
common subset of active brain regions, as shown in Table 4.1.  Due to the use 
of visual stimuli, activations are always elicited in the visual cortex [17, 18].  
For this reason, it is common to assess not only the areas of activation under 
emotional stimuli (i.e. the main effect), but also the areas that are more active 
during emotional stimuli in comparison to matched neutral stimuli (i.e. 
[pleasant > neutral], [unpleasant > neutral]).  It is also possible to consider 
task-induced deactivation; areas that are less active during emotional stimuli 
during baseline, which can be further explored using contrasts such as [neutral 
> pleasant] or [neutral > unpleasant].  Few studies discuss this, and this thesis 
will focus on task-induced positive activation only.  Table 4.2 shows brain 
regions that are reported as exhibiting activation in response to emotion and 
mood inducing visual stimuli, compared to neutral stimuli. 
 
Emotional stimulus Brain region Papers 
Fear amygdala [19] 
Negative Emotion 
dorsal cingulate cortex, 
dorsomedial prefrontal cortex 
[12] 
Pleasant / Unpleasant insula [20, 21] 
Pleasant / Unpleasant anterior cingulate cortex [22, 18] 
Pleasant / Unpleasant medial prefrontal cortex [23, 16, 24] 
Pleasant / Unpleasant ventromedial prefrontal cortex [20] 
Pleasant / Unpleasant orbito-frontal cortex [25] 
Threat amygdala [26] 
Table 4.1: Brain regions shown to exhibit activity in response to emotional and mood 
inducing visual stimuli as reported in the literature. 
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Stimulus comparison Brain region Papers 
Pleasant > Neutral amygdala [15, 27, 18, 3, 14] 
Pleasant > Neutral hippocampus [28, 29] 
Pleasant > Neutral precuneus [11, 14] 
Pleasant > Neutral insula [3] 
Pleasant > Neutral anterior cingulate cortex [3, 14] 
Pleasant > Neutral brainstem [3] 
Pleasant > Neutral right substantia innominata [9] 
Pleasant > Neutral 
middle / inferior occipital 
gyrus, fusiform gyrus 
[14] 
Pleasant > Neutral posterior cingulate cortex [14] 
Pleasant > Neutral thalamus [14] 
   
Unpleasant > Neutral amygdala [15, 27, 18, 3, 14] 
Unpleasant > Neutral hippocampus [28, 29, 14] 
Unpleasant > Neutral nucleus accumbens [11] 
Unpleasant > Neutral precuneus [11, 14] 
Unpleasant > Neutral insula [3, 14] 
Unpleasant > Neutral brainstem [3] 
Unpleasant > Neutral anterior cingulate cortex [9, 3] 
Unpleasant > Neutral red nucleus, thalamus [14] 
Unpleasant > Neutral 
fusiform gyrus, middle / 
inferior temporal gyrus, middle 
/ inferior occipital gyrus 
[14] 
Table 4.2: Brain regions exhibiting greater response to emotional visual stimuli, 
compared to neutral visual stimuli as reported in the literature. 
 
The salience network [27], comprising the bilateral insula and anterior 
cingulate cortex [30, 31], is believed to be involved in affective processes, 
such as emotional responses and interoceptive awareness [32, 33].  As shown 
in Table 4.1 and Table 4.2, these areas are widely reported as exhibiting 
increased activation in response to emotional visual stimuli, compared to 
neutral stimuli using a range of experimental designs.  Additionally, the 
amygdala is reported in the processing of emotional stimuli, particularly those 
of a negative valence. 
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4.1.3 Modulation of emotional processing 
 
It has been demonstrated that in patients with spinal cord injury that causes 
them to have a deficit in the peripheral feedback mechanism, there is a 
reduction in the level of brain activity in the interconnected emotion matrix of 
brain regions in response to an aversive fear conditioning task [6].  This 
difference was assessed using functional MRI in a study comparing brain 
activity in the spinal cord injury group with that of a healthy control group.  
The reduced activity in the task-related brain regions in the patient group was 
attributed to their reduction in feedback to emotional stimuli, thus supporting 
the hypothesis of the integration of emotion and bodily arousal. 
 
The next question to investigate is whether a pharmacological manipulation of 
peripheral reactivity induced by drugs interacts with the experience of 
emotions and the central activation to the processing of emotional stimuli. 
This pertinent question gives a more practical controlled comparison, 
analogous to the spinal cord injury group described above.  If a drug can 
replicate the disruption of the peripheral feedback mechanism found in 
patients with spinal cord injury, then it can be hypothesized that an 
experimentally induced decrease in peripheral reactivity should decrease both 
the experience of emotional intensity, as well as the accompanying brain 
activity during the processing of emotional stimuli. 
 
The amygdala response to emotional verbal stimuli has been shown to be 
reduced by a single 40 mg dose of the centrally acting beta-blocker, 
propranolol [34].  In a placebo controlled fMRI study, it was demonstrated 
that the BOLD response to memory encoding in the amygdala and to memory 
recall in the hippocampus was reduced by propranolol compared to placebo, 
without any significant effect on recall ability. 
 
Some behavioural studies have observed the effect of both peripherally and 
centrally acting beta-blockers on the memory of emotional material [35, 36].  
Cahill et al [36] investigated the proposal that emotional memory of a stressful 
experience is associated with increased levels of the beta-adrenergic stress 
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hormone.  36 subjects were given a single dose of either 40 mg propranolol or 
placebo in a single-blinded design.  One hour after tablet administration, 
subjects were presented with a sequence of slides showing a short story of 
either emotionally arousing or neutral matched content, with each slide being 
presented for 20 seconds.  Memory assessment of the emotional story was 
carried out one week following the initial session.  The study was designed to 
eliminate the confound that propranolol has been reported to affect alertness 
and concentration in patients.  If this was the case, subjects would experience 
impaired memory of the neutral story in the propranolol condition compared 
to placebo, which was not found.  Instead, the effect was selective impairment 
of the ability to recall the emotional story following propranolol compared to 
placebo; strongly supportive of the hypothesis that beta-blockade impairs the 
enhanced memory of emotional arousal. 
 
In a later emotional memory recall experiment [35], the centrally acting beta-
blocker, propranolol, the peripherally acting beta-blocker, nadolol, and a 
placebo were assessed.  Subjects were randomly placed in one of the three 
drug groups and administered a single dose of either 40 mg propranolol, 40 
mg nadolol or matched placebo.  At the appropriate peak plasma concentration 
for the drug (a delay of 3 hours for nadolol, 1 hour for propranolol; the 
placebo group were divided equally between 1 hour and 3 hour delay), 
subjects were then shown emotionally arousing stimuli in the form of a slide 
show of an emotional story across 11 slides, each presented for 20 seconds, 
each with audio narration.  This was almost identical to the slideshow 
described as the emotional stimulus in the study described prior to this one 
[36].  In this latter study, the slides that constituted the emotional story were 
grouped into neutral and emotive stimuli.  A week later, subjects were 
examined on the detail they could recall.  All subjects exhibited enhanced 
memory of the emotional stimuli compared to the neutral stimuli.  However, 
this study reported no significant differences in memory recall ability between 
the drug groups.  They concluded that the single 40 mg dose of each drug used 
in their study was insufficient to produce an effect. 
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4.1.4 Beta-blockers 
 
Beta-blockers are a class of drugs that are widely prescribed as a treatment for 
a number of indications including hypertension, atrial fibrillation and 
prophylaxis of migraine.  They act by inhibiting the stimulation caused by the 
uptake of epinephrine at the beta-receptors, thus having a negative 
chronotropic and inotropic effect on the heart, i.e. they decrease the heart‟s 
sympathetic actions of increasing the rate and strength of heart beat.  Beta-1 
receptors are located in the cardiac muscle, and a blockade of these receptors 
directly causes the observed decrease in heart rate and blood pressure.  Beta-2 
receptors are predominantly found in smooth muscles such as those that line 
the airways, (e.g. bronchial muscles).  A blockade of beta-2 receptors causes 
airway constriction and for this reason, use of beta-blockers is contra-indicated 
in subjects with asthma, even if the subject is otherwise healthy.  Some beta-
blockers selectively block beta-1 or beta-2 receptors, whereas others termed 
“non-selective” will block all beta-receptors, although often there will be a 
preference for the blockade of one receptor type.  The important distinction to 
be made in this study is that beta-blockers can be broadly divided into two 
subgroups; centrally acting and peripherally acting.  This distinction refers to 
the extent to which beta-adrenergic transmission is blocked, i.e. whether the 
effect acts mainly on the central nervous system, the peripheral nervous 
system, or both.  Centrally acting beta-blockers, such as propranolol, suppress 
autonomic responses from the central nervous system whilst peripherally 
acting beta-blockers, such as nadolol, suppress these signals from the 
peripheral nervous system.  In the study presented in this chapter, the drug has 
carefully been chosen to be a peripherally acting beta-blocker, in order to 
modulate only the peripheral autonomic feedback, minimising modulation of 
central reactivity [35]. 
 
4.1.5 Summary of experimental design 
 
Several studies have consistently demonstrated reduced amygdala 
responsiveness [34], and emotional memory encoding and retrieval under the 
influence of beta-blockade [35, 36, 38]. Much of this evidence has been the 
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product of research on post-traumatic stress disorder [39, 40].  For example, 
studies have reported that the administration of a beta-blocker to subjects who 
have recently experienced a trauma resulted in a significant reduction in their 
probability of later developing the disorder [39, 40].  The mechanism of action 
behind the effect reported in these studies however has a certain ambiguity as 
the beta-blocker used is the centrally acting beta-blocker, propranolol.  A 
centrally acting beta-blocker causes a global modulatory effect on the 
autonomic nervous system, and is expected to result in decreased central 
reactivity, such as a reduction in CBF.  When designing a study, care must be 
taken to eliminate the direct central effects of the chosen drug and disentangle 
the effects of reactions to emotional arousal compared to neutral stimuli.  
Since propranolol does not act selectively in the periphery, the modulatory 
effects that are reported in these papers may be direct central effects.  To 
disentangle these possible effects, this chapter studies the influence of the 
peripherally acting beta-blocker, nadolol, on the fMRI response to neutral, 
pleasant and unpleasant visual stimuli.  Nadolol crosses the blood brain barrier 
to a considerably lesser extent than a centrally acting beta-blocker.  Emotional 
picture stimuli are expected to induce a change in mood, which will be 
reflected by changes in brain activity.  This is further optimised by using a 
double blinded placebo controlled crossover study design. 
 
It is currently not well understood whether modulation of the peripheral 
feedback mechanism will in turn modulate activity in the brain areas 
implicated in mediating interoceptive awareness.  The idea of creating a 
pharmacological blockade of autonomous nervous responsiveness is an 
elegant way to test the James-Lange theory, and the more recent two-factor 
theory proposed by Schachter and Singer.  
 
By collating current information in the literature, it is suggested that both 
stimuli of emotional faces and emotional scenes elicit the use of overlapping 
structures due to similarities in the underlying processes [3, 14].  On this basis, 
stimuli both of emotional faces and emotional scenes are used in this chapter. 
In this way, the study can observe drug modulation by the chosen drug, 
nadolol, on all picture stimulus types across the range of image valences.  
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Emotional images provide a stimulus which induces a mental state or “mood” 
in the subject.  A block design is better suited to this type of stimulus, as it 
provides a longer period over which the stimulus acts, and a baseline period 
between stimuli of different valences allows the subject to return to baseline or 
switch “off” the mood, which will not happen as rapidly as for other visual 
stimuli [32].  Additionally, this design allows for comparison of each stimulus 
condition to a baseline, or “off” condition, assuming that its duration is long 
enough for the effect of the emotional stimulus to have worn off / dissipated.  
Further, this allows the comparison of each emotional state (pleasant, 
unpleasant) to the neutral state with respect to the baseline. 
 
The number of repeated measurements should be maximised, whilst keeping 
the length of the entire study reasonable from the perspective of participant 
attention and comfort.  Subjects‟ attention can be maintained by introducing a 
response task between stimulus blocks.  In addition, information on subjective 
arousal rating can be useful in correlating intensity of activation with intensity 
of arousal perceived.  Also, behavioural data can be used to identify or justify 
any outliers in the dataset. 
 
The primary study aim of this chapter is to determine whether nadolol 
modulates activity in brain regions within the salience network during the 
presentation of emotional visual stimuli.  Further secondary aims are: 
 To determine whether any differences in activity are specific to 
the valence of the emotional stimulus (pleasant or unpleasant); 
 To determine whether BOLD changes are associated with 
perfusion changes as measured using ASL; 
 To determine whether nadolol modulates activity in regions not 
implicated in the salience network or the processing of 
emotional stimuli, indicative of a confound by direct central 
action of a beta-blocker; 
 To determine whether there are changes in resting perfusion or 
resting functional connectivity in response to nadolol, which 
could explain the differences in response to stimuli, if found. 
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The hypothesis formed for the primary outcome measure is that a single 80 mg 
dose of nadolol reduces emotion-related bodily arousal, and in line with the 
James-Lange theory and the two-factor theory, consequently reduces the 
neural response to emotional stimuli.  Despite contradictory previous results 
[35], nadolol is also expected to reduce subjective arousal and intensity of 
perceived emotional experience. 
 
4.2 Materials and methods 
 
4.2.1 Participants 
 
The number of subjects required for statistical power can be calculated in 
terms of the effect size [41].  The effect size of previous studies with similar 
experimental designs have been adequate [42], and thus the recommendation 
of Carter et al is that an adequate sample size should be at least 15 to 20 
subjects for comparison between subjects and stimuli.  Therefore, this study 
design recruited 20 subjects, allowing for some subjects to be excluded later if 
necessary.  For this reason, ethical approval was sought for the recruitment of 
20 healthy volunteers for the pharmacological study; in addition 5 volunteers 
were recruited for the pilot study to optimise the scanning protocol and 
emotional stimuli.  The study was approved by the University of Nottingham 
Medical School Research Ethics Committee in the form of an amendment to a 
previously approved pharmacological MRI study.  Approval was also sought 
and obtained from the Nottingham University Hospitals Trust Research and 
Development department, also by amendment to a previously approved 
pharmacological MRI study.  Approval from the Medicines and Healthcare 
products Regulatory Agency (MHRA) was not required, in compliance with 
the Clinical Trial Directive [43], as the effect under investigation is not related 
to the clinical action or efficacy of the drug. 
 
Volunteers for the study were recruited via posters placed in academic and 
residential buildings on campus, in accordance with the Research Ethics 
Committee approval.  The recruitment poster is given in Appendix A.  All 
respondents to the advertisement were first screened for contra-indications to 
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MRI, including reporting negative for metal implants or prostheses, no metal 
objects in their bodies, and no history of claustrophobia, blackouts or seizures, 
and for contra-indications in their medical history against taking the beta-
blocker, nadolol, for example a history of asthma or cardiac condition.  The 
safety questionnaire used is included in Appendix B.  Further, respondents 
underwent cardiac examination including 12-lead electrocardiogram, 
interrogated for cardiac output parameters and rhythm strips administered by a 
qualified cardiology nurse in Cardiology West, Queen‟s Medical Centre, 
Nottingham.  Clinical assessment of healthy volunteers was undertaken by Dr 
A. A. Hosseini.  Participants were English speaking and had normal vision or 
were able to use contact lenses to correct their vision to normal.  Female 
participants were asked to confirm that they were not pregnant at the time of 
either scan.  Volunteers gave fully informed written consent after the 
procedure was explained to them.  Volunteers were asked to abstain from any 
psychoactive substances (including alcohol, caffeine, tea, chocolate, pain 
killers, energy drinks) on the day of each scan. All MRI scans took place 
between 4 pm and 8 pm.   
 
Volunteers completed the following psychological questionnaires preceding 
their first MRI scan, for psychological assessment independent of drug effect: 
 Hospital Anxiety and Depression Scale (HADS) [44] 
 Emotion Reactivity Scale (ERS) [45] 
 Toronto Alexithymia Scale (TAS) [46] 
 Bermond-Vorst Alexithymia Questionnaire (BVAQ) [47] 
 Interpersonal Reactivity Index (IRI) [48] 
 Body Perception Questionnaire [49] 
 
These questionnaires are provided in Appendix C. 
 
4.2.2 Drug administration 
 
Each volunteer attended two scan sessions, with a separation between sessions 
of 7 to 21 days.  In each session, the participant was given a single tablet for 
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oral administration containing either 80 mg nadolol or placebo in a double-
blinded, randomised, crossover design, as shown in Figure 4.1.  Nadolol is a 
non-selective, peripherally acting beta-blocker, typically produced by Sanofi 
Aventis under the trade name Corgard [50] as an 80 mg tablet to be swallowed 
once a day, and is prescribed to patients for the treatment of hypertension, 
angina and migraine.  The 20 tablets each of 80 mg nadolol and placebo were 
provided by the Pharmacy at the Queen‟s Medical Centre, Nottingham. 
 
 
Figure 4.1: Schematic of randomised crossover pharmacological fMRI study design. 
 
The peak plasma concentration of nadolol occurs approximately 3 hours after 
drug administration [38].  Therefore, after tablet administration, the volunteer 
waited 2 hours 30 min before commencing imaging to allow the peak plasma 
concentration of the drug to occur at the same point during each MRI scanning 
session.  In each session, the volunteer spent approximately one hour in the 
MR scanner (with image acquisition time taking approximately 42 minutes). 
 
4.2.3 Behavioural questionnaires 
 
Directly before each MR scan, subjects underwent training for the functional 
task to be presented in the MR scanner.  Following this, subjects completed 
two further behavioural questionnaires, devised by Professor Olga Pollatos: 
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 Pain empathy questionnaire: subjects were shown images of people 
in pain and not in pain and asked to rate the level of pain 
experienced, along with their rating of valence and arousal. 
 Emotional faces questionnaire: subjects were asked to categorise 
the emotion depicted on the faces of the people in the photographs 
into the categories: neutral, happy, fearful, sad, angry and 
disgusted. 
 
Copies of these questionnaires are given in Appendix D. 
 
4.2.4 Physiological measurements 
 
Blood pressure is a primary outcome measure of drug action.  Blood pressure 
was measured at the beginning of the session, following a five minute rest 
period, to allow the blood pressure to settle after the subject arrived.  This was 
followed immediately by tablet administration.  Blood pressure was measured 
again at two hours following tablet administration, and a third time after 
leaving the MRI scanner, having allowed a further five minute rest period.  
Systolic and diastolic blood pressure readings were used to calculate mean 
arterial blood pressure (MABP).  This is an estimate of the average blood 
pressure experienced throughout the cardiac cycle and is calculated from the 
systolic blood pressure (BPsys) and diastolic blood pressure (BPdia) using the 
following equation: 
 
            
           
 
 Eqn. [4.1] 
 
While systolic blood pressure and diastolic blood pressure are not described 
by a normal distribution in the population [51], mean arterial blood pressure in 
healthy adults can be approximated to a normal distribution, and thus normal 
distribution significance testing such as t-tests can be used [51, 52].  
Therefore, MABP was compared across the three readings taken in each 
session, and between drug conditions using paired t-tests. 
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Vector cardiogram and breathing rate data were acquired during the entire 
scan duration (see Section 4.2.5).  Vector cardiogram data from the resting 
state BOLD scan (duration 5 minutes) and from the emotion fMRI task 
(duration 14 minutes) were used for the calculation of the variance in cardiac 
cycle duration (peak-to-peak, or RR variance), and comparison of this effect 
between drug conditions.  This time domain assessment of heart rate variance 
has been used previously as a surrogate for heart rate variability as calculated 
using frequency domain methods such as spectral analysis [53, 54], as there is 
a strong correlation between frequency domain variability and time domain 
variance [55].  Cardiac cycle length was calculated using in-house software 
written in Matlab, which read in the physiological log files produced by the 
MRI scanner and measured the separation of the cardiac markers.  This was 
then used to calculate the variance in cardiac cycle across the duration of the 
scan.  A paired t-test was used to make comparisons between drug sessions. 
 
4.2.5 MRI scan protocol 
 
 
Figure 4.2: Complete scanning protocol for functional MRI study. 
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Figure 4.2 shows the complete scanning protocol performed.  The focus of this 
chapter is on the results of the emotional fMRI paradigm.  Resting BOLD and 
PCASL data were also acquired for baseline assessment of perfusion and 
resting state functional connectivity. 
 
All MRI data were acquired on a Philips Achieva 3.0T MRI scanner with an 
8-element SENSE head coil.  Subjects were positioned comfortably in the MR 
scanner. Physiological data were acquired throughout scanning using 
respiratory bellows and a vector cardiogram provided by Philips Healthcare.  
A soft head restraint was used to limit head movement during image 
acquisition and for comfort.  All stimuli were presented on a projector screen 
at the subjects‟ feet using the software Presentation [56]; subjects viewed the 
screen using a mirror attached to the RF coil placed approximately 10 cm from 
the face.  Subjects were also given an 8-button response device [57], which 
was demonstrated to them.  Following each task, the subject was asked if they 
were comfortable and happy to proceed, and the next task would be explained 
before proceeding.  Before the tasks, subjects underwent a standard set-up 
protocol of survey and reference, and EPI test (two dynamic pairs of the dual 
echo EPI sequence with TE = 13 / 36.5 ms, at the same resolution as the other 
EPI scans, using a TR of 10 s).  Further, 10 dynamic pairs of PCASL were 
acquired at the same parameters as the functional scan in order to test that the 
labelling scheme was working effectively.  Next, the two resting state scans 
were performed (see Section 4.2.7 for full description), followed by the 
emotion visual stimulus fMRI paradigm (acquisition methods and task 
described in Section 4.2.8 and Section 4.2.9 respectively).  After the emotion 
fMRI paradigm, subjects completed a pain empathy task, with a stimulus 
consisting of images of people in pain (to induce empathy in the subject) and 
control images of people not in pain.  Images were matched for number of 
faces, limbs, motion, etc.  Following this, subjects underwent a time 
perception task, during which no MR images were acquired.  In this task, 
participants were asked to tap a response button at a rate that feels comfortable 
to them, for an undisclosed duration that was triggered on screen with 
“START” and “STOP” signals.  The duration of the task was 60 seconds.  
During this time, subjects‟ breathing rate and cardiac output were recorded.  It 
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is hypothesised that subjects will tend to press the button at a rate that is 
related to their heart rate, and that as nadolol lowers the heart rate, their 
responses will be slower under this condition.  Anatomical MPRAGE and DTI 
scans were acquired once per subject, as they were considered to be 
independent of drug effect. 
 
Scans were acquired in the same order on both scanning sessions for each 
participant.  The scanning duration was approximately 47 minutes for the scan 
session that included the anatomical scans and 37 minutes without the 
anatomical scans.  One hour was allowed for each scanning session as the 
subjects were MRI scanner naive, and additionally would need to be reminded 
of how to perform each upcoming task. 
 
4.2.6 Optimisation of PCASL acquisition method 
 
4.2.6.1 Background 
 
In using MRI to optimally determine the brain regions that are active during 
the presentation of emotional stimuli, and further to detect modulation of this 
pattern of activity, it is essential to use a pulse sequence that provides good 
signal-to-noise ratio and contrast-to-noise ratio.  As outlined in Chapter 3 of 
this thesis, the PCASL scheme uses a steady state technique, and as such, 
provides the optimal ASL sensitivity (contrast-to-noise) of all the schemes 
commercially available.  I started to develop an unbalanced pseudo continuous 
arterial spin labelling (PCASL) pulse sequence using the pulse programming 
environment for use on the Philips 3 T Achieva MRI scanner.  However, 
during this time, an unbalanced PCASL sequence was developed within 
Philips Healthcare, and included in the new version of the software release.  
Therefore, this commercial version of PCASL was used for the study 
presented in this chapter.  Given that the study was to be performed in a 
clinical setting, this also had the additional advantage in PCASL being 
available in the commercial package of the MRI scanner, and this 
circumvented the need to apply and subsequently remove a software patch 
each scanning session. 
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A dual EPI acquisition method using two different TE values was chosen for 
the image readout, as this permits the simultaneous acquisition of two sets of 
images with different image contrasts.  Perfusion weighted contrast was 
obtained using PCASL acquired at a short echo time (TE = 13 ms) and 
subtraction of the ASL label from control images.  BOLD weighted contrast 
was subsequently acquired using the second echo of the dual echo EPI data 
collected at an echo time of 36.5 ms.  A diagram showing the dual EPI 
acquisition to simultaneously acquire BOLD and ASL weighted images is 
shown in Figure 4.3. 
 
 
Figure 4.3: Sequence diagram showing simultaneous dual acquisition of BOLD and ASL 
images using the PCASL scheme. 
 
4.2.6.2 Optimisation of PCASL for use in pharmacological fMRI studies 
 
PCASL was tested on a healthy volunteer to optimise its use for the study.  
This involved finding optimum values of the flip angle, α, label gap, labelling 
duration and post label delay.  In addition, the acquisition needed to be 
optimised for coverage and temporal resolution by determining the most 
appropriate values of echo time (TE), repetition time (TR), number of slices 
and spatial resolution.  Published literature on the optimisation of PCASL for 
use in human neuroimaging was consulted.  An example PCASL pulse 
sequence diagram is shown in Figure 4.4, showing the label as a series of 
several hundred RF pulses of flip angle, α, lasting approximately 0.5 ms, with 
a time between the start of two consecutive pulses of 1 ms.  Labelling is 
followed by the post-label delay and the subsequent image acquisition.  Figure 
4.5 shows the geometric placement of the labelling and imaging regions, and 
the label gap. 
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 Figure 4.4: PCASL pulse sequence diagram for the labelling condition.  The sequence 
used in this chapter has 1500 RF pulses, each lasting 0.5 ms. 
 
 
Figure 4.5: Diagram showing the label gap with respect to the positioning of labelling 
and imaging regions. 
 
The optimum value of RF flip angle, α, labelling duration and post-label delay 
were determined from the published literature on experimental optimisation of 
PCASL [58, 59, 60, 61].  Typically, a labelling duration of 1500 ms to 2000 
ms is used, while the post-label delay ranges from 900 ms to 1400 ms [58, 60].  
Flip angles used in previous studies (α) can be seen to vary from 18° to 45° 
[58, 59, 60].  In the PCASL sequence used in this chapter, a labelling duration 
of 1500 ms was used, consisting of 1500 RF pulses, each lasting 0.5 ms, 
repeated every 1 ms, with a post-label delay of 1350 ms and a flip angle of 
18°.  For the image readout, the shortest possible echo time (TE) of 13 ms was 
chosen to provide optimal signal-to-noise of EPI images, with a readout flip 
angle of 90° and a TR of 3500 ms.  Coverage had to be traded off against 
temporal resolution.  For this study, it was decided that at a standard fMRI EPI 
resolution of 3mm × 3mm × 5mm, 13 axial slices would be sufficient.  It is 
possible to determine the label gap experimentally [58], where the label gap is 
defined as the distance from the bottom of the imaging region to the top of the 
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selective inversion slab (Figure 4.5).  For the purpose of this experiment, the 
base of the imaging slab was aligned with the Anterior Commissure – 
Posterior Commissure (ACPC), such that the imaging region would cover the 
amygdala and insula, and extend to cover the anterior cingulate cortex, which 
are the main anatomical regions of interest in this study.  With the above 
values of label duration and post-label delay, the TR could be no shorter than 
3500 ms.  This is a compromise between the need for both temporal resolution 
and spatial resolution. 
 
Optimum label gap was verified by assessing the ASL signal on a single 
healthy volunteer for a range of label gaps (50 mm, 60 mm, 75 mm, 85 mm, 
95 mm, 120 mm and 150 mm), as shown in Figure 4.6 and Figure 4.7.  
Perfusion weighted signal intensity is proportional to the rate of perfusion.  To 
assess the efficiency of the perfusion weighted image, mean signal intensity 
was calculated over a 15 mm diameter spherical region of interest placed in 
the grey matter of the primary visual cortex (GM ROI), and compared to the 
mean signal intensities for similar regions of interest in the posterior white 
matter (WM ROI).  Figure 4.6 shows the perfusion weighted image obtained 
by labelling at each of the label gaps.  As shown in Figure 4.7, the highest 
perfusion weighted signal for grey matter and white matter was achieved at a 
label gap of 85 mm, in agreement with published literature [58].  This value 
was therefore used in future experiments. 
 
104
 Figure 4.6: Perfusion weighted images produced at differing label gaps, to determine the 
optimal label gap for maximised signal intensity. 
 
 
Figure 4.7: Mean perfusion weighted signal intensities (arbitrary units) for regions of 
interest in the grey matter (GM ROI) and white matter (WM ROI) as a function of label 
gap.  A label gap of 85 mm is shown to provide optimal signal change. 
 
4.2.7 Resting state data acquisition methods 
 
Two resting state scans were acquired in this study; the first using PCASL to 
derive quantitative resting CBF measurement; 40 dynamic ASL pairs were 
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collected, using the same image parameters and coverage as described above 
and used for the emotion stimulus task.  A total of 40 dynamic pairs resulted in 
a scan duration of 4 minutes 40 seconds.  The second resting state scan was 
performed to assess functional connectivity.  This used a conventional single 
echo EPI BOLD sequence with wider brain coverage than for the PCASL 
acquisition.  BOLD images were acquired with a TE of 40 ms, flip angle 80°, 
30 slices at 3 mm isotropic resolution.  150 dynamics were acquired at a TR of 
2 s, making the scan duration 5 minutes.  Immediately prior to both resting 
state acquisitions, four “dummy” dynamics were performed in order to induce 
a steady state to allow stabilisation of longitudinal relaxation.  For both resting 
state scans, subjects viewed a grey screen with a central fixation cross.  This 
was presented using Presentation software, version 14 [57].  Subjects were 
instructed to fixate on the cross and not to let their attention wander from it. 
 
The resting state BOLD data was also used to assess for EPI data quality.  This 
is important as the BOLD effect we are trying to extract from the EPI data is 
very small in magnitude, with subtle changes in this signal being less than 1%.  
Quality assessment was performed on the single echo BOLD data, as there are 
fewer confounds introduced by stimulation during the task.  Data were 
analysed using the EPI stability tool (Philips Healthcare, [62]) to assess a large 
region of interest covering the central slice of each scan for radius of 
decorrelation (a measure of the spatial correlation of the noise in the MR 
signal), scanner drift, signal-to-noise ratio and signal-to-fluctuation noise ratio.  
Signal-to-fluctuation noise ratio is the ratio between the signal and the 
temporal fluctuation in the noise, and is analogous to temporal signal-to-noise 
ratio, not accounting for low frequency drift. 
 
4.2.8 Emotion stimulus data acquisition methods 
 
Double echo pseudo-continuous ASL – BOLD gradient echo, echo planar 
images were acquired using echo times of 13 ms for the ASL data and 36.5 ms 
for the BOLD data.  As described above, PCASL was applied for a labelling 
duration of 1500 ms followed by a post-label delay of 1350 ms.  The distance 
from the top of the labelling region to the start of the imaging region (i.e. the 
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label gap) was fixed to 85 mm [58].  Images were acquired using a TR of 3500 
ms, a flip angle of 90° and a sense factor of 3.  13 axial slices of thickness 5 
mm were acquired with an in-plane resolution of 3 mm.  Two “dummy” 
dynamic pairs were performed at the beginning of the scan in order to induce a 
steady state, thereby reducing signal fluctuations caused by T1 saturation 
effects. 
 
4.2.9 Emotion stimulus task 
 
The emotional stimulus consisted of neutral, pleasant and unpleasant 
photographic images from the International Affective Picture System (IAPS) 
test battery [10].  The 40 image numbers chosen for each condition are shown 
in Table 4.3.  A pictorial representation of the fMRI task paradigm is shown in 
Figure 4.8.  Each image was displayed for 3.5 s.  This duration was chosen to 
match the TR of the acquisition of one ASL image.  Images were grouped into 
blocks of 4 images of the same valence, making an “on” period of 14 s, after 
which there was an “off” period (fixation cross) of 14 s, during which the 
volunteer was prompted to rate arousal on a scale of 1 to 9, as previously 
trained outside the MRI scanner.  Images chosen were standardised with 
respect to valence, arousal and dominance.  Block composition was 
standardised with respect to arousal and number of faces.  Images and blocks 
were ordered randomly, and the order differed between the two sessions to 
avoid habituation effects.  Every image was shown once per session and no 
images were repeated within a session.  This design was decided on in 
discussion with Professor Olga Pollatos from the University of Potsdam, based 
on the original study concept by Professor Dorothee Auer.  Stimuli were 
presented, and behavioural responses were collected using Presentation 
software, version 14 [57]. 
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 Valence 
 Neutral Pleasant Unpleasant 
Image 
numbers 
from IAPS 
test battery 
[10]. 
2190, 2200, 2210, 
2270, 2480, 2500, 
2514, 2850, 5020, 
5030, 5120, 5200, 
5500, 5510, 5520, 
5530, 5534, 6150, 
7004, 7009, 7020, 
7031, 7035, 7040, 
7050, 7060, 7080, 
7090, 7096, 7100, 
7130, 7140, 7150, 
7160, 7170, 7175, 
7190, 7233, 7235, 
7490 
1560, 1590, 1601, 
1603, 1710, 2000, 
2040, 2050, 2070, 
2080, 2150, 2165, 
2303, 2311, 2340, 
2341, 4599, 4601, 
4603, 4610, 4653, 
4689, 4700, 5600, 
5830, 7230, 7260, 
7325, 7330, 7350, 
8041, 8080, 8120, 
8185, 8190, 8200, 
8420, 8461, 8490,  
8510 
1050, 1090, 1110, 
1120, 1200, 1220, 
1300, 1302, 1930, 
2682, 2752, 2900, 
3030, 3100, 3140, 
3180, 3280, 3300, 
3530, 6200, 6230, 
6241, 6244, 6250, 
6314, 6350, 6510, 
6530, 6540, 6571, 
6610, 9000, 9010, 
9041, 9050, 9160, 
9190, 9220, 9280,  
9421 
Table 4.3: Numbers of photographic images in the IAPS test battery used in the 
emotional visual stimulus fMRI paradigm. 
 
 
Figure 4.8: Diagrammatic representation of the fMRI task paradigm.  This depicts one 
block of the “on” and “off” periods.  This was repeated ten times for each stimulus of 
neutral, pleasant and unpleasant valence.  Total duration = 14 minutes. 
 
4.2.10 Analysis of all MRI data 
 
Data were quality assessed, and any dataset that exhibited excessive motion 
(greater than 2 mm translation between dynamics) was excluded from further 
analysis.  All data were corrected for physiological noise caused by breathing 
and heart rate using software written by Emma Hall based on RETROICOR 
[63], then motion corrected and co-registered to MNI space [64] using an 
affine registration transformation to a voxel size of 2 mm isotropic.  Resting 
BOLD data were acquired at an original resolution of 3 mm isotropic and were 
smoothed with a Gaussian kernel of FWHM 5 mm.  Data from the emotion 
stimulus task were acquired using a slice thickness of 5 mm and thus a broader 
108
smoothing was used, with a FWHM of 8 mm.  Motion correction, realignment 
and smoothing preprocessing steps were performed using SPM8 [65]. 
 
4.2.11 Analysis of resting ASL data 
 
Following preprocessing, the voxel-by-voxel average percentage change in 
ASL signal over the scan duration was calculated.  These images were then 
divided through by the EPI base image to normalise the ASL signal to the base 
EPI signal.  Mean and standard deviation values in a grey matter mask were 
calculated for each subject, under each drug condition.  Further, using SPM8, 
a paired t-test was carried out between resting perfusion weighted data for the 
two drug conditions.  Group maps were threshold to a significance level of p < 
0.001 uncorrected, with a cluster threshold of 20 voxels. 
 
4.2.12 Analysis of resting state BOLD data 
 
Initial probabilistic independent component analysis (ICA) was carried out 
using Multivariate Exploratory Linear Optimised Decomposition into 
Independent Components (MELODIC) from FSL [66].  High pass temporal 
filtering was applied at 300 s.  No low pass temporal filtering was applied.  
Data were temporally concatenated across subjects and the group analysis was 
performed on this single concatenated 4D data set.  There was no limit given 
on the number of independent components to generate.  Independent 
component maps produced by the analysis were thresholded at p > 0.5, so that 
the voxels reported in each component have a greater probability of 
contributing to that component than to the background noise [66].  
Independent component analysis allows preliminary hypothesis-free analysis 
to confirm the presence of networks of interest, and identify appropriate seed 
regions for further hypothesis-driven analysis techniques. 
 
Psychophysiological interaction analysis was used to assess the presence of 
both the default mode network and the salience network and to determine 
whether these networks were modulated by the drug nadolol.  This analysis 
requires the selection of a seed, based on a priori knowledge of the networks 
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concerned.  Seeds for both networks were 9 mm diameter spheres placed on 
co-ordinates from the literature.  For the default mode network (DMN), a seed 
was placed at MNI co-ordinates [0 -45 30] in the posterior cingulate cortex 
(PCC) [67, 68].  For the salience network, a seed in the anterior cingulate 
cortex, MNI co-ordinates [0 18 42], was used [69].  The average BOLD signal 
was extracted for the volume of the seed for each of the 150 time points.  
Next, functional connectivity analysis was performed in SPM8 [65] using a 
general linear model.  The timecourse of the network seed was used as a 
regressor, and the motion parameters were included as covariates of no 
interest.  Higher level group comparisons were then performed in a random 
effects analysis in the form of single group t-tests of each drug condition and 
paired t-tests between the two drug conditions.  Clusters of significance p < 
0.001 uncorrected were considered. 
 
4.2.13 Analysis of BOLD fMRI Data from emotion task 
 
Random effects analysis was performed using Statistical Parametric Mapping, 
version 8 (SPM8), and software toolboxes coded in Matlab [70].  First level 
analysis used a general linear model of the stimulus duration convolved with a 
canonical haemodynamic response function to calculate the effect of the three 
stimulus conditions (neutral, pleasant and unpleasant).  The six motion 
parameters and button press for arousal rating were included in the model as 
covariates of no interest. 
 
Second level random effects analysis with a one sample t-test was used to 
assess the main effect of the task and a paired t-test to assess differences 
between the two drug conditions.  A flexible factorial design of repeated-
measures ANOVA was used to assess within-subject comparisons between the 
three stimuli (neutral, pleasant, unpleasant) and drug conditions (nadolol, 
placebo).  Subjects, stimulus valence and drug conditions were input as three 
independent factors in the design.  This allowed the interrogation of the 
interaction between the factors of drug condition and stimulus valence.  The 
difference effects between stimulus conditions ([pleasant > neutral], 
[unpleasant > neutral]) were then assessed between drug conditions; [pleasant 
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> neutral for placebo] greater than [pleasant > neutral for nadolol] and vice 
versa.  At this point, a binary mask of the main effects was applied to the data 
such that stimulus correlated changes could confidently be interpreted as 
increases or decreases in “positive BOLD” activation, and not “negative 
BOLD” deactivation.  Significance was reported for differences between drug 
conditions at p < 0.001 uncorrected. 
 
There may be detectable differences between the way that male and female 
subjects process emotional stimuli, and thus differences in drug modulation of 
this effect between the two gender groups were explored using a flexible 
factorial design for each gender group, to a significance level p < 0.001.  Due 
to the small number of subjects (n < 10) in each gender group, this subgroup 
analysis is clearly underpowered and thus exploratory only. 
 
Finally, anatomically defined regions of interest were defined using an 
anatomical atlas (WFU Pick Atlas toolbox from SPM8) [65] based on areas 
reported in the literature to be instrumental in emotional processing.  Regions 
of interest in the anterior insula, anterior cingulate cortex and amygdala were 
chosen [9, 18, 3, 14].  In addition, a control region was used in the form of a 7 
mm sphere in the primary visual cortex as this region is active during the task, 
but not implicated in emotional processing.  These regions of interest were 
used to interrogate the parameter estimates for BOLD changes (beta values) 
for each subject in the group and each drug condition.  Parameter maps were 
also interrogated using regions of interest defined from areas exhibiting 
notable differences in activity between the two drug conditions, while still 
avoiding circularity [71]. 
 
4.2.14 Analysis of PCASL fMRI Data from Emotion Task 
 
After subtraction and linear interpolation of ASL label and control pairs, the 
resulting perfusion weighted images were preprocessed as described in 
Section 4.2.10. 
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First level analysis was performed using Statistical Parametric Mapping, 
version 5 (SPM5, [65]), as described for the BOLD data, using a general linear 
model to model the effect of the three stimulus conditions (neutral, pleasant 
and unpleasant) and including the button press rating and motion parameters 
as covariates of no interest.  Higher level analysis used a flexible factorial 
design that interrogated the differences between two conditions ([pleasant > 
neutral] and [unpleasant > neutral]) for each pair of drug conditions ([nadolol 
> placebo] and [placebo > nadolol]).  As with the BOLD data, parameter maps 
were masked using a binary mask of main effects, and significance was 
reported at a level of p < 0.001.  Region of interest (ROI) analysis was 
performed as described in Section 4.2.13. 
 
4.3 Results 
 
Twenty (n = 10 male, n = 10 female) healthy, non-smoking volunteers, with a 
mean age = 22 ± 2 years took part in the study.  All participants had a body 
mass index (BMI) in the healthy range, with a group mean of 22 ± 2.  All 20 
subjects attended both scan sessions (drug and placebo); with a mean ± 
standard deviation of 13 ± 5 days between visits.  All subjects accepted both 
tablets without adverse side effects, and were compliant with the performance 
of the task and with the MRI scan and physiological monitoring. 
 
4.3.1 EPI stability data 
 
Mean, range and standard deviation of the values of radius of decorrelation, 
scanner drift, image signal-to-noise ratio and temporal signal-to-noise ratio 
define the image quality of the resting BOLD data.  Radius of decorrelation is 
a measure of the spatial auto-correlation of the noise in the signal across the 
image [62].  These values are shown in Table 4.4.  Literature shows that 
acceptable values for the radius of decorrelation cover a range between 4.4 
and 16.6 pixels [62].  Scanner drift measurements should be low.  Values of 
image signal-to-noise ratio (SNR) and temporal signal-to-fluctuation-noise 
ratio (SFNR) should be similar and as high as possible [62]. 
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Mean 
Standard 
Deviation 
Minimum Maximum 
RDC [pixel] 7.82 2.73 5.09 10.55 
Drift [%] 0.03 0.59 -0.56 0.62 
SNR mean across ROI 73.99 12.49 61.50 86.48 
SFNR mean across ROI 70.47 10.62 59.84 81.09 
Table 4.4: Quality assessment of resting state EPI data showing the radius of 
decorrelation (RDC), scanner drift, signal-to-noise ratio (SNR) and signal-to-fluctuation 
noise ratio (SFNR) as calculated using EPI Tool (Philips Healthcare, [62]). 
 
4.3.2 Physiological data 
 
Blood pressure measurements for readings before tablet administration, 2 
hours following tablet administration and following MRI scan are shown in 
Table 4.5.  All subjects experienced a reduction in blood pressure after 2 
hours.  All subjects were deemed to exhibit a high enough blood pressure to be 
safe to leave the centre after the final blood pressure measurement. 
 
 80 mg nadolol placebo 
On arrival 110/73 (±8/6) 108/69 (±8/8) 
After 2 hours 99/65 (±8/7) 104/68 (±9/8) 
After MRI scan 108/72 (±13/9) 115/74 (±10/11) 
Table 4.5: Mean (± standard deviation) values of blood pressure (systolic / diastolic) 
across the group (n = 20). 
 
Nadolol caused a drop in blood pressure of 11/8 mmHg compared to a drop of 
4/1 mmHg in the placebo group.  Individual subjects‟ mean arterial blood 
pressure (MABP), are shown in Figure 4.9, and were interrogated with a 
paired t-test; MABP (mean ± standard deviation) dropped from 85.1 ± 6.3 
mmHg to 76.7 ± 6.0 mmHg, a significant reduction of p < 5×10
-7
 correlated 
with drug administration, while MABP dropped only slightly from 82.1 ± 6.7 
mmHg to 79.6 ± 6.8 mmHg in the placebo condition, which is not significant 
(Figure 4.10).  The difference between drug conditions was significant to p < 
0.002, corrected for multiple comparisons. 
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 Figure 4.9: Mean arterial blood pressure (MABP) measurements for all subjects (n = 
20), under both drug conditions. 
 
 
Figure 4.10: Group (n = 20) average (± standard error) effect of nadolol and placebo on 
mean arterial blood pressure (MABP).  Asterisk represents a significant reduction in 
MAPB 2 hours after drug administration (p < 0.002, multiple comparisons corrected). 
 
Nadolol reduced heart rate with significantly greater effect than placebo, as 
expected.  A mean reduction of 17 beats per minute was found for nadolol 
compared to 10 beats per minute for placebo (significance of p < 0.01), as 
shown in Figure 4.11. 
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 Figure 4.11: Group (n = 20) average (± standard error) effect of nadolol and placebo on 
heart rate.  Asterisks represent a significant decrease in heart rate (p < 0.0001). 
 
Heart rate was assessed during the resting state BOLD scan (duration 5 
minutes) and during the emotion task (duration 14 minutes) using the 
physiological log files from the MRI scanner.  During the resting state BOLD 
scan, the decrease in heart rate due to nadolol was significant to p < 1×10
-5
, 
whereas during the emotional stimulus, the decrease in heart rate due to 
nadolol was significant to p < 5×10
5
.  In both drug conditions, the mean heart 
rate was higher during the emotional fMRI task than during the resting state 
BOLD scan, since the task increases the arousal of the subject by providing a 
visual stimulus and a small motor demand from the button response.  For 
subjects taking nadolol, this difference was significant to p < 0.005, whereas 
for subjects taking placebo this significance was only p < 0.05.   
 
The variance in the length of cardiac cycle (peak-to-peak, or RR variance) was 
compared between 80 mg nadolol and placebo using physiological data 
acquired during the emotional fMRI paradigm and the resting state BOLD 
scan.  There was no significant difference between the variance in cardiac 
cycle length between the two drug conditions during the resting state BOLD 
scan.  However, there was a significantly higher variance in individuals‟ 
cardiac cycle length under nadolol compared to placebo during the emotional 
stimulus task (p < 0.02).  Mean cardiac cycle length and variance in peak-to-
peak duration are given in Table 4.6 for each drug condition. 
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Peak-to-peak 
duration (ms) 
Peak-to-peak 
variance (ms
2
) 
Resting state (80 mg nadolol) 1122 ± 28 * 4993 ± 571 
Resting state (placebo) 967 ± 34 * 4165 ± 562 
Emotion task (80 mg nadolol) 1096 ± 24 ** 6588 ± 846 *** 
Emotion task (placebo) 948 ± 33 ** 4437 ± 623 *** 
Table 4.6: Mean (± standard error) cardiac cycle length (peak-to-peak duration) and 
variance in cardiac cycle length (peak-to-peak variance) in the group (n = 20) both at 
rest (duration 5 minutes) and during the emotional stimulus task (duration 14 minutes) 
for each drug condition.  Asterisks represent significant drug induced effect; (* p < 
0.00005, ** p < 0.00005, *** p < 0.02). 
 
4.3.3 ASL resting perfusion 
 
Mean ASL perfusion weighted images for the placebo and 80 mg nadolol 
groups are shown in Figure 4.12.  The mean grey matter perfusion weighted 
signal change across the group is shown in Figure 4.13.  There was no 
significant difference found between the two drug conditions.  Paired t-test in 
SPM8 showed no significant differences between the two drug conditions at a 
significance level of p < 0.001, and cluster threshold of 20 voxels. 
 
 
 
Figure 4.12: Group (n = 20) mean perfusion weighted signal in the nadolol condition 
(above), placebo condition (below).  Colour bars represent normalised ASL signal 
change. 
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 Figure 4.13: Comparison of mean ASL signal change between 80mg nadolol and placebo 
measured within a grey matter mask. 
 
4.3.4 Functional MRI data: main effects of task 
 
No significant difference in the degree of head motion was found between the 
two drug conditions.  Three subjects exhibited head motion of greater than 2 
mm displacement between consecutive dynamics in at least one drug 
condition, and thus were excluded from the data analysis.  The magnitude of 
peak relative motion between consecutive dynamics was 11 mm translation 
and 0.1° rotation for the entire group, and 2 mm translation and 0.08° rotation 
with 3 subjects excluded.  First level analyses showed that stimuli of all three 
valences elicited strong BOLD responses in the visual cortex and surrounding 
areas of the occipital lobe. 
 
Figure 4.14 shows the one sample t-tests for BOLD response in each drug 
group and stimulus valence at significance p < 0.05, corrected for false 
discovery rate (FDR), with a cluster threshold of 20 voxels.  Tabulated peak t-
statistics for regions exhibiting BOLD responses along with cluster size and 
MNI co-ordinates are given in Appendix E. 
 
Similar results were obtained for the simultaneously acquired perfusion 
weighted timeseries, but with a smaller effect size due to the lower contrast-to-
noise ratio of ASL.  Therefore, a lower threshold of uncorrected significance 
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of p < 0.001 and a cluster threshold of 20 voxels was used to interrogate the 
data (Figure 4.15).   
 
 
Figure 4.14: Group (n = 17) random effects analyses (using SPM8) showing areas of 
BOLD response to neutral, pleasant and unpleasant stimuli compared to baseline. P < 
0.05 (FDR corrected), cluster threshold = 20 voxels.  Colour bars show T statistics. 
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 Figure 4.15: Single group (n = 17) higher level analyses (using SPM8) showing areas of 
greater perfusion in response to neutral, pleasant and unpleasant stimuli compared to 
baseline. P < 0.001, cluster threshold = 20 voxels. Colour bars show values of T statistic. 
 
 
119
 Figure 4.16: Single group (n = 17) higher level analyses (using SPM8) showing areas that 
exhibited greater BOLD response under emotional stimuli compared to neutral stimuli, 
masked with a binary mask of all areas more active during task than baseline.  P < 0.05 
(FDR corrected), cluster threshold = 20.  Colour bars show values of T statistic. 
 
Figure 4.16 shows that compared to the neutral stimuli, pleasant and 
unpleasant stimuli elicited significantly greater activation in the 
middle/inferior occipital and temporal gyri, fusiform gyrus and amygdala as 
well as (but with lower significance) in the superior medial frontal cortex and 
anterior cingulate cortex.  BOLD responses for these comparisons are masked 
using a binary mask of areas more active during stimuli than baseline.  
Regions shown at a false detection rate (FDR) corrected significance of p < 
0.05, cluster threshold of 20 voxels.  Peak t-statistics for regions exhibiting 
BOLD responses along with cluster size and MNI co-ordinates are tabulated in 
Appendix E.  A similar pattern of activity is seen for perfusion weighted 
changes as for BOLD.  Perfusion responses for the same comparisons are 
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shown in Figure 4.17; at uncorrected significance level of p < 0.001, cluster 
threshold of 20 voxels. 
 
 
Figure 4.17: Single group (n = 17) higher level analyses (using SPM8) showing areas of 
greater perfusion in response to pleasant and unpleasant stimuli compared to neutral 
responses, masked with a binary mask of all areas more active during stimuli than 
during baseline.  P < 0.001, cluster threshold = 20 voxels.  Colour bars show T statistics. 
 
There were no areas of the brain that were significantly more active during 
presentation of the neutral stimuli than either of the emotional stimuli, under 
either drug condition. 
 
4.3.5 Functional MRI data: comparison between drug conditions 
 
Comparing the activation maps shown above for differences in response 
between drug conditions, there are areas of task related activity that exhibit a 
drug correlated modulation significant at p < 0.001, with a cluster threshold of 
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20 voxels.  Comparison of the conditions [pleasant > neutral] and [unpleasant 
> neutral] between drug conditions showed the right anterior insula, MNI co-
ordinates [46 20 -8] to be more active under placebo than nadolol.  Figure 4.18 
shows this for the [pleasant > neutral] condition, with a peak T statistic of 3.95 
and zmax = 3.9.  The anterior insula cortex forms part of the salience network 
and thus drug modulation of task related activity is of interest. 
 
 
Figure 4.18: Group random effects map of reduced activation under nadolol compared 
to placebo for [pleasant > neutral] (n = 17), using SPM8.  Tmax = 3.95, zmax = 3.9, p < 
0.001, cluster threshold = 20 voxels.  Colour bar shows values of T statistic. 
 
Anatomically defined left and right anterior insula cortex regions were 
interrogated using region of interest (ROI) analysis for BOLD signal changes.  
In addition, a region in the anterior cingulate cortex (ACC) was assessed, 
which also forms part of the salience network.  The region of interest in the 
anterior cingulate was selected from a paper by Machulda et al [69] for its 
functional connectivity with the salience network.  Figure 4.19 shows mean (± 
standard error) BOLD intensity changes in these regions in response to 
neutral, pleasant and unpleasant stimuli compared to “off” periods, under the 
two drug conditions of nadolol and placebo.  This reflects the random effects 
analysis, showing a significant drug induced decrease in the BOLD response 
to unpleasant stimuli in the right anterior insula.  The ACC shows a significant 
drug induced decrease in BOLD response to pleasant stimuli.  The same three 
ROIs were then used to interrogate the simultaneously acquired perfusion 
weighted ASL signal changes for each stimulus compared to “off”, as shown 
122
in Figure 4.20.  The perfusion response to pleasant stimuli in the ACC is 
significantly reduced by 80 mg nadolol. 
 
 
Figure 4.19: Group (n = 17) values for mean ± standard error BOLD intensity changes 
in anatomically defined left and right anterior insula ROIs, ACC ROI from literature 
[69].  Asterisks represent significance p < 0.05 using a paired t-test. 
 
 
Figure 4.20: Group (n = 17) values for mean ± standard error perfusion weighted 
changes in anatomical left and right anterior insula ROIs, ACC ROI from literature 
[69].  Asterisks represent significance p < 0.05 using a paired t-test. 
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Analysis of resting ASL data was used to investigate whether the drug induced 
differences elicited above arise in part from baseline changes in perfusion.  
The three ROIs were used to interrogate the resting PCASL data for drug 
induced changes in resting perfusion, by calculating the mean regional ASL 
signal in each ROI for each subject.  Group mean (± standard error) values are 
given in Figure 4.21.  None of these three ROIs elicited a statistically 
significant difference between the two drug conditions. 
 
 
Figure 4.21: ROI analysis of resting perfusion: group (n = 20) values for mean ± 
standard error % change ASL signal in anatomical ROIs in the left and right anterior 
insula, and in the ACC ROI from literature [69]. 
 
It was hypothesised that due to the involvement of the amygdala in emotional 
processing and the limbic system, particularly in the processing of unpleasant 
stimuli, amygdala activation may be modulated by nadolol.  Anatomically 
defined ROIs in the amygdalae were interrogated for differences between the 
two drug conditions in BOLD and perfusion weighted response for the whole 
group.  Interestingly, both amygdalae exhibited significant increases in BOLD 
activity under nadolol, compared to placebo, Figure 4.22.  These differences 
were not seen in the simultaneously acquired ASL signal, Figure 4.23. 
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 Figure 4.22: Group (n=17) mean and standard error BOLD intensity changes in 
anatomical ROIs in the amygdalae in response to stimuli of each valence, under each 
drug condition.  Asterisks represent significance p < 0.04 using paired t-test. 
 
 
Figure 4.23: Group (n = 17) values for mean ± standard error absolute ASL signal 
changes in anatomical amygdala ROIs, in response to each stimulus, under nadolol and 
placebo.  No significant differences found using a paired t-test. 
 
Resting perfusion data was used to investigate whether the drug induced 
BOLD differences elicited in the amygdala were present in baseline perfusion.  
There were no statistically significant differences between drug conditions, 
Figure 4.24, showing group mean values for ASL signal (± standard error). 
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 Figure 4.24: ROI analysis of resting perfusion: group (n = 20) values of mean ± standard 
error % change ASL signal in anatomically defined ROIs in the amygdalae (left and 
right amygdalae ROIs contain 220 and 248 voxels respectively). 
 
To act as a control against potential confounds, ROI analysis was performed 
on an anatomically defined region in the primary visual cortex, chosen on the 
basis of it being hypothesised to exhibit task related activity that is not 
modulated by a peripherally acting beta-blocker.  A 7 mm diameter spherical 
ROI was placed in the primary visual cortex, at MNI co-ordinates [8 -80 4].  
No significance was found between the drug conditions in the primary visual 
cortex response to stimuli of any valence using paired t-tests, Figure 4.25. 
 
 
Figure 4.25: Group (n = 17) values of mean ± standard error absolute BOLD intensity 
changes in ROIs in the primary visual cortex in response to each stimulus, under 80 mg 
nadolol and placebo.  Each 7 mm diameter spherical ROI contained 179 voxels.  No 
significance found using paired t-test. 
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4.3.6 Functional MRI data: gender differences 
 
There were also small areas of significantly different activation between the 
two gender groups (females n = 9, males n = 8).  For placebo greater than 
nadolol, for both [pleasant > neutral] and [unpleasant > neutral] conditions, 
females exhibited areas of activation in the right insula that were not 
significantly present in males, shown in Figure 4.26.  This suggests that the 
main effects described above in Section 4.3.5 are driven by the female 
subjects.  In [pleasant > neutral], this was centred at MNI co-ordinate [40 20 -
10] with a peak T = 4.18, zmax = 4.07 and was significant to p < 0.001.  In 
[unpleasant > neutral], the effect was located at MNI co-ordinate [38 14 -8], 
with peak T = 4.69, zmax = 4.53 and was significant to p < 0.001.  ROI analysis 
used 7 mm diameter spherical regions of interest centred on the MNI co-
ordinates of peak activation from the comparison [pleasant > neutral for 
placebo] greater than [pleasant > neutral for nadolol] and [unpleasant > neutral 
for placebo] greater than [unpleasant > neutral for nadolol].  BOLD signal 
changes in regions centred at [-47 24 0] and [39 17 -9] are shown in Figure 
4.27. 
 
 
Figure 4.26: Differences in activation (using SPM8) in the female group only (n = 9).  
[Pleasant > neutral]: Tmax = 4.18, zmax = 4.07. [Unpleasant > neutral]: Tmax = 4.69, zmax = 
4.53.  P < 0.001, cluster threshold = 20 voxels.  Colour bars show T statistics. 
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 Figure 4.27: Mean ± standard error BOLD intensity changes for male (n = 8) and female 
(n = 9) subjects separately, for each stimulus, under 80 mg nadolol and placebo.  7 mm 
diameter insula ROIs (each 179 voxels) placed at sites of peak difference in activation in 
the insula as defined from whole group analysis. 
 
In the male subjects there was a region of greater activation in the condition 
[unpleasant > neutral] not seen in females, for the nadolol group compared to 
the placebo group.  This was located in the bilateral amygdala / thalamus 
region and was stronger in the right cortex than left (peak T statistic of 4.75, 
zmax = 4.56, p < 0.001) at MNI co-ordinates [32 -28 -6], Figure 4.28. 
 
 
Figure 4.28: Region of greater activation seen (using SPM8) in the condition [unpleasant 
> neutral] in the male (n = 8) group only.  Tmax = 4.75, zmax = 4.56, p < 0.001, cluster 
threshold = 20 voxels.  Colour bar shows values of T statistic. 
 
This region was interrogated using ROI analysis using a 7 mm diameter sphere 
centred at the peak difference in activation at MNI co-ordinates [-14 -10 -10] 
and [32 -28 -6] for the left and right amygdala / thalamus activation regions 
128
respectively.  BOLD signal intensity changes for these regions are shown in 
Figure 4.29. 
 
 
Figure 4.29: Mean ± standard error BOLD intensity changes for male (n=8) and female 
(n=9) subjects separately.  7 mm diameter ROIs (each 179 voxels) placed at sites of peak 
difference in activation in the amygdala / thalamus region.  Asterisks represent 
significance calculated by paired t-test at p < 0.05. 
 
4.3.7 Resting state BOLD data: Independent Component Analysis 
 
No subjects exhibited head motion of greater than 2 mm displacement 
between consecutive dynamics in either drug condition, and thus all 20 
subjects‟ datasets were included in the resting state BOLD data analysis.  The 
magnitude of maximum relative motion between consecutive dynamics was 
1.8 mm translation and 0.075° rotation for the entire group.  No significant 
differences were found in the degree of motion between the two drug 
conditions. 
 
Group analysis of all 40 scans together produced 27 components.  Candidate 
components were found for networks of interest; the default mode network 
(DMN, Figure 4.30) and the salience network (SN, Figure 4.31). 
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 Figure 4.30: Default mode network components for the group (n = 20) using FSL 
MELODIC. Maps show correlation between inferior parietal lobules and anterior and 
posterior cingulate cortices. 
 
 
Figure 4.31: Salience network component for the group (n = 20) using FSL MELODIC, 
exhibiting correlation between bilateral insula and anterior cingulate cortex. 
 
Group independent component analysis on the nadolol condition alone 
extracted 26 independent components, while analysis on the placebo condition 
alone identified 28 independent components.  As the design of the analysis did 
not restrict the number of components resolved, it is possible for the same set 
of correlations to be resolved into different components each time the 
comparison is run.  As these components do not directly correspond between 
drug conditions, the statistics produced cannot be compared quantitatively, 
and the definition of networks through independent component analysis is not 
optimal for further quantitative techniques such as dual linear regression.  
Therefore, psychophysiological interactions analysis was used to determine if 
there was an effect of 80 mg nadolol on resting state functional connectivity. 
 
4.3.8 Resting state BOLD data: Psychophysiological Interaction Analysis 
 
First level analysis was run on each subject and each drug condition 
individually.  All subjects showed clear correlation in the default mode 
network between all four known nodes.  First level analysis for an example 
subject is shown in Figure 4.32, with suprathreshold voxels of correlation 
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shown in red, significant to p < 0.005, corrected for family wise error rate 
(FWE). 
 
 
Figure 4.32: First level analysis for one subject in the placebo condition demonstrating 
default mode network correlation, using a seed in the posterior cingulate cortex, SPM8.  
Significance p < 0.05 FWE, cluster threshold = 20 voxels. 
 
Single group t-tests for each drug condition are shown in Figure 4.33, at 
significance level p < 0.05 FWE corrected.  These demonstrate the consistency 
across subjects for locations of activity correlated with the posterior cingulate 
cortex.  Paired t-tests between drug conditions showed few supra-threshold 
voxels with small cluster sizes.  No supra-threshold voxels survived FWE 
correction. 
 
 
Figure 4.33: Group (n = 20) random effects analysis: t-tests using SPM8 for 80 mg 
nadolol and placebo show correlation in the default mode network using a seed in the 
posterior cingulate cortex.  Significant to p < 0.05 FWE, cluster threshold = 20 voxels. 
 
First level analysis using a seed in the anterior cingulate cortex elicited 
connectivities with the bilateral insula and superior frontal regions, in 
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agreement with the published findings of Machulda et al [69].  Single group t-
tests for nadolol and placebo are shown in Figure 4.34 at significance p < 0.05 
FWE.  Paired t-tests between drug conditions again showed no significant 
differences. 
 
 
Figure 4.34: Group (n = 20) random effects analysis: t-tests using SPM8 for 80 mg 
nadolol and placebo show correlation in the salience network using a seed in the anterior 
cingulate cortex [69].  Significant to p < 0.05 FWE, cluster threshold = 20 voxels. 
 
4.4 Discussion 
 
4.4.1 Summary of findings 
 
A single dose of 80 mg of the peripherally acting beta-blocker, nadolol, 
significantly reduced mean arterial blood pressure and heart rate but did not 
significantly affect resting cerebral blood flow, as assessed by the ASL signal 
in grey matter cortical regions.  Nadolol increased the variance in the peak-to-
peak cardiac cycle duration during the emotional stimulus task, but not during 
rest.  Assessment of BOLD and perfusion responses to neutral, pleasant and 
unpleasant visual stimuli showed robust widespread activations in the visual 
cortex.  Pleasant and unpleasant visual stimuli elicited significantly greater 
BOLD and perfusion responses in the fusiform gyrus, middle / inferior 
temporal gyrus and middle / inferior occipital gyrus regions, compared to 
responses to neutral visual stimuli. 
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On comparison of the group (n = 17) response to emotional stimuli between 
drug conditions, nadolol was shown to significantly reduce responses to 
[pleasant > neutral] stimuli in the right insula (p < 0.001 uncorrected).  The 
anterior insula and anterior cingulate are believed to contribute to the 
processing of emotions through involvement in the salience network.  Regions 
of interest placed in the bilateral anterior insula and anterior cingulate cortex 
showed that nadolol caused a significant reduction in both BOLD response 
and perfusion response to [pleasant > neutral] stimuli in the anterior cingulate 
cortex (p < 0.05).  Resting perfusion was also assessed in the anterior insula 
and ACC and showed no significant drug dependent effect.  Further region of 
interest analysis elicited a significant increase due to nadolol of BOLD signal 
in the amygdala in response to [unpleasant > neutral] stimuli.  There was no 
significant difference in the perfusion signal in these regions either in response 
to stimuli or at rest.  Region of interest analysis was used in a primary visual 
area to control for possible confounds of nadolol modulating task driven 
activity outside the areas associated with the processing of emotional stimuli.  
No significant differences were found between the two drug conditions in 
BOLD signal intensity changes in the primary visual cortex for stimuli of any 
valence. 
 
Data were interrogated for differences representing drug modulation of brain 
activity between male and female subject groups.  Reduction in insula activity 
demonstrated in the group (n = 17) was significant in the female group (n = 9, 
p < 0.001) for [pleasant > neutral] and [unpleasant > neutral] stimuli, but was 
not seen in the male group (n = 8).  The male group exhibited a significant 
drug correlated increase in task related activity in the amygdala (p < 0.001 
uncorrected).  Region of interest analysis showed this was significant in the 
left amygdala for [unpleasant > neutral] stimuli and in the right amygdala for 
[pleasant > neutral] stimuli.  This was confirmed by paired t-test (p < 0.05). 
 
Resting state BOLD data were investigated for differences in the functional 
connectivity of the DMN and salience network between drug conditions.  No 
drug correlated modulation was found using psychophysiological interaction 
analysis.  The analysis took account of motion parameters as covariates of no 
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interest, but did not control for white matter or cerebrospinal fluid nuisance 
regressors. 
 
4.4.2 Discussion of findings 
 
Nadolol is widely known to reduce heart rate and blood pressure.  The 
reduction measured in heart rate and blood pressure in 20 healthy volunteers 
was significant to p < 0.01 and p < 0.002 respectively.  Cardiac cycle length 
variance has been shown to be used as a surrogate for heart rate variability as 
it provides a strong correlation with outcomes from spectrum analysis 
methods, but can be achieved using much simpler analysis methods [55].  
Cardiac cycle length variance is negatively correlated with age [54, 72], and 
the values in the placebo condition of 4165 ± 562 ms
2
 and 4437 ± 623 ms
2
 
during the resting state BOLD scan and the emotional stimulus task 
respectively fall within the range of previously published values [72].  Nadolol 
increased variance in cardiac cycle length during the resting state BOLD scan 
and emotional stimulus task to 4933 ± 571 ms
2
 and 6588 ± 846 ms
2
 
respectively.  This was significant during the emotion stimulus task (p < 0.02).  
Beta-blockers are hypothesised to increase heart rate variability through a 
central effect on the parasympathetic drive [73]; however, nadolol is not 
expected to have a central effect.  The assessment of blood pressure, heart rate 
and cycle length variance demonstrate that adequate sympathetic blockade has 
been induced by 80 mg nadolol [74]. 
 
Percentage change in ASL signal as measured using PCASL can be assumed 
to be linearly related to CBF using a two compartment model [75] if blood 
transit time does not change.  In the absence of measurement of blood transit 
time, as there is no significant difference between percentage change in ASL 
signal between nadolol and placebo, there will be no significant difference in 
estimated blood flow between the two conditions, provided that transit time 
does not change between conditions.  In addition, region of interest analysis of 
BOLD responses in the primary visual cortex supports the assumption that 80 
mg nadolol has not modulated any activity not associated with the processing 
of emotional stimuli.  These two measures can be used to conclude that 
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nadolol has acted in the periphery only and that further assessment of 
modulation of task related activity is not confounded by central effects. 
 
Patterns of task correlated activity elicited by visual emotional stimuli concur 
with previous studies using similar stimuli.  Broadly, emotional stimuli cause 
increased BOLD and perfusion responses in the fusiform gyrus, middle / 
inferior temporal gyrus and middle / inferior occipital gyrus regions in 
comparison to neutral stimuli [14].  The insula and anterior cingulate cortex 
have been found to also exhibit increased response to emotional stimuli [14, 3, 
20, 21].  This study reports that activity in the insula has been shown to be 
significantly reduced by the administration of nadolol in comparison to 
placebo.  The insula is implicated in the processing of emotions and acts 
within the salience network.  Previous studies produce conflicting evidence as 
to whether beta-blockers (either peripherally acting or centrally acting) 
modulate the processing of emotion, or the activity within regions of the brain 
associated with the processing of emotions, such as the salience network and 
the amygdalae.  This has previously been investigated by examining the ability 
to recall emotional stimuli compared to neutral stimuli).  Propranolol has been 
reported to impair memory of the emotional stimuli compared to placebo [36]; 
supporting the hypothesis that blockade of the peripheral reactivity will impair 
emotional arousal.  Contradictory to this, neither propranolol nor nadolol were 
found to impair memory recall of emotional stimuli in a later study by the 
same group [35].  Similarly, the centrally acting beta-blocker, propranolol, has 
been shown to reduce activity in the amygdala associated with the encoding 
and retrieval of emotional verbal stimuli, without significantly affecting 
behavioural responses [34]. 
 
Region of interest analysis on the anterior cingulate cortex, a component of the 
salience network, showed a reduction in BOLD response to pleasant and 
unpleasant stimuli under nadolol compared to placebo, with the reduction in 
response to pleasant stimuli being significant (p < 0.05).  A corresponding 
significant reduction in perfusion response to pleasant and unpleasant stimuli 
under nadolol compared to placebo was also found.  There was no significant 
decrease in perfusion in the same region during rest, but the standard error of 
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the perfusion measurements in that region during rest were substantially 
greater than in other regions of the brain, likely due to the proximity of the 
region to inflowing arteries. 
 
Activity in the amygdala is associated with arousal and the processing of fear 
and threat, as well as emotional stimuli [19, 26, 15, 27, 3, 14].  Strange et al 
[34] showed that the centrally acting beta-blocker, propranolol, significantly 
reduced the activity in the amygdala in response to emotional verbal stimuli, 
without reduction of memory recall ability.  This thesis reports that there was a 
significant increase in the activity in both amygdalae in response to negative 
emotional stimuli, after the administration of nadolol compared to placebo.  
This finding contradicts previous studies using centrally acting beta-blockers 
that reported reduced amygdala response to verbal emotional stimuli [34].  
Impaired amygdala response in those studies may have been mediated by a 
central beta-adrenergic mechanism rather than a consequence of reduced 
bodily arousal.  However, the increased responsiveness of the amygdala after 
peripheral beta-blockade is difficult to explain.  One speculative theory is that 
this is due to an imbalance of central and peripheral beta-adrenergic arousal 
resulting in some form of „sensitisation‟ of central beta-adrenergic amygdala 
arousal.  It is logical to investigate the possibility of an associated reduction in 
perfusion in the same region in response to emotional visual stimuli or at rest, 
however no such difference in either task response or resting perfusion was 
found. 
 
It is intuitive to understand that there may be a difference in the way males 
and females process emotional stimuli, and thus it is interesting to explore this 
possibility.  However, analysis performed on gender subgroups of this study is 
purely exploratory due to the small size of gender subgroups (n = 8 male, n = 
9 female).  Female subjects (n = 9) exhibited a significant drug correlated 
reduction of activity in the insula in response to both [pleasant > neutral] and 
[unpleasant > neutral] stimulus comparisons.  This reduction was not 
significant in the male group (n = 8).  This could be due to a greater response 
in the insula in female subjects, which was reduced by nadolol, or alternatively 
that the insula response to emotional stimuli in male subjects was not 
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modulated to the same degree as in female subjects.  This was investigated 
using region of interest analysis on the gender subgroups, which was 
inconclusive as no statistically significant differences were found. 
 
Male subjects (n = 8) exhibited a significant drug correlated increase of 
activity in the amygdala in response to [unpleasant > neutral] stimuli.  While 
this increase was also detected significantly at the whole group level (n = 17), 
it was not significant in the female subgroup (n = 9).  Region of interest 
analysis was used to explore levels of BOLD signal intensity in the gender 
subgroups separately, and this showed that the male subjects taking nadolol 
exhibited higher activation in the amygdala in response to [emotional > 
neutral] stimuli than did the males taking placebo, or the females in either drug 
condition.  Therefore, nadolol caused an increase in amygdala response to 
emotional stimuli, with no differences being found in any other group.  The 
explanation for this is not clear. 
 
Independent component analysis is a hypothesis free method of exploring 
connectivity in the brain.  Using a temporal concatenation of all subjects‟ data, 
27 components were identified, including the default mode network and 
salience network.  Due to the randomised nature of component identification, 
direct comparisons cannot be made between drug conditions, even 
qualitatively, as analysis of each drug condition produced a different 
arrangement of components.  Quantitative comparisons between drug 
conditions cannot be made without further methods such as dual linear 
regression, which was not appropriate in this case due to suboptimal definition 
of the resting state networks from independent component analysis. 
 
Psychophysiological interaction analysis was used to successfully define the 
default mode network and the salience network based on the hypothesis that 
these networks can be defined from known seed regions within the brain.  The 
default mode network has been defined using a seed region of interest in the 
posterior cingulate cortex [68].  A prior study using this method has shown 
that the sedative propofol increases the connectivity of the posterior cingulate 
cortex with non default mode regions of the brain such as sensorimotor areas, 
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anterior thalamic nuclei and the reticular formation [76].  The technique has 
also previously been defined using a seed in the anterior cingulate cortex [69] 
to assess changes in salience network functional connectivity. The 
psychophysiological interaction analysis reported in this thesis defined group 
resting state networks that closely resemble those in previously published 
studies for both the default mode network [68] and the salience network [69].  
There was no significant difference in the amount of subject head motion 
detected between the two drug conditions, shown using a paired t-test.  The 
analysis used motion parameters as regressors of no interest, but did not 
control for covariates of no interest in the white matter or cerebrospinal fluid 
noise parameters.  Also, global demeaning can be used to further reduce 
detection of spurious correlations [77].  While the effect of these noise 
elements is not large, there is no evidence to suggest that they are not affected 
by the administration of a beta-blocker, and thus lack of control for them may 
have either introduced the possibility of detecting spurious correlations, or 
masked a small drug dependent effect on functional connectivity within the 
networks investigated.  Having said this, even by lowering the significance 
level of the paired t-tests between drug conditions, there was no discernable 
pattern to the suprathreshold voxels showing differences between the two drug 
conditions. 
 
4.4.3 Strengths of the study 
 
A single 80 mg dose of the peripherally acting beta-blocker, nadolol reduces 
sympathetic activity, as evident by the primary outcomes of significant 
reduction in heart rate and blood pressure.  However, reassuringly, perfusion 
weighted data measured using ASL does not suggest any significant global 
difference in the resting perfusion between the two drug conditions.  Further, 
there was no significant modulation of task-induced activity not associated 
with the processing of emotions, as evident in analysis of the region of interest 
in the visual cortex during the processing of visual emotional stimuli.  This 
would imply that the choice of a peripherally acting beta-blocker was correct 
and any direct central effects were avoided.  This fact alone separates the work 
presented in this thesis from previous work published that uses the centrally 
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acting beta-blocker, propranolol [34, 35, 36] as any differences in brain 
function are confounded by the central action of the drug. 
 
The sample size of 20 used here is larger than sample sizes used previously 
[34], and allowed contingency for subjects to be excluded from data analysis.  
Inevitably, three subjects were excluded from analysis of the emotional 
stimulus task, reducing the sample size to 17.  A minimum sample size of 15 
to 20 is considered acceptable for studies of this type [41].  Additionally, the 
placebo controlled randomised crossover design of drug administration 
provides greater statistical power for a given effect size. 
 
The additional information provided by simultaneously acquired BOLD and 
ASL data allows interrogation of task related response through both BOLD 
signal intensity changes and perfusion responses.  The use of dual echo ASL 
BOLD sequences for functional MRI is still not commonplace and certainly 
the use of ASL contrast for pharmacological functional MRI is in its infancy.  
Additionally, the steady state pseudo continuous ASL (PCASL) acquisition 
gives further insight into tissue perfusion responses to emotional stimuli with 
good contrast-to-noise ratio, and the assessment of potential modulation as 
caused by the beta-blocker nadolol.  Given the additional information that 
these two techniques provide when used in combination, further development 
and use is encouraged. 
 
4.4.4 Weaknesses of the study 
 
The PCASL sequence used for the assessment of drug induced changes in 
resting perfusion and response to the emotional task used a single inversion 
time (TI).  Care was taken to image and label in the same position between the 
two scanning sessions, and differences in signal intensity are accounted for by 
normalising the ASL signal images to a base EPI.  This provides a good 
assessment of any drug modulation of the PCASL signal, which can be 
assumed to have a linear relationship with CBF [75], but assuming blood 
transit time does not change between drug conditions.  A multiphase ASL 
acquisition using a pulsed ASL labelling scheme would give a quantifiable 
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measure of CBF and blood transit time, and thus drug induced modulation of 
these two quantities could be assessed.  However, the spatial coverage of such 
a scheme is limited. 
 
To improve the sensitivity of resting state network detection in BOLD data, 
more rigorous measures could be taken to regress out nuisance signal.  While 
drug correlated change in subject head motion was not shown to be 
statistically significant, no assessment was made of white matter or 
cerebrospinal fluid noise levels.  If these were substantial, or if they changed 
significantly after the administration of nadolol, they may introduce spurious 
correlations, or mask genuine correlations of low magnitude [77]. 
 
To be critical of the methods chosen for acquisition in this study, it is 
necessary to mention that the PCASL scheme results in reduced brain 
coverage and temporal resolution compared to a standard BOLD EPI 
acquisition.  The PCASL sequence was optimised prior to the study to 
maximise the coverage for a given temporal resolution, and care was taken to 
ensure that this would include the main areas of interest, from the amygdala to 
the anterior cingulate cortex.  In functional MRI studies the temporal 
resolution is important so this could not be sacrificed too greatly, and a 
repetition time (TR) of around 2000 ms is typical for a standard BOLD 
acquisition.  This had to be increased due to the requirement of the labelling 
duration and post label delay for the PCASL sequence, and a TR of 3500 ms 
was considered acceptable.  The stimulus paradigm was adapted accordingly 
to ensure that each “on” period and “off” period lasted for 14s, thus including 
two dynamic pairs of image acquisition.  However, this still resulted in 
reduced statistical power due to the fact that fewer images are acquired in each 
stimulus condition (neutral, pleasant and unpleasant) for a given total task 
duration (14 minutes). 
 
Emotional images were chosen with a variety of compositions, including 
animals, objects, faces and scenes.  Emotional faces are known to elicit 
enhanced processing in the limbic system [78].  Previous studies have tended 
to use emotional images of either faces or scenes.  In the design, it was 
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intentional to use a mixture of both emotional faces and emotional scenes in 
order to provide a broad subject matter for the emotional stimulus, as well as 
to elicit activation from all relevant brain regions and networks, and minimise 
any gender bias in the subjective arousal induced by the stimuli.  However, 
this meant that the set of images did not have a predominance of emotional 
faces, which may have limited the limbic task involvement. 
 
While the sample size was deemed to be acceptable for the study [41], despite 
the necessary exclusion of three subjects due to motion (resulting in n = 17), 
single gender subgroup sizes were not adequate for robust statistical analysis.  
Results from gender subgroups are based on group sizes of n = 8 male and n = 
9 female.  Therefore, any results reported here from gender subgroup analysis 
are exploratory only and do not carry the same statistical power as whole 
group (n = 17) analysis. 
 
4.4.5 Impact of the study, future directions 
 
Drug correlated differences have highlighted regions of the brain that are 
implicated in the salience network and in the processing of emotions, such as 
the insula and amygdala.  This goes some way towards addressing the initial 
hypothesis that the peripherally acting beta-blocker modulates emotion related 
brain function.  While some results presented here support the hypothesis, 
such as the reduction of task related activity in the insula, increased activity in 
the amygdala is counter-intuitive and contradictory to the hypothesis.  These 
results promote interesting discussion of the mechanisms behind emotion 
processing and its modulation by nadolol. 
 
A working theory could be as follows; it is possible that the blockade of the 
peripheral nervous system responses could cause the amygdala and its 
associated network of brain areas to “work harder” to compensate for the lack 
of peripheral information.  Alternatively, it could be suggested that the 
peripheral blockade may sensitize central receptors in the amygdala, and thus 
emotional stimuli cause greater activity while the amygdala is in this enhanced 
state.  An alternative speculative explanation for the paradoxical modulation 
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of amygdala response is that nadolol suppresses the processes that rationalise 
the emotional visual stimuli as merely non-threatening images, thus leaving 
the processing of threat and fear stimuli unsuppressed in the amygdala.  
However, there is no evidence that any of this speculation is correct and thus 
the topic is open for discussion and may require further analysis of 
behavioural and physiological data acquired for this study, or further 
experimentation may be needed. 
 
The suggestion of drug induced modulation of brain function that differs in the 
two gender groups would imply that emotional visual stimuli are processed 
differently by males and females.  If this were shown to be the case, a gender 
specific modulation of neural emotional processing could be exploited by 
future studies to provide more information on the mechanisms behind the 
processing of different stimuli that elicit activations in separate areas of the 
brain.  It may be possible to suppress one set of processes in males and 
compare patterns of responses to emotional stimuli with those in females, for 
example.  Such a study would require a larger number of subjects for 
comparisons between gender groups.  In line with the effect size of this study, 
group sizes of 20 males and 20 females should be performed.  
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5 ASL at 3 T in healthy volunteers: combined use of Territorial ASL and 
multi-phase ASL 
 
5.1 Introduction 
 
The objectives of this chapter are to implement a technique known as 
Territorial Arterial Spin Labelling (TASL) at 3 T, not previously performed at 
Nottingham, and use this in combination with quantitative assessment of 
perfusion and blood transit times provided by multi-phase ASL in a healthy 
volunteer study to assess and verify the cerebral haemodynamics, in particular 
the watershed regions. 
 
Arterial Spin Labelling (ASL) provides quantitative endogenous perfusion 
contrast that allows repeated image acquisition with rapid washout, as outlined 
in Chapter 3.  To date, ASL is still not widely used in the clinical setting, with 
gadolinium dynamic contrast-enhanced (DCE) perfusion imaging being 
favoured [1].  Due to the fact that DCE perfusion uses an intravenously 
administered contrast agent that will fill any and all blood vessels in the body, 
it is not possible to determine the exact arterial route by which blood arrives to 
the brain; only that it has arrived there.  In ASL, the inversion slab used to 
label inflowing blood is most typically applied to all inflowing vessels 
simultaneously.  However, ASL offers a unique opportunity to selectively 
label inflowing blood by careful placement of a selective inversion slab.  
Using this method, it is possible to determine which tissue regions are 
supplied by a particular artery or arteries.  This technique is known as 
Territorial Arterial Spin Labelling (TASL) [1, 2, 3].  TASL provides the 
potential to determine the relative contributions of different feeding arteries to 
the total blood supply, in order to map the vascular perfusion territories in the 
brain.  The technique was first demonstrated by Eastwood et al using spatially 
selective inversion pulses at 1.5 T for the purpose of labelling the left and right 
cerebral blood supplies (internal carotid and vertebral arteries) separately [4]. 
 
A study by Hendrikse et al [2] first termed the technique TASL, and used a 
TILT labelling scheme (see Section 3.5.4) at 1.5 T to delineate the flow 
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territories of the left and right internal carotid arteries and the posterior supply, 
thus providing territory maps.  Their work showed that by selectively labelling 
the internal carotid artery, labelled blood flowed into the ipsilateral anterior 
cerebral artery and middle cerebral arteries.  Further, labelling of the basilar 
artery resulted in labelled blood flowing through both posterior cerebral 
arteries [2].  In regular ASL, blood water in all inflowing arteries is labelled 
simultaneously, thus the inversion slab is positioned below, and parallel to, the 
imaging slab so that the two regions do not overlap.  However in TASL, the 
inversion slab is positioned as a “free” slab, as shown in Figure 5.1 and often 
overlaps the imaging region.  To prevent the appearance of a high intensity 
band that would otherwise appear over the intersecting regions of the image 
volume and label slab on the perfusion weighted images, in-plane pre- and 
post- saturation pulses are used [5]. 
 
 
Figure 5.1: Schematic showing locations of labelling slabs for territorial ASL.  Imaging 
region is shown in pink and can be seen to overlap the labelling region in all positions. 
 
Territorial ASL has previously been demonstrated in both healthy subjects and 
in a patient with asymptomatic high-grade artery stenosis to provide maps of 
the vascular territories of the left and right internal carotid arteries (L / R ICA) 
and of the basilar artery (BA) using a pseudo-continuous arterial spin labelling 
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(PCASL) scheme [6].  In addition, this study used TASL to quantify the 
supply fraction provided by each artery in regions of mixed territorial supply. 
 
Territorial ASL has been compared to the gold standard of digital subtraction 
angiography (DSA) in a cohort of patients with extra- or intra-cranial steno-
occlusive disease [1], for the purpose of identifying occluded cerebral arteries.  
DSA requires the injection of gadolinium contrast, whereas TASL is entirely 
non-invasive.  While TASL did not provide the same accuracy of vessel 
identification as DSA (TASL provided 89% success rate compared to 98% 
with DSA, as assessed using statistical contingency tests to measure 
agreement between methods), this was attributed to motion related artefacts 
incurred using TASL [1].  To date, there are still a strikingly small number of 
studies published in the literature that use the technique of territorial ASL. 
 
An alternative ASL method is that of a multi-phase (also termed multi-TI) 
ASL scheme.  Variants of this include inflow turbo-sampling EPI-FAIR (ITS-
FAIR) [7], Look-Locker ASL [8, 9], or quantitative STAR labelling of arterial 
regions (QUASAR) [10].  The multi-phase technique was previously outlined 
in Section 3.5.4.  In this method, an inversion label is applied to label 
inflowing blood from all arteries.  Rapid repeated imaging of the brain 
following a single label can then be used to determine information on both the 
label arrival time and perfusion rate of the tissue.  A pulse sequence for this 
method is shown schematically in Figure 5.2.  This method involves applying 
a single label and subsequently imaging several times in close succession 
allowing the entire arrival and washout / relaxation of the labelled blood to be 
modelled.  The first image is acquired at an inversion time with a post-label 
delay, TI, after the application of the labelling pulse.  Subsequent images are 
acquired at a separation time, TA, after the initial image.  A mathematical 
model of the label signal can then be used to create a fit of the response curve 
for each voxel, using the ASL signal measured at each time point [9].  This 
model accounts for inflow and exchange time, as well as the suppression by 
RF pulses, and relaxation time effects.  In comparison to single TI pulsed 
ASL, multi-phase ASL provides additional information about the transit time 
to the tissue, allowing improved perfusion estimation. Given that multi-phase 
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data collects the perfusion weighted signal at additional time points, it is 
possible to calculate blood transit time and quantitative perfusion values.  The 
number, separation (TA) and flip angle of the multiple image acquisitions, 
shown in Figure 5.3, can be varied so that the sequence is more sensitive to 
either arterial transit time (Δ) and arterial blood volume (CBVa) or capillary 
transit time (δ) and cerebral blood flow (CBF) [9].  For example, at 3 T, 
maximum sensitivity to CBF can be achieved (at a flip angle of 35° - 45°) 
using an initial TI of 300 ms, with 7 readout phases at a TA of 300 ms [9], and 
applying a vascular crushing gradient to suppress the signal originating from 
arterial blood that is flowing with a velocity greater than the specified vascular 
crushing velocity.  Vascular crushing can be achieved using a bipolar gradient, 
described in terms of the velocity of blood flow above which signal will be 
crushed (Venc) and is given in cms
-1
.  Sensitivity to CBVa requires a larger flip 
angle (for example, 50°), with more readout phases (up to 21) at a shorter TA 
(around 100 ms) thus suppressing signal from the tissue compartment [9].  
Alternatively two sets of multi-phase ASL can be acquired with the same 
timings and flip angles with and without crushing gradients.  Data acquired 
with crushing gradients can be used to suppress the arterial component and 
sensitise to tissue signal, whilst the subtraction of the two data sets provides 
sensitivity to the arterial signal (Figure 5.3), [10]. 
 
 
Figure 5.2: Pulse sequence diagram for multi-phase ASL acquisition [8], showing timings 
of image acquisitions and slice select gradients (spoiler gradients shown in red). 
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 Figure 5.3: (A) Diagram of vasculature showing relative contributions of arterial (red) 
and capillary (purple) components to the ASL signal.  (B) Schematic of the ASL signal 
changes expected in each compartment (ignoring effects of repeated suppression by the 
multi-phase acquisition).  This shows the arterial (Δ) and capillary (δ) transit times, and 
 which is the time taken for exchange between arterial and capillary compartments. 
 
The cerebral watershed areas are the cortical grey matter areas supplied by the 
most distal branches of the arterial territories, defining the border zone 
between two arterial territories.  A paper by Hendrikse et al describes the 
cerebral border zones as the regions extending from the frontal and occipital 
horns of the lateral ventricle to the fronto and parieto-occipital cortices [3].  In 
a study of healthy volunteers, it was shown that tissue in these regions exhibit 
significantly lengthened arterial transit time of blood [3].  These areas are 
considered to be at high risk of haemodynamic stroke and have possible 
involvement in thrombo-embolic stroke as a result of the reduced washout 
capacity [11, 12].  Hendrikse et al assessed global cerebral blood flow in 
patients with internal carotid artery occlusion and healthy controls.  Images 
were acquired using a TILT labelling scheme at 1.5 T at post-label delay times 
of 200 ms, 400 ms, 600 ms, 800 ms, 1200 ms and 1600 ms, where each TI was 
acquired following a single inversion pulse (i.e. a single TI method).  A 
general kinetic model [14] of the ASL signal was then used to calculate 
quantified CBF values within regions of interest in the grey matter of the 
bilateral middle cerebral arterial territories.  The group found a significant 
decrease in cerebral blood flow in the region of interest in the hemisphere with 
occlusion compared to the contralateral region of interest, and compared to 
healthy control subjects [15].  It is possible to locate regions of the brain with 
lengthened transit times using a technique similar to the multi-phase ASL 
described above. 
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The precise location and extent of watershed regions is not easily derived [16] 
from brain atlases due to a high degree of inter-individual variation.  
Additionally, watershed regions may be shifted in subjects with 
cerebrovascular disease [15].  For these reasons, there is interest in 
physiologically defining the location and variation in the cerebral watershed 
regions.  The primary aims of this chapter are as follows: 
 To acquire territorial ASL – selective maps of the vascular territories 
of the internal carotid arteries and posterior circulation, and to separate 
the vascular territories of the middle cerebral and anterior cerebral 
arteries. 
 To compare the locations and boundaries of the watershed regions at a 
group averaged level using Territorial ASL, with maps of lengthened 
arterial and capillary transit times (Δ and δ respectively) from multi-
phase ASL data, indicative of watershed areas. 
 
A secondary aim is to assess transit time variance across a range of cortical 
areas.  This would provide useful information for planning future ASL studies 
and for functional MRI studies using perfusion weighted contrast. 
 
5.2 Methods 
 
The study was approved by the University of Nottingham Medical School 
Research Ethics Committee.  All subjects gave fully informed, written consent 
after having the procedure explained to them, and confirmed that they had no 
past cerebrovascular medical history, and considered themselves to be healthy.  
This chapter reports a study in which ten subjects (age 27 ± 3 years, n = 5 
male) were scanned on a Philips Achieva 3.0 T MRI scanner with an 8 
element SENSE head coil in a single session.  A total of 21 healthy subjects 
were scanned during the development of the protocol and the period in which 
the scanner operators were familiarising themselves with the technique, and 
the study.  The scanning protocol run in ten subjects for the complete 
assessment is shown in Figure 5.4.  To overview this protocol, subjects first 
underwent a standard set-up protocol of a survey and reference, followed by 
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an EPI base scan. The EPI base scan (two dynamics of the EPI acquisition, at 
the same resolution / bandwidth as the EPI scans used for the TASL and multi-
phase CBVa readout, with a TE of 13 ms and a TR of 10 s) was used for the 
registration of the datasets to standard MNI space and to provide a measure of 
the equilibrium magnetisation, M0.  Coronal and sagittal phase contrast 
angiograms (PCA) and a time of flight (TOF) contrast angiogram, each taking 
approximately 3 minutes to collect, were used for locating inflowing arteries 
and thus for positioning selective inversion slabs for TASL.  Standard ASL 
labelling all inflowing vessels was first acquired with a single TI, for 
assessment of total perfusion and validation of labelling.  Territorial ASL was 
acquired for the four vascular territories of the left and right internal carotid 
arteries (LICA and RICA), posterior blood supply of the basilar and vertebral 
arteries (BA) and anterior cerebral artery (ACA).  Multi-phase ASL was 
acquired labelling all inflowing vessels, both without and subsequently with 
vascular crushing to provide maps of arterial blood volume and transit time 
(CBVa and Δ) and cerebral blood flow and capillary transit time (CBF and δ) 
respectively.  Each of the five single-TI ASL scans and each multi-phase ASL 
scan took approximately 4 minutes.  The total scan time for the entire scan 
card was approximately 40 minutes; however the time in the scanner was 
slightly longer when accounting for planning time. 
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 Figure 5.4: Scanning protocol for combined assessment of territorial ASL and multi-
phase ASL for haemodynamic parameter maps. 
 
5.2.1 Territorial Arterial Spin Labelling (TASL) 
 
In order to selectively label the arteries in the neck region for TASL, a fast, 
non-invasive method of determining the positions of the feeding arteries must 
first be used.  This was performed using phase contrast (PCA) and time of 
flight contrast angiography (TOF), as shown in Figure 5.5 (see Section 3.5.1). 
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 Figure 5.5: Locations of planning slabs for phase contrast angiograms (PCAs) and time 
of flight (TOF) angiogram, shown superimposed on to sagittal and coronal survey 
images. 
 
Phase contrast angiography (PCA) was collected in coronal and sagittal planes 
to aid planning of TASL and comprised two thick slices in each direction.  
The coronal slices were positioned such that the anterior vessels (internal 
carotid arteries, middle cerebral artery) could be separated from the posterior 
vessels (basilar artery, posterior cerebral artery) by placing the two coronal 
slices symmetrically about the brainstem.  The coronal PCA was acquired 
using a TE / TR of 7.6 ms / 14 ms, flip angle of 20°, and a SENSE factor of 2.  
An in-plane resolution of 0.72 mm by 1.2 mm was used for two 60 mm slices, 
with a field of view of 250 mm × 250 mm × 110 mm.  A phase contrast 
velocity encoding of 30 cms
-1
 was used so that arterial blood flowing at this 
velocity will exhibit a maximum phase difference and thus maximum signal 
intensity.  The sagittal slices were positioned such that the left and right 
internal carotid arteries could be clearly seen, i.e. that the two slices were 
positioned symmetrically about the interhemispheric fissure.  The sagittal PCA 
was acquired using a TE / TR of 7.6 ms / 20 ms, flip angle of 15° and a 
SENSE factor of 2.  An in-plane resolution of 0.72 mm by 1.2 mm was used 
for two 50 mm sagittal slices with a field of view of 230 mm × 230 mm × 95 
mm.  The phase contrast velocity encoding was again 30 cms
-1
. 
 
In the axial direction, a Time of Flight (TOF) contrast angiogram was 
collected.  This was positioned to show the Internal Carotid Arteries (ICAs) 
and the Circle of Willis.  The TOF was acquired using a TE / TR of 2.3 ms / 
23 ms, 18° flip angle, SENSE factor 2, in plane resolution of 0.543 mm ×  
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0.82 mm with one hundred 0.7 mm slices and 200 mm × 200 mm × 70 mm 
field of view.  From this, a maximum intensity projection (MIP) was formed.  
The PCAs and TOF MIPs were used for the subsequent planning of the 
selective TASL slabs [2]. 
 
Prior to TASL, single TI ASL data was acquired labelling all inflowing 
vessels (termed “all”) using a 100 mm thickness slab positioned in the neck, 
parallel to the imaging slab, and a post-label delay of 1200 ms.  In-plane 
saturation was applied to the imaging slab pre- and post-labelling (and is 
described in further detail below). This “all” single TI scan also provided a 
check as to whether the labelling was working efficiently, as the image 
subtraction tool, which is available as part of the scanner software, was used to 
check the image quality of the perfusion weighted images at the scanner. 
 
 
Figure 5.6: Locations of selective inversion labelling slabs used for TASL superimposed 
on to coronal and sagittal PCAs and axial TOF angiogram. 
 
For TASL, slabs of an approximate thickness of 50 mm were positioned to 
label the anterior blood supply in the left and right internal carotid arteries 
(ICAs) and middle cerebral arteries, and to label the posterior blood supply 
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including the basilar artery (BA), vertebral artery and posterior cerebral artery, 
as described in previous work [2], and shown in Figure 5.6.  In addition, the 
anterior cerebral arteries (ACA) were selectively labelled using a narrow 
inversion labelling slab of approximate thickness 20 mm, applied in the 
sagittal plane, as shown in Figure 5.7.  All TASL data were also collected with 
a post-label delay of 1200 ms. 
 
 
Figure 5.7: Location of the selective inversion slab used to label the anterior cerebral 
arteries, superimposed on coronal and sagittal PCAs and axial TOF angiograms. 
 
All labelling was performed using a STAR (Signal Targeting with Alternating 
Radiofrequency) ASL sequence.  This sequence uses alternately acquired label 
and control images followed by a single shot multi-slice EPI acquisition 
method.  The STAR labelling scheme comprised two successive inversion 
pulses using  hyperbolic secant adiabatic inversion pulses to form the control 
condition (180° + 180° = 360°).  For the label condition, an adiabatic 
inversion pulse with nominal 360° degree power was used.  In this way, the 
offset frequency and power used were identical for label and control STAR 
conditions, thus controlling for magnetisation transfer (MT) effects. 
 
In-plane saturation was applied to the imaging plane for all ASL schemes 
using a pre-saturation and post-saturation scheme.  Use of in-plane saturation 
is critical for TASL, as the label overlaps the imaging plane.  The in-plane pre-
saturation scheme comprised a WET (Water suppression Enhanced through 
T1 effects) scheme of four selective pulses (of flip angle 89.17°, 98.37°, 
82.31° and 156.77°) applied prior to the labelling pulse, following labelling 
the post-saturation scheme comprised a single sinc pulse.  Pre- and post- 
saturation pulses were applied to the imaging region, with additional coverage 
of 45 mm above the imaging region to prevent signal contributing from 
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inverted blood in vessels above the imaging region flowing downwards into 
the imaging region, and also 10 mm below the imaging region.  The positions 
of the imaging slices and the pre- and post- saturation slab thickness are 
shown in Figure 5.8. 
 
 
Figure 5.8: Location of imaging slab (slices shown in white) and the in-plane saturation 
pre- and post- saturation slabs (highlighted in red). The in-plane saturation had an 
additional thickness of 45 mm above and 10 mm below the imaging region. 
 
For each labelled territory, 40 pairs of label and control images were acquired 
at a post-label delay (TI) of 1200 ms to maximise ASL signal whilst 
minimising arterial contribution to the signal [2, 17], and a TR per label / 
control pair of 6 s.  As vessels could be difficult to selectively label, the 
location of the labelling slab was first tested by acquiring 5 dynamic pairs per 
territory, and subtraction of label and control images was performed on-line 
using the image subtraction tool.  If necessary the labelling slab was 
repositioned at this stage, before repeating the process until satisfactory 
labelling of the territory was achieved.  All single-TI ASL data were acquired 
with gradient echo EPI readout with 3 mm in plane resolution and a slice 
thickness of 8 mm with a 212 mm × 212 mm field of view.  A 10 slice dataset 
was acquired in ascending order, positioned as shown in Figure 5.8. 
 
Prior to the study, 11 subjects were scanned using the TASL protocol only, to 
give the scanner operators experience in using the technique and reduce the 
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effect of user dependence on planning the selective labelling.  The success rate 
of labelling individual vascular territories in these 11 subjects is listed in Table 
5.1, with complete success termed as good clear individual territories for each.  
Subsequently ten subjects were scanned for the complete protocol outlined in 
Figure 5.4. 
 
Pilot subject BA LICA RICA  Complete success? 
1      
2      
3      
4      
5  weak    
6   weak   
7      
8      
9      
10 weak     
11   weak   
Table 5.1: Success rate of labelling of vascular territories for the 11 subjects scanned 
during learning phase prior to the start of the study. 
 
It is clear that as the learning progressed, success improved, but inevitably, 
there were still occasional failures due to proximity of other vessels to target 
vessels, thus causing additional labelling in the adjacent territory, or due to 
subject motion between the planning scans and the TASL acquisition. 
 
5.2.2 Multi-phase ASL 
 
Multi-phase ASL data were collected using the STAR labelling scheme, as 
described above for TASL, but with the labelling applied to all inflowing 
vessels.  Following labelling, a multi-phase EPI readout sequence with an 
initial delay (TI) of 300 ms, and a total of 7 equally spaced acquisitions at an 
inter-phase interval (TA) of 300 ms was acquired.  These timings ensure that 
the sequence was optimised to calculate cerebral blood flow (CBF) and 
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capillary transit time (δ) [9], when vascular crushing is applied.  In the first 
instance, data were acquired without vascular crushing ensuring a large 
arterial component to the signal, providing an estimate of arterial transit time 
(Δ) and CBVa maps.  Second, the scan was repeated with the addition of a 
bipolar vascular crushing gradient applied following each excitation, thus 
suppressing the signal from fast flowing spins [18].  A bipolar gradient of Venc 
= 5 cms
-1
 was used to suppress the signal from fast flowing blood, thus 
weighting the sensitivity towards blood in the capillary compartment.  This 
was applied using a 4 ms bipolar gradient with gradient amplitude 11 mT / m 
in the foot-head axis only. The velocity encoding of the bipolar gradient can 
be calculated from: 
 
          
     Eqn. [5.1] 
 
where  is the proton gyromagnetic ratio, A is the gradient lobe amplitude and 
 is the gradient lobe duration plus half the sum of the rise and fall times.  The 
bipolar gradients will cause an attenuation of the signal from moving protons, 
such that there will be a distribution of attenuation values across flow 
velocities, and the b factor can also be estimated from: 
 
  
 
 
          Eqn. [5.2] 
 
which for this bipolar gradient was found to be equivalent to 0.37 smm
-2
.  
Vascular crushed ASL data were used to produce maps of capillary transit 
time (δ) and perfusion (CBF).   
 
All multi-phase data were acquired using a TE / TR of 14 ms / 3200 ms and a 
flip angle of 45°.  The field of view and spatial resolution was identical to that 
used for the single TI data outlined above.  However, since the multi-phase 
technique does not allow for as wide coverage as single-TI methods, due to the 
time constraints of acquiring several readouts in the interval between the 
phases, only 6 slices could be acquired.  Slices were acquired in ascending 
order, with the centre of the stack for the multi-phase data positioned to match 
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the centre of the single-TI ASL stack.  40 dynamic pairs of label and control 
images were acquired for each of the two multi-phase ASL datasets. 
 
5.2.3 Processing and Analysis 
 
To inspect the quality of the data during scanning, data sets were viewed using 
the on-line image subtraction program available on the scanner, subsequently 
data were then processed and analysed off-line as outlined below.  Single-
phase ASL label and control images were subtracted for each dynamic to form 
perfusion weighted difference images.  These individual difference images 
were then visually inspected for motion with a view to discarding degraded 
dynamics, however this was not necessary.  The data were then averaged 
across the 40 dynamics.  This was performed using software written in 
MATLAB [19].  Single-TI ASL data with all inflowing vessels labelled was 
used to calculate perfusion weighted difference images of the entire blood 
supply.  TASL label and control images were subtracted to form perfusion 
weighted difference images of vascular territories (right and left ICAs, BA and 
ACA).  All single-TI data were spatially smoothed to a FWHM of 8 mm. 
 
Multi-phase ASL label and control images were also subtracted to give a 
perfusion weighted image for each readout phase and slice.  Non-vascular 
crushed multi-phase data was then fitted on a voxel-by-voxel basis to form 
arterial transit time (Δ) and CBVa maps.  Vascular crushed data was fitted to 
form capillary transit time (δ) and perfusion (CBF) maps.  This was performed 
using in-house software developed and written in c by Dr Susan Francis. that 
used a three compartmental model of the multi-phase ASL sequence of 
perfusion measurements [9].  The model takes account of the arterial transit 
time of the blood (compartment 1) before making temporally stepwise 
calculations of the transit of blood through the arteriolar and capillary 
compartment (compartments 2 and 3 respectively).  This is to avoid 
discontinuity as the blood makes transitions from one component to the next. 
Data were fitted by entering the perfusion weighted images and EPI base data, 
and assuming a T1tissue of 1300 ms and T1blood of 1600 ms. 
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To form group maps of the vascular territories, arterial and capillary transit 
times, CBF and CBVa, the 10 slice EPI base images were first transformed 
into MNI space [20] using the FLIRT linear registration tool in FSL [21].  The 
transforms created by this process were then applied to all ASL data. 
 
Each vascular territory perfusion weighted image was threshold at a level that 
suppressed noise (approximately 0.5%) and averaged across the group.  To 
further evaluate the data a number of quantitative analyses were then 
performed: 
(i) Binary masks were formed of each territory (LICA, RICA, BA and 
ACA) from the thresholded TASL data formed above.  These masks 
were then summed across subjects to create group probability maps 
showing the coincidence of the location of each territory across the 
group.  Overlap of territorial labelling was assessed for each subject by 
calculating the number of voxels that appear in two adjacent territories 
as a proportion of each territory, as shown in Figure 5.9. 
 
 
Figure 5.9: Method of calculating overlap between territories.  Example shown is for the 
overlap of the LICA onto the BA. 
 
(ii) Binary masks for the left and right ICA and BA territories were 
summed for each subject.  This summed mask was then multiplied by a 
binary grey matter (GM) mask created using the FSL standard grey 
matter atlas, threshold at a probability of 0.5 [21].  A TASL watershed 
GM mask was then formed by subtracting the summed mask of 
vascular territories from the GM binary mask, as shown pictorially in 
Figure 5.10.  This TASL watershed GM mask was then used as a 
surrogate for an objective definition of the watershed regions to 
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interrogate arterial and capillary transit time maps and for 
correspondence with watershed regions from multi-phase ASL data. 
 
 
Figure 5.10: Method for producing a mask of watershed GM regions from the TASL 
data. Grey matter voxels that did not appear in any of the vascular territory maps were 
used to define the watershed region.   
 
(iii) Multi-phase ASL data were used to compute group haemodynamic 
parameter group maps of CBVa, Δ, CBF and δ, and the average and 
standard deviation of these values calculated across subjects. 
Watershed areas were manually defined from the multi-phase data as 
those regions displaying lengthened transit times, typically with 
arterial or capillary transit times greater than 900 ms, and classified as 
anterior, posterior and internal watersheds.  To form objective grey 
matter watershed regions of interest (ROIs), the capillary transit time 
maps were threshold at 900 ms, and a binary mask formed. These 
multi-phase watershed masks were then multiplied by the standard GM 
mask described above to form a multi-phase watershed GM mask. 
(iv) Correspondence between TASL vascular territory maps and the 
watershed areas were calculated as percentage overlap.  This was first 
performed by finding the number of voxels that appear in both the 
manually defined watershed region and the vascular territory and 
calculating this as a percentage of the number of voxels in the 
watershed region, as shown in Figure 5.11 (A). The hypothesis is that 
this percentage would be low if both methods are defining the 
watershed regions.  Secondly, the percentage of common voxels that 
appear in both the TASL watershed GM mask and the multi-phase 
watershed GM mask was assessed, as shown in Figure 5.11 (B).  The 
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hypothesis is that this value should be high if both methods define the 
watershed areas. 
 
 
Figure 5.11: (A) Procedure for calculating correspondence between vascular territories 
and watershed areas as percentage overlap.  (B) Procedure for calculating 
correspondence between methods of creating grey matter watershed masks. 
 
Mean and standard deviation CBVa, Δ, CBF and δ values were computed for 
each vascular territory (left and right ICA, BA and ACA). These values were 
also computed for each of the manually drawn watershed regions (anterior, 
posterior and internal), as well as GM watershed areas calculated from the 
TASL and multi-phase data and the watershed area formed from the 
conjunction of the two GM watershed areas. 
 
In addition, as a secondary aim, the parameters CBVa, Δ, CBF and δ were 
assessed for their mean value within anatomically defined regions of interest, 
the location and shape of which were found using the anatomical atlas (WFU 
Pick Atlas toolbox) from SPM [22].  Regions were chosen in the caudate, 
putamen, thalamus, primary somatosensory and motor cortices, insula, 
cingulate, inferior occipital cortex and occipital pole (including the primary 
visual cortex). 
 
5.3 Results 
 
5.3.1 Territorial ASL 
 
Single phase “all” ASL data provided good quality perfusion weighted 
images, with the blood supply from all inflowing vessels labelled in all ten 
subjects scanned for the complete protocol.  Group averaged images (n = 10) 
are shown in Figure 5.12.  The increased perfusion weighted signal apparent in 
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the posterior region of the brain (visual cortex and occipital pole) at this TI is 
indicative of the lengthened arterial transit time of blood to that region and 
hence a contribution from arterial blood, whereas anterior and temporal grey 
matter regions that are also highly perfused exhibit a lower perfusion weighted 
signal due to the shorter arrival time. 
 
 
Figure 5.12: Group (n = 10) perfusion weighted (single-TI) images with all inflowing 
vessels labelled.  Colour bar shows ASL signal intensity scale (arbitrary units). 
 
Efficiency of selective labelling for territorial ASL was qualitatively assessed 
by assessing the vascular territory maps for each subject, as outlined in Table 
5.2.  Selective labelling of the ACA was unsuccessful in most subjects, with 
the primary reason for this being the additional labelling of the BA territory.  
Labelling was found to be highly successful for all three of the LICA, RICA 
and BA territories in only 5 out of 10 subjects.  In the remaining subjects, only 
one or two territories were successfully labelled, with some territories 
receiving insufficient labelling and in other territories the labelling was not 
selective enough, thus labelling extra vessels additional to those intended.  
Failure was attributed to difficulty of placing labelling slabs over tortuous 
vessels and due to proximity of adjacent vessels limiting the ability to label 
only one vessel.  There is also the possibility of subject motion occurring 
between the acquisition of the planning angiography and the territorial ASL so 
that labelling slabs no longer efficiently covered the required vessel.  Figure 
5.13 and Figure 5.14 show examples of this, where the labelling slab covering 
the anterior blood vessels (particularly the LICA) has also labelled the BA, 
and where the labelling slab covering the ACA has also inadvertently covered 
the posterior cerebral artery. 
 
169
Study subject BA LICA RICA ACA  Complete success? 
1  weak  also BA*   
2  weak weak weak   
3 “all”* weak  also BA*   
4    also BA*   
5    also BA*   
6    also BA*   
7       
8 weak  weak    
9    weak   
10 weak weak     
Table 5.2: Success of labelling the three vascular territories for each subject.  Asterisks 
represent cases where adjacent territories were labelled in addition to the target 
territory. 
 
 
Figure 5.13: LICA (red) and RICA (green), shown in a subject where both anterior 
territories can be seen to overlap the territory of the BA (not shown).  This is due to the 
labelling slab labelling posterior vessels in addition to anterior vessels. 
 
 
Figure 5.14: ACA (yellow) and BA (blue) shown in a subject where labelling of the ACA 
resulted in additional labelling of the posterior cerebral artery, and thus partial coverage 
of the posterior (BA) territory. 
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The binarised average map for the group of 10 subjects is shown in Figure 
5.15, where each of the territories are colour coded using the standard 
labelling of using green, red and blue to represent the RICA, LICA and BA 
territories respectively, in addition the ACA is shown in yellow.  It is clear that 
there is a correspondence throughout the group; all healthy volunteers in the 
group displayed similar borders of vascular territories.  Probabilities of voxels 
appearing in each vascular territory across subjects scaled from 0 to 1 are 
shown in Figure 5.16 (A, B and C) for the posterior territory (BA), and left 
and right anterior territories (LICA and RICA) respectively.  Table 5.3 shows 
how each territory overlaps onto each of the other territories as a mean 
percentage across the group.  The left and right ICA territories show very little 
overlap, as expected from their geometric location.  The greatest overlap seen 
is of the BA onto the ACA, where in some subjects, the entire BA territory 
labelled was contained within the labelling of the ACA territory.  Conversely, 
the overlap of the ACA onto the BA is smaller, as in the ACA territory of 
every subject, there was at least some labelling additional to that of the BA 
territory. 
 
 
Figure 5.15: Group (n = 10) averaged maps of (A) vascular territory binary masks 
(green, yellow, red and blue represent RICA, ACA, LICA and BA respectively).  Data 
shown are for five slices of MNI co-ordinates z = 2 to z = 10. 
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 Figure 5.16: Group (n = 10) probability maps of the (A) BA, (B) LICA, (C) RICA and 
(D) ACA territories individually.  Data shown are for five slices of MNI co-ordinates z = 
2 to z = 10.  Colour bar shows the probability of co-incidence across the group. 
 
Overlap of territory Onto territory % overlap (± st.err.) 
LICA 
RICA 3.9 ± 0.7 
BA 10.5 ± 2.7 
ACA 15.5 ± 3.7 
RICA 
LICA 5.7 ± 1.4 
BA 13.5 ± 2.6 
ACA 19.8 ± 4.3 
BA 
LICA 17.7 ± 6.6 
RICA 17.1 ± 6.4 
ACA 24.9 ± 7.1 
ACA 
LICA 16.0 ± 4.3 
RICA 12.7 ± 3.3 
BA 16.3 ± 4.1 
Table 5.3: Overlap of each vascular territory onto the other vascular territories, shown 
as mean percentage (± standard error) across the group. 
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5.3.2 Multi-phase ASL 
 
Subtraction of label and control multi-phase data, and subsequent averaging 
across 40 dynamics gives perfusion weighted signal for the 7 phases (TIs) 
across each of the 6 slices, as shown in Figure 5.17 for the multi-phase ASL 
data acquired without vascular crushing, which is used for the calculation of 
CBVa and arterial transit time (Δ) maps. 
 
 
Figure 5.17: Multi-phase perfusion weighted acquired without vascular crushing for a 
representative subject, showing images at each inversion time (TI), averaged across 40 
dynamics. 
 
Figure 5.18 shows group maps of (A) mean arterial blood volume, CBVa, (B) 
arterial transit time, Δ, (D) estimated cerebral blood flow, CBF, and (E) mean 
capillary transit time, δ.  Figure 5.18 (C) and (F) show thresholded transit time 
maps, at thresholds of Δ = 900 ms and δ = 900 ms respectively.  Capillary 
transit time maps show a smaller spatial extent of lengthened transit times, 
improving delineation of the anterior, posterior and interior border zones in 
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comparison to the arterial transit maps. Thus the capillary transit time maps 
were used for definition of the watershed areas.  This allowed for manual 
definition of the watershed regions by thresholding of the capillary transit time 
maps, as shown in Figure 5.19.  The regions that were defined from these data 
correspond closely with the anatomical location of the watershed regions [23]. 
 
 
Figure 5.18: Group (n = 10) averaged maps of (A) arterial blood volume (CBVa), (B) 
arterial transit time (Δ), and (C) Δ threshold at 900 ms for the delineation of watershed 
regions.  (D) Cerebral blood flow (CBF), (E) capillary transit time (δ), and (F) δ 
threshold at 900 ms for more precise delineation of watershed regions.  Data shown are 
for five slices of MNI co-ordinates z = -6 to z = 2. 
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 Figure 5.19: The locations of the three watershed regions (anterior, internal and 
posterior), as defined by inspection of capillary transit time maps. 
 
5.3.3 Combined analysis of TASL and multi-phase ASL 
 
Comparison of locations of territories and manually defined watershed regions 
can be seen in Table 5.4 demonstrated as a percentage of each arterial territory 
that overlaps onto each manually defined watershed region. 
 
Watershed Territory % Overlap 
Anterior (L + R) ICA 20.4 
Anterior ACA 0.5 
Interior (L + R) ICA 65.9 
Interior ACA 0.3 
Posterior (L + R) ICA 19.8 
Posterior BA 1.2 
Table 5.4: Percentage overlap of arterial territories onto each of the three manually 
drawn watershed regions. 
 
Quantitative values for group haemodynamic parameters (mean ± standard 
error) calculated over territory regions and manually drawn watershed regions 
are shown in Figure 5.20 for arterial transit time (Δ), capillary transit time (δ) 
and perfusion (CBF).  The posterior (BA) territory was found to have a 
significantly lengthened transit time compared to anterior / internal carotid 
artery territories (LICA / RICA and ACA), with the anterior cerebral artery 
exhibiting the shortest transit times. 
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 Figure 5.20: Mean (± standard error) values for the group; haemodynamic parameters 
of arterial transit time (Δ), capillary transit time (δ) and perfusion (CBF), measured in 
territories and watershed regions. 
 
Perfusion rates in the watershed areas were reduced compared to mean values 
for the vascular territories, as would be expected for areas with decreased 
perfusion and delayed transit times [3]. 
 
The mask of grey matter watershed areas from the TASL scheme was used to 
interrogate blood transit time maps as a surrogate for objectively defined 
watershed regions.  The mask of GM watershed regions formed by 
thresholding capillary transit time maps was also considered, as was the 
conjunction of these two masks.  Figure 5.21 shows these three binary GM 
masks in a representative subject.  In general across the subjects, the posterior 
watershed regions were better represented than the anterior or interior 
watershed regions using either method.  The conjunction of the grey matter 
watershed masks derived from TASL and from thresholded multi-phase ASL 
maps of capillary transit time was calculated as a percentage overlap with each 
mask.  The conjunction of the two GM masks overlaps the TASL derived GM 
watershed mask by an average (± standard error) of 19 ± 4 %, and the 
thresholded capillary transit time GM watershed mask by an average (± 
standard error) of 25 ± 6 %.  Figure 5.22 shows the mean (± standard error) 
capillary transit times (δ) across each GM mask, averaged across the group of 
10 subjects, and Figure 5.23 shows the corresponding mean (± standard error) 
CBF values within the three masks. 
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 Figure 5.21: Binary grey matter masks estimating watershed regions from (A) voxels 
that do not appear in any vascular territory (B) voxels with capillary transit time > 900 
ms and (C) the conjunction of (A) and (B) in a single representative subject.  Masks 
shown for MNI co-ordinates z = -6 to z = 2. 
 
 
Figure 5.22: Mean capillary transit time (δ) within GM watershed masks derived from 
TASL, multi-phase ASL and the conjunction of both masks.  Group (n = 10) values of 
mean ± standard error are shown. 
 
177
 Figure 5.23: Mean cerebral blood flow (CBF) within GM watershed masks derived from 
TASL, multi-phase ASL and the conjunction of both masks.  Group (n = 10) values of 
mean ± standard error are shown. 
 
Cerebral blood flow and transit times were assessed for specified anatomical 
regions, namely the caudate, putamen, thalamus, primary motor and 
somatosensory cortices, insula, cingulate, inferior occipital cortex and primary 
visual cortex / occipital pole.  The caudate and putamen we found to have the 
shortest transit time, with the occipital lobe showing the longest.  CBF and 
transit time values for these regions are shown in Figure 5.24 and Figure 5.25. 
 
 
Figure 5.24: Mean cerebral blood flow values for selected anatomical brain areas; colour 
of bar indicates the corresponding territory in which the region falls. 
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 Figure 5.25: Mean capillary transit time (δ) values for selected anatomical brain regions; 
colour of bar indicates the corresponding vascular territory. 
 
5.4 Discussion 
 
5.4.1 Summary of findings 
 
A scanner protocol has been developed that provides combined territorial ASL 
and quantitative multi-phase ASL in a 40 minute scan session to determine the 
cerebral vascular territories and haemodynamic parameters of cerebral blood 
volume (CBVa), cerebral blood flow (CBF) and arterial and capillary transit 
times (Δ and δ respectively).  Using these methods, the location of the cerebral 
watershed regions in a cohort of healthy volunteers was investigated.  Three 
different methods were used to define the location and size of watershed 
regions: 
(i) Forming a grey matter mask for each subject of voxels that do not 
appear in any TASL vascular territory map; 
(ii) Manually drawing around regions of lengthened blood transit time 
using group maps of capillary transit time (δ); 
(iii) Thresholding capillary transit time (δ) maps on individual subjects to a 
threshold of δ = 900 ms and forming a grey matter (GM) mask. 
(iv) The common area between the masks formed by (i) and (iii) was 
assessed using the conjunction of the two masks. 
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Delineation of vascular territory maps showed agreement across the sample (n 
= 10).  Masks of grey matter voxels that were not present in any vascular 
territory map provided a surrogate for an objectively defined watershed 
region.  Watershed masks formed by finding voxels within a grey matter mask 
that were not present in any TASL map showed lengthened transit times and 
reduced CBF compared to other cortical regions.  These masks showed that 
watershed regions corresponded highly with the distal branches of vascular 
territories. 
 
From the multi-phase data, capillary transit time maps showed sharper 
definition of areas exhibiting lengthened transit times in comparison to arterial 
transit time maps.  Watershed regions as defined using manually drawn 
regions of longer transit time corresponded to the distal branches of vascular 
territories.  Masks of watershed regions were formed by thresholding capillary 
transit time maps to δ = 900 ms.  These watershed regions also corresponded 
to the distal branches of territories, and to watershed masks formed by 
subtracting vascular territory maps from a grey matter mask.  The mask 
formed by the conjunction of the two objective methods for creating GM 
watershed masks showed further specific delineation of the watershed regions, 
exhibiting even longer mean transit times and lower mean CBF values, as 
shown in Figure 5.22 and Figure 5.23. 
 
From inspection of anatomical ROI analysis on multi-phase data, mean values 
of capillary transit time (δ) were shown to be significantly lengthened in ROIs 
in the posterior of the brain, namely the inferior occipital cortex and the 
occipital pole / primary visual cortex (Figure 5.25). 
 
5.4.2 Discussion of findings 
 
The results presented in this chapter demonstrate the implementation of 
territorial ASL at 3 T and improvements made in the use of TASL in 
comparison to previous studies [24].  Territorial ASL has the potential for 
being a useful tool for clinical applications, as it provides a means of 
determining the route by which blood reaches certain areas of the brain.  
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However, the efficiency of this technique is highly user dependent as its 
success is reliant selective labelling of inflowing vessels.  Scanner operators 
were practiced in using the technique prior to the start of the study, as shown 
in the pilot group of 11 subjects scanned (Table 5.1).  However, in a group of 
10 healthy human subjects studied here, only 5 were shown to exhibit highly 
successful labelling of the three core vascular territories; posterior (BA) and 
left and right anterior (LICA / RICA), as shown in Table 5.2.  In the remaining 
5 subjects, definition of one or more territories was not highly successful due 
to insufficient labelling of the inflowing vessel or due to extraneous labelling 
of additional vessels.  In these cases, failure was attributed to difficulty in 
selectively labelling tortuous or closely adjacent vessels or due to subject 
motion following the planning angiography scans, resulting in the vessel 
leaving the labelling slab. 
 
Combining the techniques of multi-phase and territorial ASL provides the 
ability to construct informative individual vascular and haemodynamic 
parameter maps that can in turn be combined to build a reference atlas of 
region-specific perfusion levels.  From capillary transit time maps, the position 
and functional properties of watershed areas can easily be determined, either 
by manual definition of areas exhibiting lengthened transit time, or by the 
objective thresholding of capillary transit time maps.  Combining TASL with 
the technique of multi-phase ASL adds extra information to the technique for 
assessing the location of watershed regions, providing a means by which to 
verify TASL data, as shown by the mask formed by the subtraction of vascular 
territory GM masks from a whole brain GM mask, and further by the 
conjunction of the two masks formed by these two objective assessments of 
watershed regions.  Regions in this conjunction mask exhibited lengthened 
transit times and decreased perfusion as would be expected in watershed 
regions.  Further, perfusion values were lower and transit times lengthened in 
comparison to the GM mask formed by the use of either method in isolation 
(Figure 5.22 and Figure 5.23).  The methods outlined in this chapter provide a 
useful basis from which to study the haemodynamic effects of cerebrovascular 
disease, the physiological effects of healthy aging, blood pressure changes or 
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drugs that affect cerebrovascular dynamics through mechanisms such as 
autoregulation. 
 
A post-label delay (TI) of 1200 ms was used, as in prior studies, to minimise 
arterial contribution to the signal, as demonstrated in previous studies [2, 17].  
In patient groups and in older subjects, blood transit times are lengthened, 
suggesting the use of a longer TI for single-TI ASL.  Alternatively, it would be 
useful to combine the territorial ASL technique with a multi-phase readout to 
form territorial maps of blood flow and transit time, thus allowing for the 
quantification of the component of perfusion from each of the supplying 
vessels to each of the territories.  Then, in cases where vascular territories are 
seen to overlap, the quantified perfusion maps provided by the multi-phase 
readout could be compared with the “all” maps provided by standard ASL in 
order to determine the proportion of perfusion delivered by each of the feeding 
vessels. 
 
5.4.3 Future work and clinical applications 
 
This chapter has demonstrated that delineation of watershed areas can be 
assessed from the perimeter of vascular territories and from studying transit 
time maps for regions that display increased transit times. It may be interesting 
in future studies to further assess the length of vascular paths in combination 
with MR angiograms in order to draw a comparison between vessel length, 
vessel tortuosity and capillary transit time. 
 
This healthy volunteer study has highlighted many of the positive elements to 
the use of ASL and uncovered potential clinical applications of the technique.  
However, ASL unfortunately has limitations that prevent it from being used in 
a widespread clinical setting.  As ASL contrast is provided by a subtraction of 
the label image from the control image, it provides lower contrast to noise than 
other techniques, such as digital subtraction angiography (DSA) or dynamic 
contrast enhanced (DCE) perfusion.  This is somewhat overcome by repeating 
a single ASL measurement many times and averaging across these dynamic 
scans.  This can sometimes be very time consuming and introduce 
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prohibitively large motion artefacts.  If motion correction is used either prior 
to or following subtraction of the label and control images, this may also 
introduce artefacts correlated to the motion of the subject.  Motion is an even 
greater problem factor in patient groups than it is in healthy volunteer groups 
and so would need to be addressed before the technique can be used in clinical 
practice. 
 
This chapter demonstrates the potential of the technique, but also highlights 
that the use of territorial ASL alone is not robust enough for clinical use.  
However, the use of territorial ASL in combination with multi-phase ASL 
provides some verification.  Prior to clinical use, the technique of TASL 
would need to be demonstrated to have a significantly greater success rate, in 
line with techniques such as the gold standard, digital subtraction angiography 
(DSA), which boasts success rates as high as 98% [1]. 
 
This work could further be enhanced by acquiring comparable data using the 
above protocol an older healthy volunteer cohort, where transit times are 
expected to be lengthened and CBF to be reduced [28].  Other known factors 
affecting transit time include gender [29].  It would be very plausible to study 
the effect age or gender on blood transit times and perfusion rates using the 
methods described above; however this would require a larger cohort of 
subjects than has been studied here.  These comparisons would provide 
information about changes in perfusion during the process of healthy aging 
with a view to identifying differences in the haemodynamic properties of brain 
tissue that are displayed in patients from clinical groups, such as working age 
dementia. 
 
In some cases the blood arrival time can be delayed so significantly that the 
inversion applied to label the blood can have completely relaxed back by the 
time the blood has entered the imaging slab (i.e. if arterial transit time > T1 of 
blood).  This problem is exasperated when using techniques with multiple 
acquisitions per inversion, as the later acquisitions will not detect any labelled 
blood [30].  This would impact on the efficiency of the technique in the 
diagnosis and observation of conditions such as occlusive carotid artery 
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disease.  One solution to this would be to use the technique at higher magnetic 
field strength, where T1 times are longer [31], as discussed in Chapter 6 of this 
thesis. 
 
There are asymptomatic variations in the physiological manifestation of the 
cerebral blood supply, for example, variations in the architecture of the Circle 
of Willis [25, 26] and harmless abnormalities in the arrangement of feeding 
arteries [23].  These may account for some of the cases in which territories are 
seen to overlap in healthy subjects, and it would be of interest in future studies 
to additionally interrogate the TOF data to assess for altered vasculature in the 
healthy subjects scanned here.  An interesting enhancement to this study could 
be to examine the completeness of the Circle of Willis based on Time of Flight 
(TOF) data, to determine whether there is a haemodynamic consequence of 
this as measured using territorial ASL or multi-phase ASL.  If these variations 
in the cerebral vasculature can be identified in asymptomatic subjects, then the 
information can be used to help the clinician make a better informed decision 
regarding treatment in the case that such a subject was to suffer a vascular 
event.  In a clinical setting, it may be possible to use this information to assess 
the consequences of interventional surgery as a risk-free alternative to the 
angiographic balloon test occlusion assessment [27]. 
 
In patients with carotid artery stenosis and occlusion, Territorial ASL can be 
used to assess the vascular territories before and after medical or surgical 
intervention or other treatment of arterial stenosis or occlusion.  In addition, 
multi-phase ASL can be used to measure quantitative perfusion before and 
after intervention.  These techniques in combination would determine the 
success level of the surgery by ascertaining which areas of the brain, if any, 
were now receiving an increased blood supply, by which route that blood is 
being supplied, and whether the blood supply has been elevated / returned to 
an acceptable or normal level.  Territorial ASL could also be used to assess 
collateral blood supply in such subjects as often the cerebral vascular supply 
system will respond to a trauma or an occlusion, maintaining blood supply to a 
poorly perfused brain region by increasing the blood flow through alternative 
routes.  Territorial ASL therefore provides unique information that is not 
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deliverable using contrast enhanced perfusion methods as there is no capacity 
to be selective to only labelling one feeding artery at a time. 
 
Since the research presented in this chapter was carried out, super-selective 
TASL has been developed [32], and further, super-selective territorial 
angiography [33].  These build upon the methods described in this chapter, 
with the augmentation of further gradients applied perpendicular to either the 
artery, or to the labelling plane following the application of each label.  These 
gradients introduce a phase shift into the labelled blood, providing spatial 
information in the label.  The level of selectivity is manipulated by changing 
the strength of the gradient.  These methods allow territorial ASL with less 
dependence on the ability to plan the locations of the selective labelling slabs.  
Alternatively, velocity selective techniques [34] can be explored.  In velocity-
selective ASL, blood flowing below a specified velocity is labelled and thus 
slow and collateral CBF can be quantitatively measured.  As the label used is 
velocity selective, rather than spatially selective, these techniques completely 
remove the reliance on planning of scans.  
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6 Territorial ASL at 7 T in healthy volunteers 
 
6.1 Background 
 
Territorial Arterial Spin Labelling (TASL) has been developed and 
implemented at field strengths of 1.5 T and 3 T and shown to have the 
potential to non-invasively provide unique information on the cerebral 
vascular territories using selective labelling of inflowing blood vessels [1, 2], 
as outlined and demonstrated in Chapter 5 of this thesis.  This could prove 
clinically useful; however, it is not yet used in the clinical setting. One reason 
for this is that ASL delivers a low contrast-to-noise ratio (CNR) and thus data 
is collected at reasonably poor spatial resolution and requires a number of 
averages, making the typical scan duration around 5 minutes.  One major 
hindrance to the use of TASL, in addition to the CNR, is partial volume effects 
that limit the definition of, for example, the watershed areas.  One way of 
reducing partial volume effects is to increase the spatial resolution of the 
images acquired.  At 3 T, this would result in a significant reduction in the 
SNR of the image, requiring a significant increase in the length of the scan to 
collect a greater number of dynamics to match the SNR to that available at 
coarser resolution.  Increasing the scan duration can be potentially problematic 
as this can lead to excessive motion, especially in patient groups.  A potential 
solution may be found by collecting Territorial ASL at ultra-high field 
strength (7 T). 
 
In recent years, many MR manufacturers have introduced ultra-high field (7 T) 
MR systems into their portfolio.  The potential benefits of higher field strength 
to ASL are at least threefold: 
(i) There is an inherent increase in image signal-to-noise ratio (SNR) at 
higher field strength;  
(ii) Ultra-high field provides an increase in the longitudinal relaxation time 
(T1) of both blood and tissue (the T1 of blood is around 2 s at 7 T [4] 
compared to 1.5 s at 3 T [5], whilst grey matter T1 increases from 1.3 s 
[6] to 1.85 s [7]). This results in a theoretical increase in the perfusion 
weighted signal change and perfusion contrast-to-noise ratio [8] and 
190
allows for longer post-label delay times. This enables sensitivity to 
tissue that exhibits longer transit times, potentially advantageous for 
clinical patients where transit time are likely to be lengthened, which 
can lead to reduction of label detection at lower field strengths. Figure 
6.1 shows an idealised model of the percentage perfusion weighted 
signal at 3 T compared to 7 T, using the parameters modelled in [8].  
The continuous line shows this for the arrival of a theoretically 
continuous bolus (duration > 2200 ms) of labelled blood, whereas the 
dashed line represents the decrease in perfusion weighted signal after 
the arrival of a finite bolus of duration 1400 ms; 
 
 
Figure 6.1: Idealised perfusion weighted signal, dependent on post-label delay (TI) at 3 T 
and 7 T.  Modelled for CBF = 90 ml 100g
-1
min
-1
, capillary transit time = 800 ms, T1blood 
= 1300 ms at 3 T and 1850 ms at 7 T, T1tissue = 1600 ms at 3 T, 2100 ms at 7 T [8]. 
 
(iii) Higher-field MRI and parallel imaging work synergistically, creating 
possibilities for increasing robustness of high SENSE factors, enabling 
faster read-out strategies at higher spatial resolution [9]. 
 
However, ultra-high field strength introduces additional challenges for ASL, 
and initial experiments with ASL at ultra-high field show that the 
implementation of ASL to obtain the expected gains at 7 T is not trivial [10].  
Firstly, there is a fivefold increase in the specific absorption rate (SAR) of a 
given sequence at 7 T compared to 3 T, which is an important challenge.  This 
can potentially limit the label duration or increase the required repetition time 
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of SAR-intensive ASL-methods, which is particularly problematic for 
techniques such as CASL and PCASL, resulting in a lower SNR per unit time.  
Alternatively, the increased SAR of the labelling can reduce the slice coverage 
available.  SAR can be a problem even for PASL methods at 7 T, particularly 
when using labelling with a combination of additional background suppression 
pulses, or in–plane presaturation schemes. Secondly, the increased B0 
magnetic field inhomogeneities at ultra-high field pose problems for labelling, 
especially because these effects are most pronounced lower in the brain, in the 
region where labelling takes place.  A third challenge is the B1 inhomogeneity 
at 7 T due to the decreased electromagnetic wavelength in tissue, making the 
design and use of a body coil challenging at 7 T. Thus the common setup for 7 
T MRI scanners is to use a head RF coil for transmission, further limiting the 
potential of providing a good labelling slab in the neck region.  Together this 
results in limited B1 efficiency at the level of the brain-feeding arteries causing 
inefficiencies in the application of the selective inversion pulse, limiting the 
width, sharpness of profile and position of the labelling region, all effecting 
the labelling efficiency which can result in an underestimation of perfusion 
signal [11].  Additionally, due to the potentially poor label profile, the applied 
inversion label can be observed to “bleed” into the imaging region, causing 
partial inversion of static tissue, evident as an artefact on the image.  This can 
often be at least partially overcome with the use of in-plane saturation 
techniques, as explained later in this chapter [11].  One possible solution is to 
label higher in the brain, but this will immediately lead to a sacrifice of whole 
brain coverage, a significant disadvantage compared to current practice at 3 T, 
and also a limit of the application of TASL. 
 
Pulsed ASL schemes typically used for TASL at lower field strength include 
TILT (transfer insensitive labelling technique) and STAR (Spin Targeting 
with Alternating Radiofrequencies) schemes (see Section 3.5.4).  Both these 
schemes employ concatenated RF pulses, to eliminate magnetization transfer 
(MT) effects from the ASL signal. The inversion in TILT is achieved using 
two concatenated slice-selective 90° RF pulses with the second 90° RF pulse 
inverted in time and the second slice-selective gradient having opposite sign 
compared to the first.  For the control, the second RF pulse has a 180° phase 
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shift.  With this RF concatenation scheme, the magnetisation transfer (MT) 
signals from the static tissue in imaging slices are cancelled out between 
control and label sessions.  However, even at low field TILT can suffer from 
potentially large slice profile artifacts and poor efficiency due to using 90° 
pulses which are non-adiabatic, efficiency is made worse at ultra-high field 
where the B1 will vary across the labelling region, making this scheme 
unsuitable for ultra-high field.  The STAR sequence for multi-slice acquisition 
uses a single 180° adiabatic pulse for the label experiment and two 180° + 
180° pulses of half the power for the control experiment at the same proximal 
location.  The use of adiabatic radiofrequency pulses for labelling at 7 T has 
the advantage of reducing the sensitivity to B1 inhomogeneity.  This scheme 
relies on the two 180° pulses to achieve a control condition; this can be limited 
at 7 T due to the effects of T2 relaxation between the consecutive pulses.  
Further, SAR is increased due to the need for a nominal 360° pulse for the 
label and two 180° pulses for the control. 
 
Other limiting factors of ultra-high field are the increased sensitivity to 
physiological noise at 7 T [12].  To overcome these effects, at 7 T, ASL data is 
collected with background suppression to minimise physiological noise 
contributions by nulling the static signal in ASL images at the post-label delay 
time [19], reducing physiological noise, as well as variance introduced by 
effects such as head motion and system instabilities.  Finally, increased field 
strength leads to a reduction in the transverse relaxation time (T2 and T2*), 
which in turn can lead to signal dropout in the ASL images, and can also effect 
the quantification of perfusion [13]. 
 
To date, TASL has not yet been performed at 7 T, likely due to the challenges 
described above in its implementation.  The aim of this chapter is to develop a 
technique to implement Territorial ASL at ultra-high field strength (7 T) for 
the assessment of vascular territories in healthy adults. 
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6.2 Optimisation of TASL 
 
6.2.1 Optimisation of the Selective Labelling Scheme for use at 7 T 
 
6.2.1.1 Initial subject studies 
 
Prior to this study, the ASL scheme that had been implemented and routinely 
used on the 7 T system was that of FAIR (Flow Alternating Inversion 
Recovery), in which all blood flowing in to the slice is labelled.  This scheme 
had been shown to be more efficient for standard ASL than STAR [8], which 
uses an alternating label and control proximal and distal to the image slice.  
However, a selective label is required for TASL, making FAIR unsuitable for 
this purpose. Therefore the optimal labelling scheme for selective labelling 
required investigation.  Further the efficiency of placing labelling slabs at 
oblique angles to the imaging plane needed to be assessed.  Initially, the multi-
slice STAR (Signal Targeting with Alternating Radiofrequency) scheme, 
which was implemented in Chapter 5 for Territorial ASL at 3 T, was assessed 
at 7 T.  This uses a 180° inversion pulse to form a label (adiabatic 180° pulse 
with nominal 360° power to control for magnetisation transfer effects) and two 
consecutive inversion pulses for the control (180° + 180° = 360°), as shown in 
Figure 6.2. 
 
 
Figure 6.2: STAR pulse sequence showing slice select gradients in the z axis and RF 
pulses for label and control conditions, as a screen capture from Philips Graphical 
Viewer [14]. 
 
Pilot data was collected using STAR in a similar manner to that described in 
Chapter 5 for 3 T, with the addition of background suppression pulses at 7 T 
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(see Method for further details).  STAR was initially assessed in 3 subjects to 
label all the inflowing blood in comparison to the standard FAIR acquisition 
routinely used at 7 T. However, STAR resulted in poor perfusion weighted 
images in all 3 subjects when compared to the standard FAIR scheme, as 
illustrated in Figure 6.3. 
 
 
Figure 6.3: Use of the STAR labelling scheme results in poor perfusion weighted signal 
at 7 T in comparison to the standard FAIR scheme.  Perfusion weighted images shown 
with EPI base. 
 
6.2.1.2 Phantom studies 
 
To understand the limitations of the STAR scheme, the efficiency of the label 
and control were assessed on an oblate ellipsoid agar gel gadolinium doped 
phantom of 20 cm diameter.  The phantom comprised a saline solution 
containing 2 % wt / wt agar and 0.038 % v / v gadolinium (0.5 M Magnevist 
[15]) resulting in a longitudinal relaxation time, T1, of approximately 1750 ms 
(with an inversion recovery curve null point of approximately 1200 ms) and T2 
of approximately 80 ms.  It became apparent that the two consecutive 180° 
pulses in the STAR scheme resulted in a very poor control condition; however 
the single adiabatic pulse with nominal 360° flip angle led to an efficient label, 
as shown in Figure 6.4.   
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Label image: Control image: 
  
Figure 6.4: Coronal slice (level of cerebellum) through agar-doped phantom showing 
STAR label and control profiles.  Images shown at phantom inversion recovery null 
point. 
 
Therefore, alternative selective labelling schemes were considered, in 
particular, the PICORE (Proximal Inversion with a Control for Off-Resonance 
Effects – [16]) scheme.  PICORE uses a single 180° adiabatic pulse for both 
label and control conditions, as shown in Figure 6.5.  The label is applied 
using a selective inversion slab just below the imaging slice.  In the control 
condition, an off-resonance inversion pulse without any slice-select gradient is 
utilized.  This creates the same MT effect in the imaging slice for the control 
condition as for the label condition, as the frequency offset of the pulse used 
for each is matched.  A further advantage of PICORE is that the labelling 
pulse can be applied at 180° power, thus producing much lower SAR 
compared to the STAR implementation.  The PICORE scheme was therefore 
coded into the Philips 7 T pulse programming environment. 
 
 
Figure 6.5: PICORE pulse sequence for label (left) and control (right) conditions, as a 
screen capture from Philips Graphical Viewer [14]. 
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STAR and PICORE schemes were assessed on the agar phantom to compare 
the efficiency for three adiabatic pulse shapes, each of length 13 ms: 
 A hyperbolic secant (HSC) pulse, the standard pulse used in the Philips 
software; 
 C-shaped FOCI (Frequency Offset Corrected Inversion) pulses, with 
higher pulse frequency bandwidths, which have previously been found 
to give sharper profiles than a hyperbolic secant [17, 18].  These pulses 
can be described using the radiofrequency amplitude range, Gmin to 
Gmax, the pulse length parameter, β, and the side to width parameter, μ 
[19].  Two FOCI pulses were assessed:  
o FOCI1: using Philips default settings for (Gmin, Gmax, β and μ): 
(0, 1, 8, 9), BW 981 Hz; 
o FOCI2: optimised for the field strength of 7 T using values of 
(Gmin, Gmax, β and μ): (0, 4.42, 4.33, 7.75), BW 2870 Hz.  
 
To assess the efficiency, images were collected at the null point of the 
inversion recovery curve (approximately 1200 ms for the agar phantom) to 
visualise the degree of inversion efficiency and the profile of the selective 
inversion slabs.  The selective label was placed below the image slice to 
imitate the label used in standard ASL to label all inflowing blood. 
 
Figure 6.6 shows example label and control profiles for STAR and PICORE 
labelling schemes, for each of the three inversion pulses, collected using 
sagittal profiles through the imaging volume.  As shown above, it is clear the 
use of two consecutive 180° pulses for the STAR control does not provide a 
good control condition.  In contrast, for this slab placement, PICORE provides 
a good control condition with fully recovered magnetisation.  STAR had 
significantly (P < 0.001) reduced label efficiency () compared to PICORE ( 
~94 % PICORE /  ~77 % STAR) from region of interest (ROI) analysis. In 
addition, STAR increased SAR, limiting the number of slices that could be 
acquired.  Further, it was evident the FOCI2 inversion pulse provided an 
improved pulse profile over that of the HSC and FOCI1 pulses. A sharp 
profile is advantageous for territorial ASL to accurately label individual 
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feeding arteries and prevent labelling of multiple territories.  The PICORE 
scheme with FOCI2 pulses was therefore the chosen scheme for TASL at 7 T. 
 
 STAR label STAR control PICORE label PICORE control 
HSC 
    
FOCI1 
    
FOCI2 
    
Figure 6.6: Coronal slice through phantom showing PICORE and STAR label and 
control profiles for three different pulses, acquired at inversion recovery null point. 
 
6.2.1.3 Evaluating PICORE for standard ASL in-vivo 
 
All in vivo imaging performed in this study was approved by the University of 
Nottingham Medical School Ethics Committee, and all subjects that 
participated in the investigation gave written, fully informed consent.  
Participants disclosed no past cerebrovascular medical history, and were 
considered healthy.  All data are collected on the 7 T Philips Achieva system 
with a 32 channel SENSE receive coil, which was installed at Nottingham 
during the initial phase of this study.  The 32 channel coil provided improved 
coil coverage in the neck region compared to the 16 channel coil. 
 
The PICORE scheme was first evaluated for the condition of labelling all 
inflowing blood as performed in standard ASL.  Single-TI STAR and PICORE 
data were first acquired with the label proximal to the imaging slice (thus 
labelling all inflowing blood) for each of the three adiabatic inversion pulses. 
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For each, a label thickness of 120 mm was used with a post-label delay (TI) of 
1550 ms. ASL images were collected using a gradient echo (GE) EPI 
acquisition with a TE of 10 ms, and a spatial resolution of 3 mm in-plane and 
5 mm slice thickness, with 10 slices being acquired with minimal spacing.  
The repetition time (TR) per ASL label / control was 3500 ms.  In-plane 
saturation was applied to the image volume  using the WET (Water 
suppression Enhanced through T1 effects) scheme for presaturation 
(comprising  four selective pulses of flip angles 106.8°, 86.8°, 76° and 153.6°) 
and a sinc pulse for post-saturation.  In addition, all sequences performed at 7 
T were implemented with background suppression.  The background 
suppression scheme comprised two non-selective inversion pulses at inversion 
times TI1 / TI2 = 402 ms / 639 ms to suppress the static signal and reduce 
physiological noise and system variance.  50 dynamic ASL pairs were 
acquired labelling all arteries flowing into the head.  Figure 6.7 and Figure 6.8 
show the average subtraction perfusion weighted images for the STAR and 
PICORE schemes respectively for each of the adiabatic inversion pulses. 
Although absolute quantification is not performed, the signal intensities are 
proportional to perfusion and can be used for a qualitative assessment. 
 
 
Figure 6.7: ASL perfusion weighted image using STAR for each pulse shape described 
above - row 1: HSC, row 2: FOCI1, row 3: FOCI2. 
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 Figure 6.8: ASL perfusion weighted image using PICORE for each pulse shape 
described above – row 1: HSC, row 2: FOCI1, row 3: FOCI2. 
 
Poor perfusion weighted images are seen for the STAR scheme due to the 
inefficiency of the control condition.  The PICORE scheme can be seen to 
provide optimal labelling.  These images were quantitatively assessed using 
region of interest (ROI) analysis for a 5 mm cube placed in the posterior grey 
matter.  As shown in Figure 6.9, the PICORE scheme using FOCI2, gives 
marginally greater perfusion weighted signal than FOCI1, a substantial 
improvement on the hyperbolic secant pulse. 
 
 
Figure 6.9: Mean (± standard error) perfusion weighted signal calculated in a grey 
matter region of interest for each pulse shape using the PICORE scheme given in Figure 
6.8. 
 
 
 
200
6.2.2 Using PICORE for TASL at 7 T 
 
6.2.2.1 Theory  
 
Having demonstrated the advantage of PICORE to label a slab proximal to the 
imaging plane, the next step was to evaluate the use of PICORE (with the 
FOCI2 pulse) as a „free‟ selective label slab for territorial ASL, in which the 
slab can be placed at any geometry in order to label the blood flowing through 
a single artery en route to the brain.  As described in Chapter 5, in TASL, 
inversion slabs are positioned to selectively label inflowing blood through the 
left and right ICA and BA [20], also shown in Figure 6.10. 
 
 
Figure 6.10: Schematic showing the posterior locations of labelling slabs used for 
territorial ASL. 
 
The profile and efficiency of PICORE was assessed in-vivo for each position 
of the labelling slab.  This was qualitatively performed by removing the in-
plane saturation pulse from the ASL sequence, and acquiring data at the null 
point of the inversion recovery curve.  However, on viewing the images, when 
the selective label was moved from its conventional position used for standard 
ASL (in the neck parallel to the imaging region to label all inflowing blood), a 
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dramatic loss of efficiency was observed in the control condition for certain 
orientations.  This lack of efficiency in the control condition was observed 
more frequently for the hyperbolic secant pulse than for the higher bandwidth 
FOCI pulse. 
 
To understand the origin of this effect, it is necessary to further consider how 
the PICORE scheme works, and the issues that arise at 7 T that can limit the 
efficiency of the scheme.  As described above, PICORE uses a 180° adiabatic 
pulse for the label and control conditions.  For the control condition, the same 
off-resonance inversion pulse is applied as for the label, but without any slice-
select gradient, thus ensuring the same magnetisation transfer effect in the 
imaging slice but no inversion.  However, this requires that the pulse is far 
enough off-resonance for this to be true.  This may not be the case at ultra-
high magnetic field strength. 
 
The off-resonant frequency of the label pulse is determined by several factors; 
the geometric separation of the centre of the labelling slab from the imaging 
slab, herein known as the label offset distance (d), the thickness of the 
labelling slab (Δz), and the bandwidth of the radiofrequency pulse (Δω).  As 
described in Chapter 2, the application of a gradient, G, at a position, r, 
modulates the Larmor frequency, , of the spins: 
 
            Eqn. [6.1] 
 
Thus, applying an inversion pulse containing a range of frequencies of 
bandwidth, , centred at   .  
This range of frequencies corresponds to a label slab thickness (z) given by: 
 
   
  
   
 Eqn. [6.2] 
 
If this is centred at a label offset distance d from the centre of the imaging 
plane, then d is given Eqn. [6.3]. 
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 Eqn. [6.3] 
 
Combining these two expressions it can be seen that the frequency offset of 
the inversion pulse is given by: 
 
        
    
  
 Eqn. [6.4] 
 
For effective use of PICORE, the offset frequency must be large, such that the 
inversion pulse is off-resonance in the control condition.  This is particularly 
an issue at 7 T, where there is a larger range of off-resonance frequencies, for 
example due to poor shimming.  If this condition is not met, then the control 
condition will not be off-resonance and will effectively invert the spins.  Eqn. 
[6.4] demonstrates that the off-resonance condition can be improved by (i) 
increasing the bandwidth of the pulse (Δω) (ii) maximising the label offset 
distance between the centre of the label and image slice (d), however this can 
limit the label efficiency, or (iii) reducing the slab thickness (Δz), but again 
this reduces the label duration and thus the perfusion weighted signal. 
 
In general, FOCI pulses have a higher bandwidth than hyperbolic secant 
pulses (here, a bandwidth 981 Hz for the hyperbolic secant pulse compared to 
2870 Hz for FOCI2), suggesting that the FOCI2 pulse will be more optimal for 
the implementation of TASL using PICORE. 
 
For conventional ASL where the label is proximal and parallel to the image 
slice, and all inflowing arteries are being labelled, the arrangement is similar 
to that shown in Figure 6.11 (A), and the label offset distance, d, is large, 
resulting in a large offset.  However, TASL requires the labelling region to be 
applied oblique to the image plane, in order to selectively label individual 
inflowing arteries, as shown in Figure 6.11 (B).  In this case, care must be 
taken to ensure that the label offset distance is maximised to result in the 
maximal frequency offset, ωoffset.  As the distance between the label slab and 
the imaging slab is not constant (i.e. the imaging volume and label slabs are 
not parallel), it is also of importance over which axis the separation, d, is 
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measured, given by the orientation of the labelling slab as defined on the 
scanner.  For example, if the label slab has transverse orientation, then the 
separation between the labelling and imaging slabs will be taken from the 
geometric offset in the foot-head direction.  Whilst if the label slab is 
coronally oriented, then the anterior-posterior separation will be used, and if 
the label slab is sagittal, then the left-right offset distance will be of 
importance. 
 
 
Figure 6.11: Label offset distance, d, between the image and label slabs on a spherical 
phantom.  (A): Image and label slabs are oriented parallel and so the label offset 
distance (d) is the perpendicular separation.  (B): Selective label applied oblique to the 
image slab and so the offset distance, d, is the separation along the axis corresponding to 
the orientation of the label slab (in this case sagittal, so d is in the left-right direction). 
 
6.2.2.2 Phantom Verification 
 
Having identified this geometric dependence for PICORE, this theory was 
then tested on the agar gel phantom by (i) changing the label offset distance 
(d) while keeping the slab thickness (Δz) and orientation constant, (ii) varying 
the label slab thickness (Δz) while keeping the label offset distance (d) and 
orientation of the labelling slab constant.  By performing these experiments on 
the phantom, it was possible to confirm the theory of the correlation of control 
efficiency with the off-resonance frequency (ωoffset) of the inversion pulse. 
 
For a sagittal label orientation with an axial orientation of the imaging slab, 
analogous to a LICA or RICA TASL scan, as shown in Figure 6.11 (B), and a 
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constant label thickness (Δz) of 20 mm, PICORE control condition efficiency 
was assessed for left-right label offset distances (d) ranging from 0 mm to 50 
mm in 10 mm steps.  For a sagittal label orientation at a fixed left-right label 
offset distance (d) of 10 mm, PICORE was assessed for label thicknesses (Δz) 
ranging from 20 mm to 100 mm in 20 mm steps.  For each of the above 
geometries, the off-resonance frequency (ωoffset) of the FOCI2 pulse was 
calculated using Eqn. [6.4].   For a FOCI2 pulse with a bandwidth of 2870 Hz, 
these labelling geometries correspond to offset frequencies shown in Table 
6.1.  Inefficiency of control condition was often immediately apparent through 
visual inspection of data showing that there was still substantial inversion 
remaining in the control condition. 
 
(i) Constant slab thickness 
Δz = 20 mm 
(ii) Constant label offset distance 
d = 10 mm 
d (mm) ωoffset (Hz) Δz (mm) ωoffset (Hz) 
0 0 20 1435 
10 1435 40 717.5 
20 2870 60 478.3 
30 4305 80 358.75 
40 5740 100 287 
50 7175   
Table 6.1: Off resonance frequencies of FOCI2 pulses calculated using Eqn. [6.4] for a 
variety of label offset distances (d) and label thicknesses (Δz). 
 
Figure 6.12 shows an example case of when the left-right label offset distance 
of a sagittally placed label slab (d) is compared between 10 mm and 50 mm 
for a label thickness (Δz) of 20 mm.  At a left-right label offset distance, d = 
10 mm, corresponding to a ωoffset of 1.435 kHz, labelling is inefficient as 
significant inversion is exhibited in the control condition, whereas increasing 
the left-right offset distance to d = 50 mm, no inversion is present in the 
control condition, and thus optimal labelling is achieved. 
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 Figure 6.12: Effect of varying the left-right label offset distance (d) for constant thickness 
of the imaging slab (z).  (A) Inefficient labelling and (B) improved, efficient labelling.  
This was demonstrated with a TI at the null point of the phantom (TI = 1200 ms). 
 
A further example is shown in Figure 6.13, where here a constant left-right 
label offset distance (d = 10 mm) is used and the label thickness is compared 
between z = 50 mm and z = 10 mm, with the label placed in the sagittal 
orientation. 
 
 
Figure 6.13: Comparison of different thicknesses of label slab (z) for a constant left-
right distance between the label slab and the imaging slab (d), demonstrated using TI = 
1200ms.  (A) shows inefficient labelling due to inversion present in the control condition 
and (B) shows improved labelling efficiency. 
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It was found by visual inspection of data that geometries of label slabs using 
the FOCI2 pulse corresponding to an off-resonance frequency of below 
approximately 1.5 kHz resulted in poor control condition efficiency for 
PICORE, while geometries that provided off resonance frequencies of greater 
than 1.5 kHz were successful in providing a good control condition in the 
phantom.  This was confirmed by quantitative interrogation of control images 
using a 50 mm cube region of interest in the phantom.  Figure 6.14 shows 
measured mean signal intensities in the control condition as a function of label 
offset frequency, ωoffset.  For low values of ωoffset, the signal intensity can be 
seen to improve up to a frequency offset of approximately 1.5 kHz, after 
which the control signal intensity does not improve further. 
 
 
Figure 6.14: Measured mean signal intensity in the control condition as a function of the 
frequency offset of the pulse (ωoffset). 
 
Effect of labelling slab orientation was also investigated by changing the 
orientation of the label slab, while keeping the imaging slab axially orientated 
for constant labelling slab thickness and label offset distance.  Efficiency was 
found to be independent of label slab orientation (i.e. axial, coronal or 
sagittal), provided that the label offset distance along the corresponding axis 
was taken into account (as shown in Figure 6.11). 
 
As further verification, the above procedure was also performed using 
PICORE with a hyperbolic secant pulse, which has a lower bandwidth.  The 
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same principle was found to hold true, but the efficiency of the labelling broke 
down much more quickly (i.e. required greater label offset distances, d, and 
narrower slab thicknesses, Δz) than for the FOCI2 pulse due to the 
comparatively lower bandwidth of the hyperbolic secant pulse. 
 
6.2.2.3 In-vivo verification 
 
PICORE was then was then assessed on a healthy human subject using TASL.  
In-vivo, it must be considered there is a greater degree of inhomogeneity, and 
thus a greater range of offset frequencies due to magnetic susceptibility 
variations.  It was therefore expected that in order to achieve efficiency of 
labelling, the threshold for off-resonance frequency would be higher in vivo 
than in the phantom.  For TASL with oblique placement of label slabs, in-
plane saturation pulses are applied before and after the inversion to cancel out 
the remaining static inversion signal in the tissue.  However, in order to 
observe the location, profile and efficiency of the label slab on the brain, these 
pre- and post-saturation pulses were removed, and the brain imaged as normal, 
thus allowing inversion to be visible in the tissue.  Figure 6.15 shows the label 
(lines 1, 3 and 5) and control (lines 2, 4 and 6) for PICORE when labelling 
inflowing blood in the basilar artery (BA), which provides the posterior blood 
supply to the brain and left / right internal carotid arteries (L / R ICA), provide 
the left and right sides respectively of the anterior blood supply.  It is clear that 
PICORE is efficient at inverting the slab i.e. the labelling condition exhibits 
inversion and the edges of the slab are sharply defined.  Also it is clear that 
there is no visible inversion in the control condition.  Both of these factors 
demonstrate the adequate overall labelling efficiency provided by the PICORE 
sequence. 
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Figure 6.15: Label / control profiles for PICORE for the BA, RICA and LICA achieved 
by imaging without the application of in-plane saturation. 
 
6.3 Optimised TASL in healthy volunteers 
 
6.3.1 Participants 
 
This study was approved by the University of Nottingham Medical School 
Ethics Committee, and all subjects that participated in the investigation gave 
written, fully informed consent.  Participants disclosed no past cerebrovascular 
medical history, and considered themselves to be healthy. 
 
6.3.2 TASL assessment 
 
The complete series of TASL acquisitions was performed on 3 healthy human 
subjects using the PICORE ASL scheme with the FOCI2 pulse, as described 
in Section 6.2.2.  Subjects were scanned on a Philips Achieva 7.0 T MRI 
scanner with a 32 element SENSE head coil for a single session lasting 
approximately 30 minutes. The complete protocol is outlined in Figure 6.16. 
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 Figure 6.16: Scanning protocol for complete assessment of TASL at 7 T. 
 
Subjects first underwent a standard set-up protocol of a survey, reference and 
EPI base scan (two dynamic pairs of basic EPI at 3 mm × 3 mm × 5 mm 
resolution and the same bandwidth as the TASL readout, using a TE / TR of 
10 ms / 10 s) for the registration of datasets to MNI space.  An image-based 
shimming technique with third-order shims was used to correct field 
inhomogeneities and minimize geometric distortions.  The shim box was large 
to encompass the image volume and the labelling plane.  Shimming was 
calculated using in-house software written in MATLAB [21] and data 
acquired from a B0 map.  Following this, the EPI base was again acquired to 
confirm success of shimming.  As described in Chapter 5, coronal and sagittal 
phase contrast angiograms (PCAs) and a time of flight (TOF) contrast 
angiogram are required to locate the feeding arteries and thus to plan 
positioning of the selective label slabs for territorial ASL.  PCAs were 
collected with an in-plane resolution of 0.72 mm × 1.2 mm, TE / TR of 7.6 ms 
/ 20 ms, 20° flip angle, phase contrast velocity of 30 cms
-1
, and SENSE factor 
2.  Two 50 mm PCA slices were acquired to visualize anterior and posterior 
feeding arteries (coronal) and left and right ICAs (sagittal), using the slice 
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positioning as described in Chapter 5.  The TOF was performed using TE / TR 
= 3.5 ms / 41 ms, 20° flip angle, SENSE factor 1.5, in plane resolution of 0.62 
mm, 60 slices of thickness 0.9 mm and 240 × 240 × 54 field of view.  The 
TOF was used to form a maximum intensity projection (MIP).  Positioning of 
selective labelling slabs using PCAs and TOF is shown in Figure 6.17. 
 
 
Figure 6.17: Locations of selective label slabs used for labelling TASL superimposed on 
to coronal and sagittal PCAs and axial TOF angiograms acquired at 7 T. 
 
ASL data (standard ASL and TASL) were collected using a gradient echo 
(GE) EPI acquisition with SENSE factor 2 and TE of 10 ms, the data was 
collected with resolution of 3 mm × 3 mm × 5 mm, and 10 slices acquired 
with minimal temporal spacing.  ASL data was collected with a post-label 
delay of 1550 ms, ASL time per label / control of TRASL = 3500 ms.  In TASL, 
the label slab inevitably overlaps the imaging region on the labelling 
condition, as shown in Figure 6.18.  Therefore it is essential that the effect of 
the inversion within the imaging slice itself is suppressed to prevent static 
offset signal not related to perfusion.  To achieve this, in-plane saturation 
pulses must be applied to the imaging region immediately preceding (pre-
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saturation) and following (post-saturation) the inversion pulse [11].  Four 
selective pulses known as the WET (Water suppression Enhanced through T1 
effects) scheme were used for in-plane saturation.  As described in Chapter 5, 
the pre- and post- saturation region covered the entire imaging region and 
extended upwards by 45 mm to prevent signal contributing from inverted 
blood in vessels above the imaging region flowing downwards into the 
imaging region, and also 10 mm below the imaging region. 
 
 
Figure 6.18: Overlap of labelling region on to imaging region, demonstrating the need 
for in-plane saturation. 
 
Background suppression pulses were applied with inversion times TI1 / TI2 = 
402 ms / 639 ms, these had previously been optimised to null the static signal 
at TI = 1550 ms.  50 dynamic ASL pairs were collected for each of the 
following arterial territories; left and right internal carotid arteries (LICA and 
RICA) and posterior blood supply of the basilar and vertebral arteries (BA) 
[20].   
 
6.3.3 Data analysis 
 
To inspect the quality of the data during scanning, data sets were viewed using 
the on-line image subtraction program available on the scanner, subsequently 
data were then processed and analysed off-line as outlined below. 
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Single-phase ASL label and control images were subtracted for each dynamic 
to form perfusion weighted difference images.  These individual difference 
images were then visually inspected for motion with a view to discarding any 
dynamics displaying excessive motion (greater than one voxel).  Territorial 
ASL label and control images were subtracted to form maps of each of the 
three vascular territories; posterior territory (BA) and left and right anterior 
territories (LICA and RICA).  This was performed for each subject 
individually.  EPI base images were transformed into standard MNI space [22] 
using the FLIRT linear registration tool from the FSL Software suite [23].  
Registration transforms were then further applied to vascular territory maps of 
each subject.  Further, a group average image was formed for each vascular 
territory across the three subjects. 
 
6.4 Results 
 
Figure 6.19 shows the results of the “all” scan in a single subject, where all 
inflowing vessels were labelled using a selective label slab placed in the neck, 
parallel to the imaging slab.  This shows high contrast-to-noise perfusion 
weighted signal in the grey matter, as expected. 
 
 
Figure 6.19: Standard ASL using PICORE to label all inflowing vessels in a 
representative subject. 
 
On the first healthy volunteer, labelling of the basilar artery was not totally 
successful, but can still be seen.  This limited success of labelling of the 
posterior blood supply is most likely due to the limited coverage of the 
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transmitting RF coil in the neck at 7 T.  Labelling of the right and left internal 
carotid arteries was highly successful.  Figure 6.20 shows a colour coded map 
of the RICA, LICA and BA territories as acquired at 7 T on the first healthy 
volunteer. 
 
 
Figure 6.20: Colour coded map of TASL (RICA = green, LICA = red, BA = blue) at 7 T. 
 
Two further subjects were assessed using the same protocol of territorial ASL, 
this time with greater success in labelling the posterior territory.  Mean 
vascular territory maps for the three subjects are shown in Figure 6.21. 
 
 
Figure 6.21: Group (n = 3) territorial ASL map displaying the vascular territories of (A) 
RICA, (B) LICA and (C) BA.  Slices shown represent MNI co-ordinates z = 2 to z = 12. 
 
These results highlight the feasibility and potential of using PICORE to 
perform territorial ASL at ultra-high field.  
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6.5 Discussion 
 
This chapter has outlined the challenges presented and developments made to 
the TASL technique for use at ultra-high field.  This work has demonstrated 
that using a PICORE labelling scheme, it is possible to perform Territorial 
Arterial Spin Labelling at 7 T to selectively label the LICA, RICA and BA. 
 
Success of TASL was found to be highly dependent on the efficiency of the 
PICORE control condition, which was found to be dependent on the frequency 
offset, ωoffset, of the inversion pulse used.  This in turn is dependent on the 
bandwidth of the pulse (Δω), the thickness of the labelling slab (Δz) and the 
distance between the centre of the label and image slabs along the direction 
corresponding to the orientation plane of the label slab (d).  TASL geometries 
with a frequency offset of greater than approximately 1.5 kHz were considered 
to be successful.  Achieving this condition required the use of a high 
bandwidth pulse and minimising the thickness of the labelling slab, while 
maximising the distance between the centres of the imaging and labelling 
slabs, as shown in Figure 6.12 and Figure 6.13. 
 
The use of TASL at 7 T has not previously been reported, due to B0 and B1 
inhomogeneity, but with careful planning and the use of an optimised 
sequence it is possible to perform, as has been demonstrated in this chapter 
(Figure 6.20 and Figure 6.21).  This opens up the discussion of the benefits of 
ultra-high field to TASL. 
Ultra-high field potentially provides improvement in contrast-to-noise ratio of 
any ASL technique, due to lengthened T1 [8].  In addition, ultra-high field is 
known to provide higher image signal-to-noise ratio.  This allows for images 
to be acquired at higher spatial resolution, thus providing reduced partial 
volume effects and finer delineation of vascular territory boundaries.  Further 
developments in the area should assess the improvement to the technique in 
terms of increased spatial resolution. 
 
The primary limitation to TASL is good labelling efficiency, which can be 
limited by B1 inhomogeneities.  Recently a method has been suggested for 
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improved B1 transmission in the neck through the additional use of dielectric 
pads containing high permittivity material [24]), which are wrapped around 
the neck.  These have been shown to result in improved B1 homogeneity at the 
level of labelling; however, it is uncertain whether this benefit is large enough 
to enable a sufficient increase in labelling efficiency required for performing 
TASL. 
 
It would be interesting to see further work using this technique take place in a 
cohort similar to that described in Chapter 5 of this thesis, where subjects were 
scanned at 3 T to provide a direct measure of the benefit of increased field 
strength to the technique.  Additionally, the lengthened T1 values afforded by 
ultra-high field strength may be exploited to study perfusion in elderly 
subjects or those with cerebrovascular disease, where blood transit times are 
likely to be longer [3], as mentioned in Chapter 5 of this thesis.  In these cases, 
a longer post-label delay, TI may be beneficial, or alternatively, the use of a 
multi-phase readout, used at 3 T in Chapter 5 of this thesis in combination 
with territorial labelling, as this would provide additional information about 
the transit time of blood, thus allowing for quantification of perfusion 
measurements.  Having optimised these techniques in a healthy group, it 
would be of interest in future studies to implement these techniques with a 
view to studying patients with cerebrovascular impairment. 
 
This chapter reports the use of TASL with gradient-echo (GE) EPI readout 
only.  Alternative image readouts, such as true FISP (true Fast Imaging with 
Steady-state Precession [25]) may produce images with less distortion at ultra-
high field than GE-EPI and so may be more suitable for use in the clinical 
setting, particularly if the technique is to be applied to high spatial resolution 
acquisitions. 
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7 Conclusion and discussion 
 
7.1 Summary of work presented in this thesis 
 
This thesis describes technical developments made using the endogenous 
perfusion contrast, arterial spin labelling (ASL), and further application to 
pharmacological fMRI studies.  Chapter 4 describes the use of blood oxygen 
level dependent (BOLD) contrast, in combination with the ASL technique of 
pseudo-continuous arterial spin labelling (PCASL), to study the effect of a 
peripherally acting beta-blocker on brain activity.  The combination of BOLD 
and ASL allowing better interpretation of the effects of the pharmacological 
modulation on the underlying haemodynamic changes associated with an 
emotional visual stimulus, and on resting state brain activity.  Chapter 5 
describes the use of territorial and multi-phase ASL in combination for the 
quantitative assessment of cerebral haemodynamics at 3 T.  In particular, the 
location and haemodynamic properties of the cerebral watershed regions are 
investigated using the two different ASL methods and investigation is 
enhanced by the use of these methods in conjunction.  Chapter 6 describes the 
development of territorial ASL for use at 7 T, with the challenges of 
implementing the technique being discussed. 
 
7.2 Discussion of beta-blocker modulation of task induced and resting 
state brain activity 
 
Chapter 4 of this thesis investigates the effect of administering the peripherally 
acting beta blocker, nadolol, on task-induced brain activity and resting state 
functional connectivity.  The drug was administered in a randomised placebo 
controlled crossover study design in 20 healthy subjects.  Previous studies 
have used the centrally acting beta-blocker, propranolol, however, these 
results are ambiguous as propranolol does not act selectively in the periphery, 
and thus there may be confounds from direct central modulation.  
Additionally, previous studies have not assessed resting cerebral blood flow 
for drug-induced changes.  Results from these studies have demonstrated 
reduced amygdala responsiveness, emotional memory encoding and retrieval 
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under the influence of the centrally acting beta-blocker, propranolol [1].  The 
sample size was deemed to be appropriate for testing of statistical significance 
in line with sample sizes used in other studies [2].  A single 80 mg dose of the 
peripherally acting beta blocker, nadolol, significantly reduced peripheral 
reactivity as assessed by mean arterial blood pressure and heart rate compared 
to a similarly administered placebo.  Nadolol did not significantly decrease the 
resting perfusion or the BOLD response to visual emotional stimuli in a region 
in the primary visual cortex compared to placebo, thus confirming the 
peripheral action of the drug and minimising confounds from direct central 
effects. 
 
Reduction of activity in the anterior insula supports the theory that reduction 
of peripheral feedback selectively reduces the processing of emotional visual 
stimuli, in agreement with the James-Lang theory [3] and the two factor theory 
of emotion [4], and is complementary to previous studies reporting memory 
impairment of emotional stimuli induced by the centrally acting beta blocker, 
propranolol [5].  This is also in support of studies where participant groups 
have experienced blockade of peripheral feedback by means of spinal cord 
injury [6]. 
 
The increase in amygdala activity associated with the administration of 
nadolol contradicts previously reported findings [1].  It is possible that nadolol 
causes a hypersensitisation selective to the amygdala due to lack of peripheral 
feedback, however, there is no previous evidence for this.  Alternatively, it 
may be that the natural processing of emotional visual stimuli involves 
suppressing the fear / threat response in the amygdala.  Nadolol may act to 
remove this suppressive process, allowing the amygdala to respond freely to 
emotional visual stimuli as if they were a real threat.  This drug induced 
increase was found to be dominated by the response in the male group 
however, sample sizes in single gender subgroups were small in this study, 
and care must be taken in their interpretation.  Further investigation in a larger 
cohort of males may provide more insight into the mechanism behind the 
modulation. 
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The acquisition method of dual readout of pseudo-continuous ASL (PCASL) 
and BOLD allowed the underlying haemodynamics to be assessed in this 
pharmacological study.  The acquisition of a baseline or “off” period between 
each block of stimuli could be utilised to provide a baseline measure of 
perfusion and BOLD for calibration of responses, thus possibly eliminating 
the necessity to acquire an additional baseline perfusion scan in future studies.  
Alternatively, in order to quantitatively measure drug induced perfusion 
changes; ASL could be acquired with a multi-phase readout, as described in 
Chapter 5 of this thesis.  Analysis of resting state functional connectivity 
showed no obvious drug induced changes, but a more rigorous analysis would 
include additional regression of noise measures. 
 
7.3 Discussion of ASL results at 3 T and 7 T 
 
Chapter 5 of this thesis implemented Territorial Arterial Spin Labelling 
(TASL) in combination with multiphase ASL for the comparison of vascular 
territory maps with haemodynamic parameter maps of quantitative CBF and 
blood transit times.  Vascular territories were shown to be highly consistent 
between subjects.  The cerebral watershed regions are known to exhibit 
lengthened blood transit times and as such are most susceptible to 
haemodynamic ischaemia.  Thus, it is suggested that maps of arterial and 
capillary transit time can give information on the locations of the watershed 
regions.  Compared to arterial transit time, capillary transit time was found to 
produce closer delineation of watershed regions by thresholding maps at a 
fixed value. 
 
Quantitative analysis showed that watershed region masks formed using 
information from either TASL or multi-phase ASL showed increased capillary 
transit times and reduced perfusion rates compared to other cortical regions.  
Definition of the posterior watershed showed adequate delineation in most 
subjects, whereas assessment of anterior and internal watersheds was limited.  
However, the combination of the two techniques provided enhanced watershed 
region definition, thus demonstrating the benefit of the combined use of 
territorial ASL and multi-phase ASL for the non-invasive assessment of the 
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cerebral watershed regions, which could provide a means to study the 
haemodynamic effects on the watershed regions of blood pressure changes or 
pharmacological intervention, or the processes of healthy ageing or disease. 
 
TASL was implemented and optimised over the course of a pilot study on 11 
subjects, during which scanner operators became practiced in positioning of 
the labelling slabs.  However, selective labelling is still highly scanner 
operator dependent and also dependent on the arrangement of the cerebral 
vasculature.  Recently developed techniques such as super-selective TASL and 
super-selective ASL angiography may provide superior labelling efficiency, 
and higher success rates [7, 8].  Further, techniques such as velocity selective 
ASL [9] remove the dependence on the scanner operator’s ability to 
effectively position labelling slabs. 
 
The combination of territorial ASL with multiphase ASL may provide 
advantages in clinical groups, and carries the additional advantage of being 
non-invasive.  For example, in asymptomatic subjects, there may be variations 
in the cerebrovascular architecture that can be explored using TASL and 
further interrogated using haemodynamic parameter maps provided by 
multiphase ASL.  TASL used in combination with knowledge of the 
completeness of the Circle of Willis [10, 11] from Time of Flight angiography 
could provide insight into the effect of asymptomatic variations on the 
vascular territories and collateral supply.  In patients with vascular disease, 
brain regions exhibiting exceptionally long transit times may signify that 
blood is supplied to the tissue via an atypical route.  Combined assessment 
using territorial ASL and multi-phase ASL could prove useful for the 
assessment of patients with arterial occlusion or stenosis [12], or arteriovenous 
malformation, to assess collateral blood supply, or additionally by making 
comparisons before and after interventional surgery to determine its success.  
However, in the older population, blood transit times are longer, suggesting 
the use of a longer inversion time (TI) than used in this study, or alternatively, 
the use of a multi-phase readout.  Additionally, in patients with 
cerebrovascular impairment, blood transit times are sometimes sufficiently 
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long (i.e. > T1 of blood) that the inversion label has completely decayed, 
making detection of the label impossible. 
 
Keeping in mind the potential applications listed above, the technique of 
territorial ASL (TASL) was developed for use at 7 T, where longitudinal 
relaxation times (T1) increase [13].  As reported in Chapter 6 of this thesis, 
ultra-high field led to challenges associated with sensitivity to B1 
inhomogeneity, and the labelling efficiency.  Use of a PICORE (Proximal 
Inversion with a Control for Off-Resonance Effects) ASL scheme provided a 
method for selective labelling and a high bandwidth FOCI (Frequency Offset 
Corrected Inversion) inversion pulse allowed good profile labelling and high 
frequency offset from resonance, overcoming issues with the efficiency of the 
control condition and facilitating the use of TASL at 7 T. 
 
Performing such studies at ultra-high field enables images to be acquired at 
higher spatial resolution than at lower field, due to the increased signal-to-
noise ratio and contrast-to-noise ratio.  Additionally, the lengthened T1 at 
ultra-high field allows for the imaging of perfusion in cases where blood 
transit times are exceptionally long.  However, limitations of performing this 
technique at ultra-high field remain in terms of sensitivity to B1 
inhomogeneity and limited coverage of the transmit radiofrequency coil.  With 
additional technical developments, these problems are likely to be overcome, 
for example, the placement of dielectric pads containing high permittivity 
material around the neck, improving B1 delivery below the coverage of the 
transit coil [14]. 
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Appendix A: Recruitment poster 
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Appendix B: Safety questionnaire 
 
 
MR Volunteer Safety Screening Questionnaire:  
 
NAME Date of Birth 
 
ADDRESS Weight 
 
Height 
 
Phone number 
 
 
 
MR scanning uses strong magnetic fields. For your own safety and the safety of others it is very 
important that you do not go into the magnet halls with any metal in or on your body or clothing.  
Please answer the following questions carefully and ask if anything is not clear.  All information is 
held in the strictest confidence. 
 
1. Do you have any implants in your body? e.g. replacement joints, drug pumps          Y/N 
2. Do you have aneurysm clips (clips put around blood vessels during surgery)?     Y/N 
3. Do you have a pacemaker or artificial heart valve? (These stop working near MR Scanners) Y/N 
4. Have you ever had any surgery? Please give brief details over.  Y/N 
      (We do not need to know about uncomplicated caesarean delivery, vasectomy or termination of pregnancy)     
5.  Do you have any foreign bodies in your body (e.g. shrapnel)?  Y/N       
6. Have you ever worked in a machine tool shop without eye protection?   Y/N 
7. Do you wear a hearing aid or cochlear implant?      Y/N 
8. Could you be pregnant? (Pregnancy tests are available in the female toilets)  Y/N 
9. Have you ever suffered from tinnitus?                             Y/N 
10. Do you wear dentures, a dental plate or a brace?         Y/N 
11. Are you susceptible to claustrophobia?       Y/N 
12. Do you suffer from blackouts, epilepsy or fits?      Y/N 
13. Do you have any tattoos? (If yes, you may be asked to read and sign another form) Y/N 
14. Do you have any body piercing jewellery that cannot be removed?   Y/N 
15. Do you have any skin patches (trans-dermal patches)?     Y/N 
16. Do you have a coil in place (IUD) for contraception? Do you know what type?   Y/N 
17. Do you wear glasses to correct your vision? (please state below whether or not you can 
see without them, and if you can wear contact lenses)     Y/N 
18. Do you have any condition that may affect your ability to control your temperature ? Y/N 
(e.g. Do you have a fever, cardiovascular disease, hypertension, diabetes or cerebrovascular disease?)        
19. Will you remove all metal including coins, body-piercing jewellery, false-teeth, hearing aids 
 etc. before entering the magnet hall? (lockers available by the changing rooms)  Y/N 
 
19. Is there anything else you think we should know (please write below)?   Y/N 
 
 
  
On the interaction between pharmacologically reducing 
bodily feedback and emotion-related brain activity 
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Appendix C: Psychological questionnaires 
 
Hospital Anxiety and Depression Scale (HADS) 
Read these questions and think about how you currently feel.  Please 
choose one response from the four given for each interview.   Please try 
to give an immediate response and do not think too long about your 
answers.   
I feel tense or 'wound up': 
1. Most of the time 2. A lot of the time 
3. From time to time, occasionally 4. Not at all 
I still enjoy the things I used to enjoy: 
1. Definitely as much 2. Not quite so much 
3. Only a little 4. Hardly at all 
 I get a sort of frightened feeling as if something awful is about to 
happen: 
1. Very definitely and quite badly 2. Yes, but not too badly 
3. A little, but it doesn't worry me 4. Not at all 
 I can laugh and see the funny side of things: 
1. As much as I always could 2. Not quite so much now 
3. Definitely not so much now 4. Not at all 
Worrying thoughts go through my mind: 
1. A great deal of the time 2. A lot of the time 
3. From time to time, but not too 
often 
4. Only occasionally 
I feel cheerful: 
1. Not at all 2. Not often 
3. Sometimes 4. Most of the time 
I can sit at ease and feel relaxed: 
1. Definitely 2. Usually 
3. Not Often 4. Not at all 
 I feel as if I am slowed down: 
1. Nearly all the time 2. Very often 
3. Sometimes 4. Not at all 
 I get a sort of frightened feeling like 'butterflies' in the stomach: 
1. Not at all 2. Occasionally 
3. Quite Often 4. Very Often 
I have lost interest in my appearance: 
1. Definitely 2. I don't take as much care as I 
should 
3. I may not take quite as much 
care 
4. I take just as much care as ever 
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I feel restless as I have to be on the move: 
1. Very much indeed 2. Quite a lot 
3. Not very much 4. Not at all 
I look forward with enjoyment to things: 
1. As much as I ever did 2. Rather less than I used to 
3. Definitely less than I used to 4. Hardly at all 
 I get sudden feelings of panic: 
1. Very often indeed 2. Quite often 
3. Not very often 4. Not at all 
I can enjoy a good book or radio or TV program: 
1. Often 2. Sometimes 
3. Not often 4. Very seldom 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reference: 
Zigmond and Snaith (1983) 
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ERS 
 
This questionnaire asks different questions about how you experience emotions on a 
regular basis (for example, each day). When you are asked about being “emotional,” 
this may refer to being angry, sad, excited, or some other emotion.  Please rate the 
following statements. 
 
0 
Not at all 
like me 
1 
A little like 
me 
2 
Somewhat 
like me 
3 
A lot  
like me 
4 
Completely 
like me 
 
1 When something happens that upsets me, it’s all 
I can think about it for a long time. 
0 1 2 3 4 
2 My feelings get hurt easily. 0 1 2 3 4 
3 When I experience emotions, I feel them very 
strongly/intensely. 
0 1 2 3 4 
4 When I’m emotionally upset, my whole body 
gets physically upset as well. 
0 1 2 3 4 
5 I tend to get very emotional very easily. 0 1 2 3 4 
6 I experience emotions very strongly. 0 1 2 3 4 
7 I often feel extremely anxious. 0 1 2 3 4 
8 When I feel emotional, it's hard for me to 
imagine feeling any other way. 
0 1 2 3 4 
9 Even the littlest things make me emotional. 0 1 2 3 4 
10 If I have a disagreement with someone, it takes 
a long time for me to get over it. 
0 1 2 3 4 
11 When I am angry/upset, it takes me much 
longer than most people to calm down. 
0 1 2 3 4 
12 I get angry at people very easily. 0 1 2 3 4 
13 I am often bothered by things that other people 
don’t react to. 
0 1 2 3 4 
14 I am easily agitated. 0 1 2 3 4 
15 My emotions go from neutral to extreme in an 
instant. 
0 1 2 3 4 
16 When something bad happens, my mood 
changes very quickly. People tell me I have a 
very short fuse. 
0 1 2 3 4 
17 People tell me that my emotions are often too 
intense for the situation. 
0 1 2 3 4 
18 I am a very sensitive person. 0 1 2 3 4 
19 My moods are very strong and powerful. 0 1 2 3 4 
20 I often get so upset it’s hard for me to think 
straight. 
0 1 2 3 4 
21 Other people tell me I'm overreacting. 0 1 2 3 4 
 
Other relevant questions/comments: 
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TAS 20 
 
Answer the following questions as spontaneously as possible. If you get stuck on a 
question, leave it out and continue with the next. Each question can have one of 5 
possible answers. Thank you. 
 
ANSWER SCALE:  1 = strongly disagree – 2 – 3 – 4 – 5 = strongly agree 
                                         
 
1. I am often confused about what emotion I am feeling. 1 –   2 –    3 –   4 -   5 
2. It is difficult for me to find the right words for my feelings. 1 –   2 –    3 –   4 -   5 
3. I have physical sensations that even doctors don’t 
understand. 
1 –   2 –    3 –   4 -   5 
4. I am able to describe my feelings easily. 1 –   2 –    3 –   4 -   5 
5. I prefer to analyze problems rather than just describe 
them. 
1 –   2 –    3 –   4 -   5 
6. When I am upset, I don’t know if I am sad, frightened, or 
angry. 
1 –   2 –    3 –   4 -   5 
7. I am often puzzled by sensations in my body. 1 –   2 –    3 –   4 -   5 
8. I prefer to just let things happen rather than to 
understand why they turned out that way. 
1 –   2 –    3 –   4 -   5 
9. I have feelings that I can’t quite identify. 1 –   2 –    3 –   4 -   5 
10. Being in touch with emotions is essential. 1 –   2 –    3 –   4 -   5 
11. I find it hard to describe how I feel about people 1 –   2 –    3 –   4 -   5 
12. People tell me to describe my feelings more. 1 –   2 –    3 –   4 -   5 
13. I don’t know what’s going on inside me. 1 –   2 –    3 –   4 -   5 
14. I often don’t know why I am angry. 1 –   2 –    3 –   4 -   5 
15. I prefer talking to people about their daily activities rather 
than their feelings. 
1 –   2 –    3 –   4 -   5 
16. I prefer to watch “light” entertainment shows rather than 
psychological dramas.  
1 –   2 –    3 –   4 -   5 
17. It is difficult for me to reveal my innermost feelings, even 
to close friends. 
1 –   2 –    3 –   4 -   5 
18. I can feel close to someone, even in moments of silence. 1 –   2 –    3 –   4 -   5 
19. I find examination of my feelings useful in solving 
personal problems.  
1 –   2 –    3 –   4 -   5 
20. Looking for hidden meanings in movies or plays distracts 
from their enjoyment.  
1 –   2 –    3 –   4 -   5 
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BVAQ 
 
On the next page you will find a list of statements about how you react in live 
generally. Under each statement you find five categories of answers. The categories 
consist of five boxes. The boxes represent five answers ranging from `This definitely 
applies' to `This in no way applies'. The purpose of this questionnaire, is to indicate 
on the scale to what extent your personal way of reacting or responding corresponds 
to the statement. Put only one cross in one of the boxes. 
 
An example. 
  
 Seeing kittens arouses feelings of tenderness 
  
 This definitely applies |___|___|___|___|___| This in no way applies 
 
 
If you think that this statement fully corresponds to the way in which you react or 
respond, put a cross in the box furthest to the left. 
 
If you think that this statement in no way corresponds with the way in which you 
react or respond, put a cross in the box furthest to the right.  
 
If you think that the way in which you respond is less clear-cut than is described 
above, put a cross slightly more to the middle. Only use the centre box in the scale 
when it is impossible for you to judge the response as described in the statement. 
 
Now you can turn the page and start filling in the questionnaire. 
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1) I find it difficult to express my feelings verbally. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
2) Before I fall asleep, I imagine all kinds of events, encounters and conversations. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
3) When I am upset, I know whether I am afraid or sad or angry. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
4) When something unexpected happens, I remain calm and unmoved. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
5) I hardly ever consider my feelings. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
6) I like to tell others about how I feel. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
7) I have few daydreams and fantasies. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
8) When I am tense, it remains unclear from which of my feelings this comes. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
9) When I see somebody crying uncontrollably, I remain unmoved. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
10) You should try to figure out feelings. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
11) Even with a friend, I find it difficult to talk about my feelings. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
12) I often use my imagination. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
13) When things get to be a bit overwhelming, I usually understand why. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
14) When friends around me argue violently, I become emotional. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
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15) When I feel uncomfortable, I will not trouble myself even more by asking myself 
why. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
16) When I want to express how unhappy I feel, I find it easy to find the right words. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
17) I have little interest in fantasies and weird stories. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
18) When I feel good, it remains unclear as to whether I am cheerful or elated or 
happy. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
19) Often emotions well up inside me unexpectedly. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
20) When I feel uneasy, I try to find out why I feel that way. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
21) People often say that I should talk more about my feelings. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
22) I hardly ever fantasize. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
23) I do not know what's is on my mind. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
24) Even when others are wildly enthusiastic about something, I remain unmoved. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
25) There is not much to understand as far as emotions are concerned. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
26) When I am upset by something, I talk with others about my feelings.  
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
27) I like to think up unusual imaginative stories. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
28) When I feel unhappy, I know whether I am afraid or dejected or sad. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
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 29) Unexpected events often overwhelm me with emotion. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
30) I think that you should keep in tune with your feelings. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
31) I can express my feelings verbally. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
32) I think that fantasizing about imaginary things or events is a waste of time. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
33) When I am hard on myself, it remains unclear to me whether I am sad or afraid 
or unhappy. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
34) I accept disappointments without emotion. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
35) I find it strange that others analyse their emotions so often. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
36) When I talk to people, I prefer to talk about daily activities rather than about my 
emotions. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
37) When I don't have much to do, I daydream. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
38) When I am in a sunny mood, I know whether I am enthusiastic or cheerful or 
elated. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
39) When I see someone else sobbing heavily, I feel sadness well up inside me. 
 
 This definitely applies |___|___|___|___|___| This in no way applies 
 
40) When I am nervous, I want to know exactly where that feeling comes from. 
 
 This definitely applies |___|___|___|___|___| This in no way applies
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INTERPERSONAL REACTIVITY INDEX 
 
The following statements inquire about your thoughts and feelings in a variety of 
situations.  For each item, indicate how well it describes you by choosing the 
appropriate letter on the scale at the top of the page:  A, B, C, D, or E.  When you 
have decided on your answer, fill in the letter on the answer sheet next to the item 
number.  READ EACH ITEM CAREFULLY BEFORE RESPONDING.  Answer as 
honestly as you can.  Thank you. 
 
ANSWER SCALE: 
  
A  B  C  D  E 
DOES NOT DESCRIBE ME VERY WELL - DESCRIBES ME VERY WELL 
 
I daydream and fantasize, with some regularity, about 
things that might happen to me.  
A –   B –    C –   D -   E 
I often have tender, concerned feelings for people less 
fortunate than me. 
A –   B –    C –   D -   E 
I sometimes find it difficult to see things from the "other 
guy's" point of view. 
A –   B –    C –   D -   E 
Sometimes I don't feel very sorry for other people when 
they are having problems. 
A –   B –    C –   D -   E 
I really get involved with the feelings of the characters in a 
novel. 
A –   B –    C –   D -   E 
In emergency situations, I feel apprehensive and ill-at-ease. 
 
A –   B –    C –   D -   E 
I am usually objective when I watch a movie or play, and I 
don't often get completely caught up in it. 
A –   B –    C –   D -   E 
I try to look at everybody's side of a disagreement before I 
make a decision. 
A –   B –    C –   D -   E 
When I see someone being taken advantage of, I feel kind 
of protective towards them. 
A –   B –    C –   D -   E 
I sometimes feel helpless when I am in the middle of a very 
emotional situation. 
A –   B –    C –   D -   E 
I sometimes try to understand my friends better by 
imagining how things look from their perspective. 
A –   B –    C –   D -   E 
Becoming extremely involved in a good book or movie is 
somewhat rare for me. 
A –   B –    C –   D -   E 
When I see someone get hurt, I tend to remain calm. 
 
A –   B –    C –   D -   E 
Other people's misfortunes do not usually disturb me a 
great deal. 
A –   B –    C –   D -   E 
If I'm sure I'm right about something, I don't waste much 
time listening to other people's arguments. 
A –   B –    C –   D -   E 
After seeing a play or movie, I have felt as though I were 
one of the characters. 
A –   B –    C –   D -   E 
Being in a tense emotional situation scares me. 
 
A –   B –    C –   D -   E 
When I see someone being treated unfairly, I sometimes 
don't feel very much pity for them. 
A –   B –    C –   D -   E 
I am usually pretty effective in dealing with emergencies. 
 
A –   B –    C –   D -   E 
I am often quite touched by things that I see happen. 
 
A –   B –    C –   D -   E 
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I believe that there are two sides to every question and try 
to look at them both. 
A –   B –    C –   D -   E 
I would describe myself as a pretty soft-hearted person. 
 
A –   B –    C –   D -   E 
When I watch a good movie, I can very easily put myself in 
the place of a leading character. 
A –   B –    C –   D -   E 
I tend to lose control during emergencies. 
 
A –   B –    C –   D -   E 
When I'm upset at someone, I usually try to "put myself in 
his shoes" for a while. 
A –   B –    C –   D -   E 
When I am reading an interesting story or novel, I imagine 
how I would feel if the events in the story were happening 
to me. 
A –   B –    C –   D -   E 
When I see someone who badly needs help in an 
emergency, I go to pieces. 
A –   B –    C –   D -   E 
Before criticizing somebody, I try to imagine how I would 
feel if I were in their place. 
A –   B –    C –   D -   E 
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BODY PERCEPTION QUESTIONNAIRE 
(S.W. Porges) 
 
I: AWARENESS 
 
Image how aware you are of your body processes.  Select the 
answer that most accurately describes you.  Rate your 
awareness on each of the characteristics described below 
using the following 5-point scale: 
 
a) never b) occasionally c) sometimes d) usually e) always 
 
During most situations I am aware of: 
 
1. swallowing frequently a – b – c – d - e 
2. a ringing in my ears a – b – c – d - e 
3. an urge to cough to clear my throat a – b – c – d - e 
4. my body swaying when I am standing  a – b – c – d - e 
5. my mouth being dry a – b – c – d - e 
6. how fast I am breathing a – b – c – d - e 
7. watering or tearing of my eyes a – b – c – d - e 
8. my skin itching a – b – c – d - e 
9. noises associated with my digestion  a – b – c – d - e 
10. eye fatigue or pain  a – b – c – d - e 
11. muscle tension in my back and neck a – b – c – d - e 
12. a swelling of my body or parts of my 
body 
a – b – c – d - e 
13. an urge to urinate a – b – c – d - e 
14. tremor in my hands a – b – c – d - e 
15. an urge to defecate a – b – c – d - e 
16. muscle tension in my arms and legs a – b – c – d - e 
17. a bloated feeling because of water 
retention 
a – b – c – d - e 
18. muscle tension in my face a – b – c – d - e 
19. goose bumps a – b – c – d - e 
20. facial twitches a – b – c – d - e 
21. being exhausted a – b – c – d - e 
22. stomach and gut pains a – b – c – d - e 
23. rolling or fluttering my eyes a – b – c – d - e 
24. stomach distension or bloatedness  a – b – c – d - e 
25. palms sweating a – b – c – d - e 
26. sweat on my forehead  a – b – c – d - e 
27. clumsiness or bumping into people  a – b – c – d - e 
28. tremor in my lips a – b – c – d - e 
29. sweat in my armpits  a – b – c – d - e 
30. sensations of prickling, tingling, or 
numbness in my body 
a – b – c – d - e 
31. the temperature of my face 
(especially my ears) 
a – b – c – d - e 
32. grinding my teeth a – b – c – d - e 
33. general jitteriness a – b – c – d - e 
34. muscle pain  a – b – c – d - e 
35. joint pain a – b – c – d - e 
36. fullness of my bladder a – b – c – d - e 
37. my eye movements a – b – c – d - e 
38. back pain a – b – c – d - e 
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39. my nose itching a – b – c – d - e 
40. the hair on the back of my neck 
"standing up" 
a – b – c – d - e 
41. needing to rest a – b – c – d - e 
42. difficulty in focusing a – b – c – d - e 
43. an urge to swallow a – b – c – d - e 
44. how hard my heart is beating a – b – c – d - e 
45. feeling constipated a – b – c – d - e 
 
 
II: STRESS RESPONSE 
 
Imagine yourself in a very stressful situation or during 
periods of severe stress.  Using the following 5-point 
scale,rate your awareness of perceived changes due to stress 
in each of the global response systems described below  
 
a) never b) occasionally c) sometimes d) usually e) always 
 
During stressful situations I am aware of: 
 
46.  vascular responses such as my face 
becoming flushed or pallid, or feeling 
faint. 
a – b – c – d - e 
47.  body posture shifts such as being 
hunched over, head down, and knees 
locked. 
a – b – c – d - e 
48.  muscle tone or tremor such as arms 
and legs feeling weak, hands shaking, and 
lips quivering. 
a – b – c – d - e 
49.  breathing more rapidly and 
shallowly, and having difficulty in 
catching mybreath. 
a – b – c – d - e 
50.  digestive responses including 
gastric distress, gas, cramps, and 
diarrhea. 
a – b – c – d - e 
51.  difficulty in paying attention with 
my mind wondering or day dreaming.  
a – b – c – d - e 
52.  difficulties in sensory abilities 
such as problems hearing, seeing, 
smelling, or feeling touch. 
a – b – c – d - e 
53. emotional problems such as more 
frequent feelings of depression, 
frustration, rage, or anger. 
a – b – c – d - e 
54. difficulty organizing my thoughts.  a – b – c – d - e 
55. difficulty speaking clearly and 
understandably.  
a – b – c – d - e 
 
 
III: AUTONOMIC NERVOUS SYSTEM REACTIVITY  
 
The autonomic nervous system is the part of your nervous 
system that controls your cardiovascular, respiratory, 
digestive, and temperature regulation systems.  It is also 
involved in the experience and expression of emotions.  
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The autonomic nervous system functions differently among 
people.  This scale has been developed to measure how your 
autonomic nervous system reacts. 
 
Using the following 5-point scale, rate yourself on each of 
the statements below:  
 
a) never b)occasionally c) sometimes d)usually e) always 
 
56. I feel nauseous. a – b – c – d - e 
57. I have difficulty coordinating 
breathing and eating. 
a – b – c – d - e 
58. My nose is runny, even when I am not 
sick. 
a – b – c – d - e 
59. When I am eating, I have difficulty 
talking. 
a – b – c – d - e 
60. My heart often beats irregularly. a – b – c – d - e 
61. When I eat, food feels dry and sticks 
to my mouth and throat. 
a – b – c – d - e 
62. I have "sour" stomach. a – b – c – d - e 
63. I feel like vomiting. a – b – c – d - e 
64. I feel shortness of breath. a – b – c – d - e 
65. I have difficulty coordinating 
breathing with talking. 
a – b – c – d - e 
66. When I eat, I have difficulty 
coordinating swallowing, chewing, and/or 
sucking with breathing. 
a – b – c – d - e 
67. I have a persistent cough that 
interferes with my talking and eating. 
a – b – c – d - e 
68. I drool, especially when I am 
excited. 
a – b – c – d - e 
69. I gag from the saliva in my mouth. a – b – c – d - e 
70. I produce a lot of saliva even when I 
am not eating.  
a – b – c – d - e 
71. I have difficulty adjusting my eyes 
to changes in illumination. 
a – b – c – d - e 
72. I have chest pains.  a – b – c – d - e 
73. I gag when I eat. a – b – c – d - e 
74. When I talk, I often feel I should 
cough or swallow the saliva in my mouth. 
a – b – c – d - e 
75. I am constipated. a – b – c – d - e 
76. I have indigestion. a – b – c – d - e 
77. After eating I have digestive 
problems. 
a – b – c – d - e 
78. I have diarrhea. a – b – c – d - e 
79. When I breath, I feel like I cannot 
get enough oxygen. 
a – b – c – d - e 
80. I have difficulty controlling my 
eyes. 
a – b – c – d - e 
81. I get dizzy when urinating or having 
a bowel movement. 
a – b – c – d - e 
82. I have trouble focusing when I go 
into dimly or brightly illuminated 
places. 
a – b – c – d - e 
 
 
IV: STRESS STYLE 1 
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 Each of us responds differently to stressful events and 
conditions.  The Stress Style 1 Scale evaluates your style 
ofresponding to stress. 
 
Using the following 5-point scale, rate yourself on each of 
the statements below:  
 
a) never b) occasionally c) sometimes d) usually e) always 
 
When I am emotionally stressed because of a specific 
problem: 
 
83.  I approach the problem head-on. a – b – c – d - e 
84.  I withdraw. a – b – c – d - e 
85.  I know that things will be better 
later, so I wait until I feel better 
before acting. 
a – b – c – d - e 
86.  I know that things will go better if 
I act immediately. 
a – b – c – d - e 
87.  I feel mental tension. a – b – c – d - e 
88.  I feel frustrated. a – b – c – d - e 
89.  I feel insecure. a – b – c – d - e 
90.  I feel aimless. a – b – c – d - e 
 
 
V: STRESS STYLE 2 
 
Each of us responds differently to stressful events and 
conditions.  The Stress Style 2 Scale evaluates your style 
of responding to stress. 
 
Using the following 5-point scale, rate yourself on each of 
the statements below:  
 
a) never b) occasionally c) sometimes d) usually e) always 
 
When I am emotionally stressed because of a specific 
problem: 
 
91.  I feel dizzy. a – b – c – d - e 
92.  I have difficulty speaking. a – b – c – d - e 
93.  I feel a tingling in my face. a – b – c – d - e 
94.  I feel my blood sugar drop. a – b – c – d - e 
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Appendix D: Behavioural questionnaires on pain empathy and facial emotion 
recognition: 
PAIN EMPATHY QUESTIONNAIRE 
You will see several pictures depicting persons who suffer from pain.  
 
We ask you to judge: 
 
 1. How much pain are they experiencing? 
 
2. How unpleasant do you feel while looking at this picture? 
 
3. How aroused are you while looking at this picture? Or how intense are 
your bodily reactions in response to the picture? 
Please remember: Use the whole range of all scales. 
 
 
 
The pictures are similar to those presented in the MRI session. 
 
You can start with your rating while the picture is presented or in the 
rating period. 
 
Please try to finish every rating and do not leave out any items. 
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The following scales were presented for each of 15 images shown on 
computer screen: 
 
Picture 1: 
Experienced pain (Mark the line!) 
1_____________________________________________________________9 
no pain at all        severe pain 
 
 
 
 
 
Experienced valence (Mark the line!) 
                    
 
1_____________________________________________________________9 
very unpleasant               very pleasant  
 
 
 
 
 
Experienced arousal (Mark the line!) 
                           
1_____________________________________________________________9 
very calm                very aroused 
 
 
 
 
Last question: How long was this picture presentation experiment?  (seconds) 
  
244
Rating of Emotional Faces Questionnaire 
 
You will see several faces with certain emotional and non-emotional 
expressions. 
Please categorize depicted faces according to one of theses categories: 
 
NEUTRAL  HAPPY FEARFUL ANGRY SAD DISGUSTED 
 
 
 
Answer as quick and as correct as possible on the answer sheet by making 
a cross at the corresponding category. 
For example when you recognize a happy face: 
 
NEUTRAL  HAPPY FEARFUL ANGRY SAD DISGUSTED 
  X     
 
 
 
Please start now! 
 
 NEUTRAL HAPPY FEARFUL ANGRY SAD DISGUSTED 
1       
2       
3       
…       
 
 
30 pictures were presented in total, with a short break after the 10
th
 and 20
th
 
pictures. 
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Appendix E: Tables of activated regions showing BOLD changes 
Regions active during neutral stimuli (80mg nadolol) 
Peak T Statistic Cluster Size MNI Co-ordinates 
11.66 984 [-32 -94 8] 
11.58 1163 [32 -84 14] 
9.69 87 [-22 -36 -4] 
9.01 89 [-48 40 16] 
7.09 116 [50 28 18] 
6.81 67 [22 -34 -4] 
 
Regions active during pleasant stimuli (80mg nadolol) 
Peak T Statistic Cluster Size MNI Co-ordinates 
10.68 1188 [-12 -96 18] 
10.14 1400 [44 -82 8] 
7.53 36 [-48 22 -2] 
6.79 45 [-58 22 12] 
6.49 29 [-24 -38 8] 
 
Regions active during unpleasant stimuli (80mg nadolol) 
Peak T Statistic Cluster Size MNI Co-ordinates 
10.47 1631 [42 -80 10] 
10.18 1205 [-28 -86 20] 
8.65 169 [-22 -36 6] 
7.55 96 [22 -36 -4] 
6.16 36 [-50 32 10] 
 
Regions active during pleasant > neutral stimuli (80mg nadolol) 
Peak T Statistic Cluster Size MNI Co-ordinates 
10.27 115 [48 -70 10] 
 
Regions active during unpleasant > neutral stimuli (80mg nadolol) 
Peak T Statistic Cluster Size MNI Co-ordinates 
10.29 178 [48 -68 10] 
8.17 52 [-52 -68 16] 
8.03 27 [-44 -62 22] 
7.97 33 [-42 -76 12] 
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Regions active during neutral stimuli (placebo) 
Peak T Statistic Cluster Size MNI Co-ordinates 
15.30 1370 [-32 -96 10] 
11.98 1382 [32 -84 18] 
7.64 78 [52 30 14] 
 
Regions active during pleasant stimuli (placebo) 
Peak T Statistic Cluster Size MNI Co-ordinates 
15.20 3407 [-10 -102 14] 
10.32 607 [50 30 20] 
9.11 120 [24 -30 -4] 
7.98 104 [-20 -32 -2] 
7.96 110 [-52 30 20] 
 
Regions active during unpleasant stimuli (placebo) 
Peak T Statistic Cluster Size MNI Co-ordinates 
14.78 3814 [-14 -96 8] 
11.75 311 [48 30 18] 
11.53 104 [-22 -34 -4] 
10.08 115 [26 -36 -4] 
8.21 97 [50 12 24] 
7.40 32 [38 26 -12] 
 
Regions active during pleasant > neutral stimuli (placebo) 
Peak T Statistic Cluster Size MNI Co-ordinates 
9.35 105 [50 -62 4] 
 
Regions active during unpleasant > neutral stimuli (placebo) 
Peak T Statistic Cluster Size MNI Co-ordinates 
8.67 22 [50 -64 6] 
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